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ABSTRACT 
 
The Cronobacter genus is a member of the family Enterobacteriaceae, comprising of seven species C. 
sakazakii, C. malonaticus, C. turicensis, C. dublinensis, C. muytjensii, C. universalis, and C. condimenti. 
Cronobacter is gaining importance as a pathogen due to the severity of the infection caused such as 
septicaemia, necrotizing entercolitis and severe infantile meningitis, and the numerous outbreaks reported. 
Clinical cases are associated with the three species C. malonaticus, C. turicensis and, in particular, with C. 
sakazakii multilocus sequence type 4. The understanding of its pathogenicity is still not fully understood 
despite the clinical evidence, resulting in the concern the FAO-WHO. 
 
Therefore, this study aimed to apply the Multiple Locus Sequence Typing scheme (MLST) to three 
collections of clinical strains which had not been previously profiled by MLST. These were from USA 
(2011), Israel (2000), and the Czech Republic (2007-2012). The strains from the latter two collections had 
only been identified as E. sakazakii, at that point. Among the Israeli strain collection, isolates from infants 
ranging from 2 to 36 weeks old, 7/9 strains were identified as belonging to the ST4 clonal complex. 
Similarly, 10/15 of the C.sakazakii strains isolated from US infant cases were found to belong to the ST4 
clonal complex. Whereas 11 strains of the Czech isolates were from various age groups and were identified 
as C.malonaticus especially ST7, which is also the most clinically predominant ST of that species among 
non-infant infections and 6 strains were found to belong ST4. This research reported the first meningitis case 
by Cronobacter malonaticus (CC112) which was from an infant (age <1 month) with severe brain damage 
which led to their death. 
 
Of particular interest in this research was the finding that C. sakazakii and some strains of C. turicensis were 
unique in the Cronobacter genus in utilization of exogenous sialic acid as a carbon source which may have a 
role in the organism’s virulence. The presence of sialic acid utilization genes could be relatively recent 
evolution, as high levels of sialic acid are accessible to bacteria in intestinal mucosa and the brain.  
 
Another important finding was, the presence of a number of key virulence associated genes assessed by 
laboratory studies in Cronobacter sakazakii strains (in particular with ST4). In this study, 36 clinical isolates 
were analysed that included: two iron acquisition system gene clusters (eitA and iucC), a pla- like homologue 
named Cronobacter plasminogen activator (Cpa) ,and type VI  secretion (T6SS) gene cluster. The majority 
of C. sakazakii strains were serum resistant (32/36), and thus, they had the ability to survive in blood by 
preventing serum-mediated killing. Also, different iron acquisition systems were encoded by C. sakazakii 
97% to attain iron from the host. Some C. sakazakii strains encoding T6SS patterns were from of clinical 
cases such as NECII and severe meningitis strains  
 
Plasmid profiling experiments were carried out on the Cronobacter sakazakii  strains sequenced in a parallel 
study. The high-size plasmid (molecular weight between 138 and 118 kb) was observed as common in 
(27/34) of all strains which known to encode an assortment of virulence factors. Also, plasmid DNA analysis 
publicised that there was no specific plasmid profiling among clinical strains. Furthermore, it shown there is 
no correlation observed between sequence type and present or absent the plasmid.  
 
Furthermore, it was of interest whether the presence of plasmid pESA3 is linked with virulence in C. 
sakakzaii. This research work developed a tool by inserting the plasmid pESA3 into a plasmid-less strain and 
observeing the significance changes in the phenotypic and virulence associated behaviour. Stains encoding 
large plasmid were able to invade human intestinal epithelial cells Caco-2, brain endothelial cells HBMEC 
and rBCEC4. Also have been reported significant observation in siderophore production and serum survival 
values whereas plasmid less strain and not shown less significant associated virulence. 
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1. THE GENUS CRONOBACTER 
 
1.1 TAXONOMY 
Cronobacter (formerly known as Enterobacter sakazakii) are a rare cause of neonatal Gram-
negative infections that can develop into necrotizing enterocolitis, meningitis, and brain abscess 
formation. Following these infections, one third of infants die and 75% of survivors suffer severe 
neurological impairment. These infections are opportunistic since they can be part of the natural 
intestinal flora and not all infants that are colonized become infected. The bacterium has been the 
source of numerous nosocomial outbreaks in neonatal hospital wards and has been found to 
contaminate powdered infant formula (PIF). The diverse genus consists of 7 species: C. sakazakii, 
C. malonaticus, C. muytjensii, C. turicensis, C. dublinensis, C. universalis, and C. condimenti 
(Iversen et al. 2008; Joseph et al. 2011). 
Proper classification of an organism is an important requirement for controlling the organism so 
that it can be differentiated from other closely related organisms that can be also be recovered with 
the target organism. Hence, regulatory control of bacteria is essentially based on comprehensive 
and precise bacterial taxonomy for distinguishing the target bacteria. Initial techniques for the 
detection of Cronobacter are not considered to be sufficiently reliable as they were mostly based 
on a limited number of strains which were poorly characterized or even misidentified (Forsythe et 
al. 2014)  
Our knowledge regarding the taxonomy of the genus Cronobacter was improved by applying NGS 
(Next Generation Sequencing). The genus Cronobacter is a member of the family 
Enterobacteriaceae and the bacterial class gammaproteobacteria. The recently characterized genus 
Kosakonia together with the well-established genera like Pantoea and Citrobacter serve to be the 
most closely related organisms to the Cronobacter. Certain isolates like Enterobacter ludwiggii and 
Enterobacter hormaechei have been identified incorrectly as Cronobacter and this has led to 
confusion in the literature. Just like most of the Cronobacter strains, organisms belonging to the 
genus Pantoea are mainly plant-borne and mostly form yellow pigments. Similarly, Citrobacter 
koseri, an important member of the genus Citrobacter, has been found to cause invasive neonatal 
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meningitis involving brain abscess formation and associated symptoms. These presentations of the 
infection resemble with the symptoms of meningitis caused by Cronobacter species; however, they 
are different from the symptoms of neonatal meningitis caused by the E. coli K1 pathovar 
(Kucerova et al. 2011). 
Enterobacter cloacae-like bacterial strains which produced yellow pigments were identified as 
Enterobacter sakazakii prior to the first FAO-WHO expert meeting (2004). Upon detailed analysis, 
all of the strains previously identified as E. sakazakii were initially regarded as the Cronobacter 
genus. Iversen et al (2007) defined 6 Cronobacter species in part based on the sixteen E. sakazakii 
biotypes i.e. C. sakazakii (biotypes 1–5, 7, 8, 9, 11, 13 and 14), C. dublinensis (biotypes 6, 10 and 
12), C. muytjensii (biotype 15) and C. turicensis (biotypes 16, 16a and 16b). However, this 
differentiation was later updated (Iversen et al. 2008) by adding C. malonaticus (biotypes 5, 9 and 
14), which was previously characterized as a sub-species of C. sakazakii. This was because Iversen 
et al (2007) was unable to differentiate between C. malonaticus and C. sakazakii on the basis of 
16S rDNA sequencing. This differentiation between the above mentioned species proved to be 
challenging mainly because of two facts: 1) Classification of Cronobacter species using biotype 
profiles was not robust since certain biotype index strains were actually misidentified (Baldwin et 
al. 2009; Joseph et al. 2013) 2) Cronobacter genome contains 7 copies of rDNA and for that 
reason, intrageneric variations can cause inconsistent and doubtful base calls resulting in errors in 
GenBank records. 
Joseph et al (2012) on the other hand, employed bacterial strains chosen on the basis of seven loci 
multilocus sequence analysis (MLSA; 3036 bp concatenated length) as representatives for the 
genus Cronobacter and hence came up with a grouping that prevailed over the previous grouping 
made on the basis of phenotyping. Two additional species of Cronobacter i.e. C. condimentii and 
C. universalis were characterized as a result of these research studies (Joseph et al. 2012). These 
and other recent developments made in the taxonomy of the genus Cronobacter are conveniently 
adapted with the help of sequence-based MLST method; however, several techniques like PCR 
probes which have been recently accepted still need to be re-evaluated. In order to re-examine the 
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taxonomic classification of Enterobacter turicensis, E. pulveris and E. helveticus, Brady et al. 
(2013) executed MLSA using only four loci (atpD, infB, rpoB, and gyrB). This resulted in naming 
of these organisms as C. zurichensis, C. pulveris and C. helveticus, respectively. Since small 
number of loci (less than the standard five) was used in this specific re-examination, findings of 
this study were considered to be questionable. Moreover, this particular development resulted in 
issues relating to control of Cronobacter species internationally in powdered infant formula 
because several techniques for the detection of these strains used the above mentioned 
Enterobacter species as negative controls (Masood et al. 2013; Jackson et al. 2014). However, 
Stephan and co-workers later suggested that the latter species should constitute new genera naming 
Siccibacter and Franconibacter (Stephen et al. 2014) This is evident from Figure 1.1 that 7-loci 
MLSA validates this update in the Cronobacter taxonomy as they do not demonstrate clustering 
with the 7 species of Cronobacter. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Maximum likehood tree of MLST loci (concatenated length 3036 base pair) of Cronobacter 
genus and related Enterobacteriaceae (Franconibacter and Siccibacter) genera. The NTU strains IDs are 
showed at the top of each branch, the tree is drawn to scale using MEGA5, with 1000 bootstap replicates. 
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1.2 EPIDEMIOLOGY 
 
Cronobacter spp. has been known to cause various life threatening diseases such as meningitis, 
necrotising enterocolitis (NEC), septicaemia and pneumonia (Caubilla-Barron et al. 2007; 
Muytjens et al. 1983). 
Cronobacter spp. affects infants, specifically pre-term, low birth weight infants, i.e. <2500 g and 
less than 28 days of age (Lai et al. 2001), which suffer from infection symptoms such as abscess, 
bacteraemia or sepsis, conjunctivitis, digestive problems, necrotising enterocolitis, meningitis and 
tonsillitis. Meningitis followed by bacteraemia and necrotising enterocolitis are the most common 
conditions seen (Healy et al. 2009). Cronobacter meningitis or bacteraemia was seen in 1 case 
among 100,000 infants per year according to a survey conducted by the Food borne Diseases 
Active Surveillance Network (FoodNet) in 2002 (Bowen and Braden 2008). There have been many 
factors contributed to NEC for example incomplete immune system, hypothermia, hypoxia and 
consumption of the enteral formula feed as an alternative to breast milk which including 
constructive contents (Grishin et al. 2013). The central nervous system (CNS) infections 
Cronobacter has a tropism near the central nervous system, once it arrives the systemic circulation 
it may cause sepsis and bacteraemia in babies with higher birth-weight  and meningitis specially in 
low birth-weight babies (Yan et al. 2012). According to Jardaat et al. 2014, ventricle phenomenon 
have been happened by abnormal accumulation of CSF which caused cranial pressure on the brain 
cell. 
  
Elderly or immunocompromised adults older than 50 years (Lai 2001) are also affected by 
Cronobacter and had experienced bacteraemia, sepsis, pneumonia and wound infection but not as 
serious as the infants. Some adult Cronobacter infections have also arisen as secondary infections, 
due to other underlying problems such as malignancies. Most adult infections have been associated 
with conjunctivitis, urinary tract infection and environmental source. For example medical tools, 
water and route of transmission person to person (Friedemann. 2009; Flores et al. 2011).  No 
Cronobacter meningitis has been reported in any adults (Friedemann. 2009). 
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1.3 OUTBREAKS 
• The first Cronobacter outbreak was recorded by Muytjens et al. (1983) in which eight 
infants from The Netherlands had neonatal meningitis; five were from the same hospital 
and the remaining three from three different hospitals. Six infants died, mostly due to 
contamination of infant formula. Moreover, the organism was also found in the powdered 
formula tin, dishwashing brush and spoon. 
• In 1994, in the NICU of a French hospital, a Cronobacter spp. outbreak took place and was 
reported by Caubilla-Barron et al. (2007). They performed a thorough phenotypic and 
genotypic examination of the 31 Cronobacter spp. strains taken from 16 infected infants, 
(of which 3 infants died) and prepared and unprepared infant formula tins. 
• The first outbreak which proved a strong link between Cronobacter and NEC cases 
occurred in Belgium, where twelve infants had Cronobacter NEC recorded by Van Acker 
et al. (2001). All the 12 infants were pre-term, low birth weight, formula-fed infants. Two 
infants eventually died. Three diverse profiles among the patient isolates contained the 
strains from which were examined by randomly primed polymerase chain reaction (AP-
PCR) to reveal three different profiles among the patient isolate. 
• Five infants in a hospital in Jerusalem had bacteraemia and meningitis and colonizations 
recorded by Block et al. (2002). These bacterial strains were negative for nitrite reduction. 
A blender in the hospital, in which the formula was processed, also contained Cronobacter 
strain of the same pulse type as the ones from the infants when tested by pulsed field gel 
electrophoresis (PFGE). Despite constant decontaminations, the organism was constantly 
present for up to 5 months, proving the creation of an environmental niche by Cronobacter 
spp. in the blender. 
• Himelright et al. (2002) recorded the outbreak of Cronobacter spp. in a hospital in 
Tennessee. Forty nine hospitalized infants were tested after a meningitic infant’s death, 
eight infants were found to be positive. Two infants had respiratory illnesses while six 
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were asymptomatic. Eventually, there was a recall of the product by the manufacturer. The 
formula was a commercial formula product not proposed for use by neonates, unless 
advised by the neonatologists. 
• In December 2011, in four different US states (Florida, Illinois, Missouri and Oklahoma), 
the Centres for Disease Control and Prevention (CDC) reported cases of Cronobacter spp. 
infections, in which three of the infants were meningitic, two of which died (in Missouri 
and Florida). As a result, the supermarket giant Walmart removed infant formula from their 
shelves. A PFGE analysis of the strains from Illinois and Missouri was undertaken by 
CDC. In Missouri, an opened PIF tin, prepared PIF and opened nursery water bottle, used 
to prepare the PIF, all contained the organism; whereas in Illinois, an opened nursery water 
bottle contained the organism (CDC 2011). 
 
1.4 SOURCES OF CRONOBACTER SPECIES 
Sources of Cronobacter spp. are widespread, ranging from various types of herbs, spices, cereals, 
ready-to-eat products such as salads and confectionery, cheese products, meat and vegetables 
(Iversen et al. 2004; Friedemann 2007; Baumgartner et al. 2009), from which many associate with 
the proposed natural plant habitat for Cronobacter spp., and the raw materials cause the 
contamination of the organism. Among the environmental sources, freshwater contained the 
species type strain of C. universalis (previously Cronobacter. genomospecies 1) NCTC 9529 
(Iversen et al. 2007). 
Among animals sources, Cronobacter strain has been isolated from the nostril of a stable horse 
(Holy et al. 2011), wild house flies (Muscadomestica), filth flies, larvae of the stable fly (Stomoxys 
calcitrans) and the guts of Mexican fruit fly (Anastrephaludens) (Kuzina et al. 2001; Mramba et al. 
2006; Butler et al. 2010; Pava-Ripoll et al. 2012), which leads to another option that flies act as a 
vector for Cronobacter spp. 
Blood, cerebrospinal fluid (CSF), sputum, bone marrow, urine, faeces, wound infections have also 
been shown to contain Cronobacter spp (Farmer et al. 1980; Muytjens et al. 1983; Gallagher and 
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Ball 1991; Iversen et al. 2006; Caubilla-Barron et al. 2007). Moreover, a strain of the species C. 
malonaticus, LMG 23826T, was isolated from a breast abscess, and C. sakazakii from neonatal 
enteral feeding tubes in intensive care units (Hurrell et al. 2009b). 
The most consumed source of this organism is baby food, specifically follow up formula (FUF) 
and PIF, i.e. powdered infant formula (Chap et al. 2009), which is often used in place of breast 
milk for infants. 
According to Forsythe et al. (2014), the Cronobacter MLST database contains records of >1000 
isolates indicating the source, geographic and temporal diversity of the genus. C. sakazakii NCIMB 
8282, the oldest isolate was isolated in 1950 from dried milk powder. Now, its genome has been 
sequenced and is included in the >100 genomes available in the PubMLST database (Masood et al. 
2013). Different strains of Cronobacter have been isolated from 36 different countries and from 
various sources including environment (35.15%), infant formula (21.6%), clinical specimens 
(20.4%), food and related items (14.2%), water and other sources (4%) (Table 1.1). In the past, 
researchers had reported isolation of Cronobacter species from different food items and plants 
(herbs, rice, spices and wheat) Iversen et al (2004).  
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Table 1.1 Summary of Cronobacter isolates in the Cronobacter PubMLST database by Forsythe et al. 
(2014). 
 
1.5 PHENOTYPIC IDENTIFICATION METHODS AND CULTURE 
The development of efficient techniques to detect Cronobacter species has become extremely 
important considering the diversity of sources and their presence in clinical specimens. Standard 
methods for isolating Cronobacter from PIF have been approved by the U.S. Food and Drug 
Administration (FDA). In these methods, the organism is isolated on the basis of enrichment and 
biochemical characterization. Previously, these bacteria were isolated using methods that were 
similar to the methods of isolating Salmonella species from samples of powdered milk (FDA, 
2002). These protocols involved a pre-enrichment step carried out using buffered peptone water 
(BPW) or distilled water. Next step was enrichment  overnight at 36°C in the Enterobacteriaceae 
enrichment (EE) broth. This was followed by streaking the sample on Violet Red Bile Glucose 
(VRBG) agar plates which were incubated at 36°C. After overnight incubation, the plates were 
then examined for colonies of Enterobacteriaceae. In particular, the bacteria form purple colonies 
on this medium. These colonies are surrounded by purple halo formed due to the precipitation of 
bile acids. During the next step, TSA plates are inoculated with five presumptively positive 
colonies and incubated at 25oC to check for the growth of yellow colonies. Finally the 
identification of bacteria is verified with the help of API20E strips and determination of Most 
Probable Number (MPN) is made for the bacteria. 
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The above protocol had several drawbacks. Since all members of Enterobcacteriaceae are enriched 
when cultured in the EE broth, it is possible that the growth of Cronobacter species was suppressed 
by other bacteria. Hence, the method is not efficiently selective for Cronobacter species right from 
the start. Besides this, the method may lead to false negative identifications as only 80% 
Cronobacter species form yellow colonies. The method was quite time consuming and strenuous as 
well since it needed almost five days for execution. The latest method approved by FDA which was 
published in 2012 addresses all these limitations, however,  is only useable for the US. In this 
method, the pre-enrichment is carried out for one day using sterile BPW followed by 
centrifugation. The pellets thus formed are transferred to phosphate buffered saline (PBS). Aliquots 
of this suspension are cultured followed by screening to detect Cronobacter species. Screening 
made use of chromogenic media like R&F agar and Druggan-Forsythe-Iversen (DFI) agar, real-
time PCR assays and biochemical tests (Rapid ID32E or VITEK 2.0). The whole procedure can be 
executed in only two days including confirmation of the identification of the organism. (Chen et al. 
2010; Chen et al. 2011a). 
International Organization for Standardization (ISO) method is valid in the rest of the world for the 
detection of Cronobacter spp. in PIF isolates. In this method, the pre-enrichment step with BPW is 
followed by the inoculation of 100 μl of the culture to 10 ml of a selective enrichment medium 
called the modified lauryl sulphate (mLST) broth and incubation at 44 oC for 24 hours. Followed 
by streaking on the chromogenic Enterobacter sakazakii isolation agar (ESIA) for growth at 44 oC, 
and subsequent sub-culture on TSA plates for yellow pigmentation at 25 oC. The yellow pigmented 
colonies are then selected for biochemical test (Anonymous 2006). 
 
1.6 PHYSIOLOGY 
A number of unique physiological characteristics are demonstrated by Cronobacter species relating 
to their growth on powdered infant formula (PIF). Formation of huge quantities of capsular 
polysaccharides is one of these characteristics. Capsule production may enable the organism to 
resist desiccation. It has been demonstrated by Caubilla-Barron and Forsythe (2007) during their 
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study which made use of 27 strains of Enterobacteriaceae that capsule forming Cronobacter 
species can be isolated from dehydrated PIF even after two and a half years. Besides resistance to 
desiccation, capsule formation is also involved in formation of biofilms which have been detected 
in enteral feeding tubes of neonates in NICUs (Hurrel et al. 2009a). The ability of these bacteria to 
resist dryness is also an important characteristic. It has been found that they are more tolerant to 
osmotic stress as compared to other bacterial strains found in PIF like Citrobacter species, 
Salmonella species and E. coli (Breeuwer et al. 2003). Researchers have proposed different 
mechanisms for this tolerance to osmotic stress. For instance, Riedel and Lehner (2007) have 
identified 53 protein groups that take part in the response of Cronobacter species to the osmotic 
stress. Trehalose synthesis has also been reported to be involved in resistance to osmotic stress as 
trehalose is capable of functioning as molecular chaperon offering protection to cellular 
membranes and proteins from denaturation. This role of trehalose was seen in E. coli strains 
(Breeuwer et al. 2003; Horlacher and Boos. 1997). 
Another important characteristic of Cronobacter species that has been extensively researched is 
their thermotolerance. Variations in the ability of different Cronobacter species to resist heat have 
been reported. Nevertheless, pasteurization temperatures (72oC) inactivate all of these bacteria 
(Nazarowec-White and Farber 1997; Iversen et al. 2004b; Breeuwer et al. 2003; Nazarowec-White 
et al. 1999). The guidelines for preparation of PIF in order to minimize the risk of growth of these 
bacteria in PIF were reviewed on the basis of the above mentioned finding (FAO-WHO, 2004; 
2006). According to Adekunte et al. (2010), numbers of C. sakazakii in reconstituted PIF was 
significantly reduced through a combination of ultrasound parameters and temperature. However, 
this combination requires optimization and validation by additional studies. Iversen et al. (2004) 
has reported that Cronobacter is capable of surviving at a broad temperature range of 6-47oC in 
reconstituted PIF. Laboratory studies showed that Cronobacter species are conveniently grown in 
various media like MacConkey agar and Trypticase Soy Agar (TSA) at 37oC in 16-18 hours. 
Furthermore, 80% strains of Cronobacter form yellow pigment when cultured at 25oC on TSA. It 
has been observed that the number of pigmented strains decreased when cultured at 37oC indicating 
that the pigment production is dependent on temperature (Iversen and Forsythe. 2007). 
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Iversen and Forsythe (2003) hypothesized that plants are the natural habitats of Cronobacter as 
they demonstrate characteristics like resistance to desiccation, pigment formation and formation of 
polysaccharides. Formation of pigments is a characteristic that allows protection against oxygen 
radicals formed by radiations of sun. Moreover, this characteristic can also be associated with 
existence of these bacteria in starches that serve to be the main constituent of different products 
like PIF. On the other hand, capsule production helps the organism to attach to any surface. Lastly, 
the bacterium’s ability to resist desiccation allows it to survive in extreme environmental 
conditions. 
Resistance of Cronobacter strains to acidic conditions has also been reported. Kim and Beuchat 
(2005) have reported that Cronobacter species can survive for up to two days at 25oC in several 
vegetables and fruits which are acidic in nature. According to Edelson-Mammel et al. (2006), 
certain strains of Cronobacter demonstrate moderate resistance to pH values up to 3.0; however, 
pre-exposure to non-lethal pH values can cause improvement in this resistance. 
In context of food preservation, acids can act as antimicrobial agents as they can inactivate bacteria 
like Cronobacter species, especially in baby food items like PIF. Both survival and growth of 
Cronobacter species in fluids like baby food and fruit juices have been demonstrated to be 
inhibited by organic acids, acetic acid and propionic acid (Back et al. 2009). According to Al-Holy 
et al. (2010), Cronobacter species are also shown to be inactivated by sub-lethal concentrations of 
copper used in combination with lactic acid. Similarly, Kim et al. (2010) proposed that the 
antimicrobial action of red muscadine (Vitis rotundifolia) juices against C. sakazakii is due to the 
combined action of acids (tannic acid, tartaric acid and malic acid) present in them. 
 
1.7 IDENTIFICATION METHODS AND MOLECULAR TYPING  
Significant developments have been made in last few years regarding Cronobacter. Identification 
and characterization of different strains of Cronobacter have been improved with the development 
of innovative molecular typing techniques. Just like the methods for identification of 
Enterobacteriaceae, most of the molecular techniques for the identification of Cronobacter 
initially made use of the 16S rDNA region. Researchers have devised several different probes 
12 
 
CHAPTER 1 GENERAL INTRODUCTION (OVERVIEW OF CRONOBACTER GENUS)  
 
which analyse various genome sequences for identification of isolates or for detection of organisms 
(Keyser et al. 2003; Lehner et al. 2004; Iversen et al. 2007). The TaqMan real-time PCR assay is 
one of these methods (Malorny and Wagner. 2005). The 16S rDNA and hsp60 sequences were 
used for the analysis of diversity and phylogenetic relationships of Cronobacter species (though it 
was regarded as E. sakazakii at that time). As per the findings of the analysis, the strains were 
grouped into four different phylogenetic clusters. Moreover, these findings strongly indicated that 
these strains constitute a separate genus (Iversen et al. 2004). In another study involving utilization 
of Artifical Neural Networks (ANN), sequences specific to E. sakazakii were identified in the 
partial 16S rDNA sequence. In particular, it is a 528bp long sequence that can be utilized for 
identification of Cronobacter (Iversen et al. 2006). In contrast to this, entire length of 16S rDNA 
sequences (over 1300bp) is targeted for phylogenetic analysis. Researchers have been using 
variations in 16S rDNA sequences in order to specify genus (5%) and species (3%) boundaries in 
case of prokaryotes. Still, the 16S rDNA sequence analysis has some limitations when subjected to 
closely related bacteria as variations in the sequences are minimal. Additionally, multiple copies of 
16S rDNA operon are found in most of the organisms and variation in their sequences may lead to 
erroneous results (Acinas et al. 2004). Same is the case with Cronobacter species, especially when 
distinguishing between C. malonaticus and C. sakazakii. 16S rDNA of these two strains 
demonstrate 99.7% resemblance, although as per the findings of DDH (DNA-DNA hybridization) 
studies, they are over 70% related. When E. sakazakii species were being reclassified as the genus 
Cronobacter, C. malonaticus was first classified as a subspecies of C. sakazakii (Iversen et al. 
2007). Later, its classification as a separate species was made (Iversen et al. 2008). 
Researchers have used TaqMan Real-time PCR probes and oligonucleotide arrays to study internal 
transcribed spacer (ITS) regions in order to detect Cronobacter in PIF (Liu et al. 2006a & 2006b). 
ITS is the region present between 16S and 23S rDNA genes of bacterial cells. Seo and Brackett 
(2005) have developed a specific real-time PCR assay for detecting the bacterium in PIF by using 
the partial macromolecular synthesis operon, particularly the genes encoding rpsU and primase 
(dnaG). It is worth mentioning that in these techniques, the probes were developed on the basis of 
small number of E. sakazakii strains. For that reason, these probes still need to be validated, 
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especially considering the updated taxonomy of Cronobacter. 
Different molecular techniques were used during the research that caused classification of E. 
sakazakii as a separate genus Cronobacter. These techniques allowed detection of variations within 
this strain. Besides the standard biochemical tests which are performed for validation of the 
phenotypic features of the species, some other schemes like full length 16S rDNA sequencing, f-
AFLP employing EcoRI and TaqI, DDH and ribotyping were carried out to characterize the 
Cronobacter genus (Iversen et al. 2007 & 2008). 
The methodology of PFGE is based on a PulseNet approved protocol developed for Salmonella 
species (Swaminathan et al. 2001) that makes use of the most extensively employed restriction 
endonuclease i.e. XbaI. This technique served to be the most reliable method for surveillance of the 
organism, source tracking and outbreak analysis (Caubilla-Barron et al. 2007; Nazarowec-White & 
Farber. 1997; Craven et al. 2010; CDC. 2011). It has been demonstrated through several studies 
that PFGE is efficient enough to differentiate Cronobacter species. Still, there are some drawbacks 
of this method which limit its utilization. Moreover, it is laborious and time consuming too. PFGE 
has recently been modified specifically for Cronobacter strains. During a study conducted by 
Caubilla-Barron et al. (2007), thirty Cronobacter strains were subjected to PFGE analysis. All 
these strains were isolated from a fatal NICU outbreak that occurred in France. The analysis 
indicated that strains isolated from single infant demonstrated multiple pulsetypes. It was therefore 
recommended that multiple colonies should be analysed from single sample. PFGE has also been 
carried out in several research studies for characterizing Cronobacter species isolated from 
powdered milk and processing plants for infant formula so that distribution of these isolates can be 
traced in the manufacturing area or in the entire factory (Craven et al. 2010; Jacobs et al. 2011). 
Phenotypic and genotypic techniques have been used for a number of Cronobacter species (E. 
sakazaki) by Nazarowec-White and Farber (1999) in order to determine their efficiency in 
characterizing. This method included PFGE, random amplification of polymorphic DNA (RAPD) 
and ribotyping. As per the findings, PFGE and RAPD proved to be efficient for differentiating 
between the strains. 
Mullane et al. (2008a) put forward a multi-locus variable-number tandem-repeat analysis (MLVA) 
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scheme for Cronobacter which was evaluated using 112 strains of the organism. This technique 
used genome sequence of C. sakazakii BAA-894. At the same time when this study was being 
carried out, it was proposed that E. sakazakii should be classified as a separate genus Cronobacter 
(Iversen et al. 2007). Moreover, findings of the mentioned study indicated significant diversity 
which was in accordance with the reclassification. Nevertheless, the technique was not re-analysed 
after this taxonomic revision. 
Gram-negative bacteria possess O-antigen, which is found in their cell walls. Production of O-
antigen is considered to be an important characteristic as different serotypes have been identified 
on the basis of variation in O-antigen. In case of Enterobacteriaceae, genes encoding for O-antigen 
are found at the rfb locus that codes for dTDP-D-glucose 4,6 dehydratase between the gnd and 
galF genes coding for gluconate-6-phosphate dehydrogenase and UDP-glucose pyrophosphorylase 
respectively. Because of variation in these genes, several molecular typing techniques make use of 
these genes. For instance, the PCR base O-serotyping methods have been specifically devised for 
the Cronobacter species (Mullane et al. 2008b; Jarvis et al. 2011; Sun et al. 2011). Using the PCR 
probes that targeted wehI and wehC genes, the O2 and O1 serotypes were identified for the 
Cronobacter species (then E. sakazakii) (Mullane et al. 2008b). Later, these were named as 
serotypes of C. sakazakii (Jarvis et al. 2011). The research was extended to cover different strains 
of the genus Cronobacter resulting in identification of 10 additional sertoypes including four 
serotypes O3, O4, O5, O6 and O7 for C. sakazakii, two serotypes O1 and O2 for C. malonaticus, 
two serotypes O1 and O2 for C. turicensis and one serotype O1 for C. muytjensii.  
 
Several PCR probes are available for Cronobacter which have been developed on the basis 
separate housekeeping genes like rpoB and gyrB (Dauga & Breeuwer. 2008; Stoop et al. 2009). 
The method using the rpoB gene has been revised recently considering the taxonomic updates so 
that all seven species of Cronobacter can be covered. This method offers the ease of employing 
only one target gene for identifying the species as different sets of primers with different 
amplification conditions are used for each species (Lehner et al. 2012). Another probe which has 
been designed for detection of Cronobacter in infant formula targets the ompA gene. This gene 
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encodes for an outer membrane protein which is found associated with virulence of the bacterium 
(Nair and Venkitanarayanan, 2006). PFGE and BOX-PCR technique have been analysed in another 
study for detecting Cronobacter by using 27 Cronobacter spp. strains. BOX-PCR is basically a 
PCR-RFLP sequencing technique targeting the flagellin gene fliC. The results indicated that fliC 
gene is not a suitable target gene for detecting the variation among strains. Still, the efficiency of 
both the techniques proved to be quite comparable for differentiating between the isolates (Proudy 
et al. 2008). A multiplexed PCR assay has recently been developed which targets the di-guanylate 
cyclise gene, cdgc1. This technique is capable of differentiating 6 out of 7 species of Cronobacter. 
(Carter et al. 2012) 
In case of Enterobacteriaceae, examinations carried on the basis of multiple housekeeping genes 
like those using multilocus sequence analysis (MLSA) were found to generate good results (Lacher 
et al. 2007; Ibarz Pavón and Maiden. 2009). During a research, MLSA targeting the thdF, rpoA and 
recN genes was performed for Cronobacter and Enterobacteriaceae related to Cronobacter. This 
method also employed multiple primers with different amplification conditions for every target 
gene. Findings of the analysis could be used to describe the phylogenetic linkages between 
different species (Kuhnert et al. 2009). 
Pagotto and Farber used the multi-locus sequence typing (MLST) technique for Cronobacter for 
the first time. Ten genes namely rpoB, rplB, recA, recG, pyrG, lepA, ileS, gyrB and fusA were used 
(Fanning & Forsythe. 2008). Yet, the research publication lacks information about primers, target 
sequences and results and has never been published in a jurnal article. 
In order to identify and characterize C. malonaticus and C. sakazakii, a seven-loci MLST method 
was devised (Baldwin et al. 2009). It involved partial sequence analysis of seven housekeeping 
genes namely atpD, fusA, gltB, glnS, infB, gyrB and ppsA. These seven genes are constituted from 
3036 nucleotides when taken together. The method proved to be efficient enough to distinguish 
between the above mentioned two species phylogenetically though they were not differentiable by 
other techniques like 16S rDNA sequencing. According to the researchers, the two species were 
not reliably differentiable before because of the misleading speciation of certain biotype index 
strains. It can therefore be stated that there can be errors in the characterization of species through 
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phenotyping. The MLST scheme for Cronobacter can be accessed freely at 
http://www.pubmlst.org/cronobacter. 
It is worth mentioning that certain techniques of detection and typing discussed above were 
designed during the period when the issue of microbiological safety of PIF was just raised. 
Moreover, certain techniques made use of poorly characterized strains of bacteria, particularly the 
E. sakazakii strains which were unable to embody all the variations correctly. Moreover, all 
techniques cannot be used now for the detecting Cronobacter species considering the validation 
required after the taxonomic updates. It is important that the end-detection technique is efficient 
enough to encompass all known species of Cronobacter. This is because each 10g of PIF should be 
totally free of Cronobacter species as per the latest international regulations. 
 
1.8 GENOME STUDIES 
Recent years have witnessed many developments made in the field of genomics of Cronobacter. It 
was C. sakazakii strain BAA-894 whose genome was sequenced first at the Genome Centre, 
Washington University, USA. During this project, the whole genome shotgun method was used 
together with end sequencing of fosmid library. The strain BAA-894 has been isolated from a tin of 
formula that caused a Cronobacter NICU outbreak in Tennessee, USA (Section 1.3 in details). As 
per the results, a 4.4Mb chromosome together with a pair of plasmids (pESA2 31 kb in size and 
pESA3 131 kb in size) constituted the genome of the organism (Accession No. NC_009778 – 80). 
Kucerova et al. (2010) published the sequence of the entire BAA-894 genome in a whole-genome 
microarray research for investigating the diversity of the genus Cronobacter. This sequence was 
utilized while constructing a 384,030 probe oligonucleotide tiling DNA microarray. Ten strains 
from 5 species of the genus (C. dublinensis, C. muytjensii, C. turicensis, C. malonaticus, C. 
sakazakii) were included in this probe. As per the findings of the microarray research, the genome 
comprised of mobile elements together with the 55% core genome for C. sakazakii and 43% core 
genome for the genus Cronobacter. Moreover, it was reported that the mobile elements which 
included the prophage regions gave rise to the diversity seen among the members of the genus. 
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During  follow-up research, it was found that several virulence factors are also present in the 
genome like fimbrial clusters, type six secretion system and iron acquisition systems (Kucerova et 
al. 2011). 
The Institute for Food Safety and Hygiene, Zurich, Switzerland, carried out sequencing of genome 
of C. turicensis strain z3032 soon after the first research study. This strain was isolated back in 
2005 from a patient in Zurich’s Children’s Hospital. According to the results reported, the size of 
the chromosome of this strain was 4.38 Mb. Besides chromosome, the genome comprise of three 
plasmids of sizes 22kb, 53kb and 138kb (Accession No. NC_013282 – 85) (Stephan et al. 2011). 
Bigger plasmids mentioned above (pESA3 131kb and pCTU1 138kb) were compared during a 
study and it was found that the two plasmids shared a great proportion of content. Moreover, these 
were regarded as virulence plasmids as they contained genes for filamentous haemagglutinin, 
plasminogen activator, iron acquisition system and type six secretion systems (Franco et al. 2011). 
Joseph et al. (2012) have conducted an extensive comparative genomic study for analysis of 14 
genomes from 7 species of Cronobacter. During the study, the researchers determined a larger pan-
genome consisting of more than 6000 genes and a shorter core genome containing 2000 genes. The 
presence of genes coding for virulence factors demonstrate significant level of variation among 
genomes. These virulence factor genes include genes for adhesins, heavy metal resistance such as 
resistance against silver, copper, tellurite and genes for T6SS other system as well. It was found 
that genome of C. sakazakii is unique in the sense that it contained genes required for the 
utilization of exogenous sialic acid. Other members of this genus analysed at this time did not have 
sialic acid utilization genes.  
 
1.9 PATHOGENICITY AND VIRULENCE FACTORS 
 Despite Cronobacter spp. infections are not very frequent, it is still emphasized due to severity of 
infections the organism causes, as well as the sensitive age group of the neonates that are affected 
by them; therefore research is being done to determine the pathogenesis of Cronobacter. 
The bacteria have the capability to attack the epithelial cells and also survive within macrophages 
as shown in the laboratory studies (Townsend et al. 2007). The occurrence of invasive meningitis 
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proves that the organism can translocate across the human blood brain barrier. Moreover, the 
responsibility of dendritic cells in causing tissue damage during necrotising enterocolitis has been 
evident in recent in vitro studies (Emami et al. 2011). 
Ever since the C. sakazakii BAA-894 and C. turicensis z3032 genomes were available, 
examination of the virulence of the organism has been done at a genomic level (Kucerova et al. 
2010; Stephan et al. 2011). T6SS, iron acquisition, blood-brain barrier (BBB) penetration, 
enterobactin and aerobactin synthesis are acknowledged as the supposed virulence factors related 
to biofilm formation according to researchers  (Kucerova et al. 2011; Hartmann et al. 2010; Franco 
et al. 2011). 
It is not proven that all Cronobacter species are infective in infants. Until now C. sakazakii has 
been the most prevalent among clinical infant cases. 
As mentioned before, genomic studies assist in determining the mode of virulence of this organism 
and also in establishing what differentiates the virulent Cronobacter strains from the non-virulent 
ones. Similarly, the various putative virulence factors have also been mentioned before. 
The virulence of Cronobacter spp was seen to be associated with the presence of an outer 
membrane protein A (OmpA) according to various studies, because according to Singamsetty et al. 
(2008) OmpA expression is responsible for Cronobacter invasion of HBMEC cells. The role of the 
OmpA protein in causing meningitis by multiplication in blood and traversal of the BBB was 
proved by Mittal et al. (2009) using ompA-mutants of Cronobacter spp. Moreover, OmpA was also 
attributed for starting the invasion of brain microvascular endothelial cells of the BBB as it is the 
major fibronectin-binding protein in Cronobacter spp. (Nair et al. 2009). 
Zinc-containing metalloprotease (zpx) factor was found to contribute to Cronobacter spp virulence 
by Kothary et al. (2007). It caused the necrosis and cellular destruction during the NEC in infants. 
Cronobacter plasminogen activator (Cpa), which was a plasmid borne outer membrane protease, 
was present along with C. sakazakii in causing the organism’s serum resistance. Cpa had a great 
similarity with the Pla subfamily of omptins, as it was recognized as a virulence factor in various 
Enterobacteriaceae members (Franco et al. 2011). The function of the sodA gene in macrophage 
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survival of the organism by resistance to oxidative stress conditions was shown with the help of 
microarray analysis by Townsend et al (2007). 
It has been established that human intestinal cells are invaded by the Cronobacter which multiply 
in macrophages and finally the blood brain barrier is invaded (Townsed et al. 2007 ; 2008). 
Moreover, the infection is possibly established when the bacteria get attached to and invade the 
intestinal cells. Several possible virulence factors have been identified through whole genome 
sequencing; however, some of them need to be validated through research studies (Kucerova et al. 
2011; Joseph et al. 2012). Furthermore, BLAST analysis as well as comparative genomic analysis 
through the PubMLST database can be performed using the current 107 strains of Cronobacter 
including fifty C. sakazakii ST4. 
Genomes of Cronobacter species are reported to contain ten fimbriae clusters (Joseph et al. 2012) 
With a couple of exceptions; several fimbriae clusters are shared by all species. It is only the C. 
sakazakii which encodes for β-fimbriae while curli fimbriae are found in other species. Moreover, 
members of the genus Cronobacter demonstrate iron assimilation through several mechanisms 
(Grim et al. 2012). Because of these mechanisms, these bacteria can utilize iron from infant 
formula and breast milk. Researchers have detected five Type VI secretion system (T6SS) clusters 
in the genomes of Cronobacter which might have a role in attachment, invasion in host cell, 
multiplication within macrophages, persistence inside host and cytotoxicity. Penetration of these 
bacteria in the blood brain barrier has been reported to involve proteins found in the outer 
membrane i.e. OmpA and OmpX (Kim et al. 2010). However, the mechanism (s) through which 
brain cells are destroyed still needs to be determined. Several haemolysins are also encoded by 
Cronobacter (Joseph et al. 2012). Besides these, plasmid-associated characteristics like expressing 
the outer membrane protease referred to Cronobacter plasminogen activator are also demonstrated 
by Cronobacter. Proteins belonging to this subfamily can cause degradation of several serum 
proteins like the circulating complement. In this way, protection against complement-dependent 
serum killing is ensured (Franco et al. 2011). A well-maintained open access database containing 
107 genomes for the genus Cronobacter can prove to be helpful in evaluation of known virulence 
factors as well as identification of more. Utilization of BLAST facility, for instance, indicates that 
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C. sakazakii strains (n=72 genomes) contains cpa gene whereas C. malonaticus lacks it. Variation 
in susceptibility of host can partly be justified with this difference in genome. 
Genomic analysis of the Cronobacter genomes has revealed the existence of several different genes 
responsible for resistance to heavy metals such as tellurite, zine, silver and copper and genes for 
capsule formation which can be helpful in protection against disinfectants. Consumption of 
exogenous sialic acid by C. sakazakii can be clinically important. It has been shown by 
comparative genomic projects that nanATKR gene cluster is present in C. sakazakii and this enables 
the bacterium to utilize sialic acid (Joseph et al. 2012; 2013). As sialic acid is present in 
gangliosides, mucin and breast milk, consumption of sialic acid by this bacterium as a source of 
carbon can be viewed as an important evolutionary adaptation to the host environment. However, 
powdered infant formula also contains sialic acid as it is required for development of the brain. 
Researchers have conducted studies to validate consumption of sialic acid by C. sakazakii and 
these studies have demonstrated that the same organism can also grow on ganglioside GM1 using it 
as a source of carbon (Joseph et al. 2013). Conversely, C. sakazakii cannot consume malonic acid, 
though other species of Cronobacter are able to use it. It has been revealed by genomic analysis 
that genes for malonate decarboxylase are present adjacent to the auxin efflux carrier which can be 
involved in the uptake of malonate. Since malonic acid is present in plant tissues, ability of 
Cronobacter to consume malonic acid indicates their association with plants. Hence, loss of the 
ability to use malonate and development of the ability to consume sialic acid can be seen as an 
adaptation of C. sakazakii for the new environment and this can be clinically important. 
Food and Agricultural Organisation-World Health Organisation (2004 and 2006) was considering 
the debilitating consequences of Cronobacter infection in neonates and its association with the 
consumption of contaminated powdered infant formula, it is highly recommended that an 
internationally accepted technique for the recognition and molecular typing of Cronobacter should 
be developed. MLST profiles of strains isolated from outbreaks occurred all across the world have 
been included in the Cronobacter PubMLST database. All known Cronobacter species are covered 
by the MLST technique so that the interspecific as well as intraspecific diversity of Cronobacter 
can be measured efficient and the strains can be characterized as per the source and virulence 
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factors. The database also allows retrospective analysis of historic outbreaks and cases once the 
strains have been re-identified. Taxonomic re-examinations can cause loss of these strains. 
The seven-loci MLST scheme was later devised to address different limitations of 16S rDNA 
sequence analysis and phenotyping. In particular, subjective results were generated by phenotypic 
tests and 16S rRNA gene sequence analysis could not differentiate between all species of 
Cronobacter. This newly developed scheme involves partial sequence analysis of 7 housekeeping 
genes namely phosphoenolpyruvate synthase A (ppsA), translation initiation factor IF-2 (infB), 
glutaminyl tRNA synthetase (glnS), elongation factor G (fusA), ATP synthase b chain (atpD), 
gyrase subunit B (gyrB) and glutamate synthase large subunit (gltB). These sequences constitute 
3036 nucleotides in total when contatenated together and for that reason their analysis is known as 
multilocus sequence analysis (MLSA). Figure 1.1 shows a phylogenetic tree for the genus 
Cronobacter and closely related Siccibacter and Franconibacter genera obtained through MLSA. 
 
1.10 FUTURE DIRECTIONS AND PUBLIC HEALTH SIGNIFICANCE 
 
Execution of appropriate strategies for controlling the growth of Cronobacter essentially requires 
identification of different risks to public health caused by this organism, although it does not 
frequently cause infections. In particular, maintenance of the microbiological safety of baby food 
items like PIF should be given immense attention considering the fact that Cronobacter infection is 
mostly seen among infants and the main source of infection is mostly PIF. This attention must be 
given not only in the factories manufacturing these products but also during handing of these 
products especially preparing infant feeds. Although, PIF is not manufactured as sterile item; 
microbial count should be kept at minimum to reduce the contamination. 
Considering these and other risks associated with consumption of infant formula, WHO has 
recommended that infants younger than six months should be fed on breast-milk. However, when 
infant formula is needed for some reason, some measures must be taken both during the 
manufacturing process as well as during the reconstitution process. In particular, all possible efforts 
must be made at the manufacturing unit to ensure maintenance of aseptic conditions and to prevent 
exposure of these products to temperatures which permit growth of the bacteria. Moreover, medical 
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personnel, caregivers and mothers must be given appropriate training to deliver information 
regarding possible risks associated with reconstitution of the infant formula and how these risks 
can be minimized. It has been suggested that a temperature of 70oC is suitable for reconstitution of 
milk as bacteria (if present) are inactivated at this temperature. Additionally, the milk must be 
taken within half an hour of preparation or alternatively it can be refrigerated for only one day 
(Iversen and Forsythe 2003; WHO 2007). 
The microbiological criteria of the Codex Alimentarius Commission remained unchanged till 2008, 
even though the risk assessment meeting of WHO/FAO were initiated back in 2004. Currently, 
these are applicable on PIF for infants with age up to 6 months. Still, the criteria were not 
recommended for infant formula which is usually termed as follow-up formula used for infants 
with age above six months (weaning stage). Literature contains evidences indicating isolation of 
Cronobacter species from infant formula and other food items given at weaning stage, additional 
microbiological testing has not been recommended to manufacturers as there are not sufficient 
epidemiological data which could support such strategies (FAO/WHO, 2008). 
Above all, the committee of WHO/FAO (2004) meeting has emphasized on the requirement of 
execution of further studies as these studies would improve our knowledge related to the taxonomy 
and virulence of the organism. It is evident from this literature review that taxonomic classification 
of newly discovered as well as known bacteria is an ongoing process and it will keep on making 
progress in the future. 
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AIMS & OBJECTIVES 
 
 
Despite Cronobacter spp. infections being infrequent, it is still of high concern due to the severity 
of the infections the organism causes, as well as the sensitive age group of the neonates that are 
affected by them. In the last two decade the researchers have been caught the attention particular in 
Cronobacter sakazakii which have particular lineage called clonal complex 4. This lineage has 
been associated with neonatal meningitis which have been established by our group at NTU 
previously. There have been numerous outbreaks of this emerging food borne pathogen 
Cronobacter that claimed the lives of babies. The overall aim of this research project was to 
identify the virulence determinants of the neonatal meningitic bacterium C. sakazakii. This was 
achieved according to the following objectives: 
I. Studying the diversity of the Cronobacter strains obtained from outbreaks, as analysed by  
multilocus sequence typing scheme (MLST) as a reliable detection and molecular typing 
methods developed for the control of Cronobacter spp..  
 
II. Describing the variation in growth by members of the Cronobacter genus in sialic acid, 
genomic structure and  the variation in the gene content of Cronobacter associated with 
sialic acid utilization.  
 
 
III. Investigation the pathogenesis of Cronobacter sakazakii by determining the presence of a 
number of key virulence associated genes which included: two iron acquisition system 
gene clusters (eitA and iucC), Cronobacter plasminogen activator (Cpa), and type IV 
secretion (T6SS) gene cluster using laboratory studies in Cronobacter sakazakii strains, 
particularly with ST4 strains regarding the location on plasmid and total DNA.  
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IV. Developing a tool in order to show the insertion of the well characterized plasmid pESA3 into 
plasmid less strain (NTU 6) and observing any changes in its phenotypic and virulence 
associated behaviour including serum resistance, siderophore and tissue culture.  
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2. MATERIALS & METHODS 
 
2.1 SAFETY CONSIDERATIONS 
Suitable COSHH forms were completed and all the materials and protocols were analysed and 
assessed methodically. All the experiments were conducted according to the Health and Safety 
Code of practice for Microbiology Containment Level 2. While handling microbes, media and 
chemicals and good microbiological laboratory practices were followed. Also good laboratory 
practices were followed while operating laboratory equipment. All material was disposed 
according to the instructions that were stated in material safety data sheets. 
 
2.2 BACTERIAL STRAINS 
All the bacterial strains that were used in this study were from the culture collection of 
Cronobacter spp. of Nottingham Trent University (NTU). Table 2.1 lists the details of the strains 
that have been isolated and used in this study. 
 
Table 2.1 List of Cronobacter strains used in this study 
Species NTU ID Country Source Year of Isolation Comments*  
C. malonaticus 1826 CR** Clinical- Canula 2007 A B C D E F 
 
C. malonaticus 1827 CR** Clinical- Canula 2007 √       
C. malonaticus 1829 CR** Clinical-Nose Swab 2007 √       
C. malonaticus 1830 CR** Clinical-Throat Swab 2007 √       
C. malonaticus 1831 CR** Clinical-Throat Swab 2007 √       
C. malonaticus 1832 CR** Clinical-Throat Swab 2009 √       
C. malonaticus 1833 CR** Clinical-Stool Dissection 2010 √       
C. malonaticus 1834 CR** Clinical-Throat Swab 2010 √       
C. malonaticus 1835 CR** Clinical-Throat Swab 2012 √       
C. sakazakii 1836 CR** Clinical-Wound Swab 2012 √       
C. sakazakii 1837 CR** Clinical-Wound Swab 2012 √       
C. muytjensii 1838 CR** Clinical-Sputum 2012 √       
C. sakazakii 1839 CR** Clinical-Smear from curtaneas 2012 √       
C. sakazakii 1840 CR** Clinical-Sputum 2012 √       
27 
 
CHAPTER 2 MATERIALS AND METHODS 
 
C. sakazakii 1841 CR** Clinical-Sputum 2012 √       
C. sakazakii 1842 CR** Clinical-Sputum 2012 √       
C. sakazakii 1901 CR** Clinical-Sputum 2012 √       
C. sakazakii 1902 CR** Clinical-Sputum 2012 √       
C. sakazakii 1903 CR** Clinical-Sputum 2012 √       
C. malonaticus 1914 CR** Clinical-Sputum 2012 √       
C. sakazakii 1915 CR** Clinical-Sputum 2012 √       
C. sakazakii 1916 CR** Clinical-Sputum 2012 √       
C. malonaticus 1917 CR** Clinical-Sputum 2012 √       
C. sakazakii 1580 Israel Clinical-Faecal 2000 √       
C. sakazakii 1581 Israel Infant Formula 2000 √       
C. sakazakii 1582 Israel Environment 2000 √       
C. sakazakii 1583 Israel Clinical-Faecal 2000 √       
C. sakazakii 1584 Israel Clinical-Faecal 2000 √       
C. sakazakii 1585 Israel Clinical-Blood 1999 √  √  √   
C. sakazakii 1586 Israel Clinical-Blood 1998 √  √  √   
C. sakazakii 1587 Israel Clinical-CSF 2000 √  √ √ √   
C. sakazakii 1588 Israel Clinical-Blood 2012 √  √  √   
C. sakazakii 1565 USA*** Clinical-CSF 2011 √       
C. sakazakii 1566 USA*** Clinical-CSF 2011 √       
C. sakazakii 1567 USA*** Clinical- Faecal 2011 √       
C. sakazakii 1568 USA*** Infant formula 2011 √       
C. sakazakii 1570 USA*** Clinical-CSF 2011 √       
C. sakazakii 1571 USA*** Infant formula 2011 √       
C. sakazakii 1572 USA*** Infant formula 2011 √       
C. sakazakii 1573 USA*** Infant formula 2011 √       
C. sakazakii 1574 USA*** Clinical-Faecal 2011 √       
C. sakazakii 1575 USA*** Clinical- Faecal 2011 √       
C. sakazakii 1576 USA*** Clinical-Tracheal Secretion 2011 √       
C. sakazakii 1577 USA*** Clinical-CSF 2011 √       
C. sakazakii 1578 USA*** Water 2011 √       
C. malonaticus 1569 USA*** Clinical-Blood 2011 √       
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C. sakazakii 1 USA*** Clinical-Thorat 1980   √ √ √  
C. sakazakii 4 Canada Clinical 2003   √ √ √  
C. sakazakii 5 Canada ††Unk 1990   √ √ √   
C. sakazakii 12 CR** Clinical- Faecal 2004   √ √ √   
C. sakazakii 20 CR** Clinical- Faecal 2003   √ √ √   
C. sakazakii 140 ††Unk Spice 2005   √ √ √   
C. sakazakii 150 Korea Spice 2005   √ √ √   
C. sakazakii 553 ††Unk ††Unk -   √ √ √   
C. sakazakii 555 Netherlands Clinical 1979   √  √   
C. sakazakii 658 USA*** Infant Formula 2001  √ √ √ √   
C. sakazakii 680 USA*** Clinical-CSF 1977   √ √    
C. sakazakii 696 France Clinical- Faecal 1994   √ √ √   
C. sakazakii 701 France Clinical 1994   √ √ √   
C. sakazakii 1220 USA*** Clinical-CSF 2003   √ √ √   
C. sakazakii 1221 USA*** Clinical-CSF 2003   √ √ √   
C. sakazakii 1225 USA*** Clinical-Blood 2007   √ √ √   
C. sakazakii 1231 - Clinical- Faecal -    √ √   
C. sakazakii 716 France Infant formula 1994    √    
C. sakazakii 978 UK Clinical 2007    √    
C. sakazakii 709 France Clinical 1994    √    
C. sakazakii 377 France Milk powder 1950    √    
C. sakazakii 1105 UK Weaning food 2008    √    
C. sakazakii 690 France Clinical 1994    √    
C. sakazakii 693 France Clinical 1994    √    
C. malonaticus 510 CR** Food 1985    √    
C. sakazakii 1218 USA*** Clinical 2001    √    
C. sakazakii 1249 UK Clinical 2010    √    
C. malonaticus 685 USA*** Clinical 1977    √    
C. dublinensis 583 UK Enviromental 1956    √    
C. malonaticus 687 CR** Clinical 2004    √    
C. sakazakii 694 France Clinical 1994    √    
C. sakazakii 708 France Clinical 1994    √    
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C. sakazakii 711 France Clinical 1994    √    
C. sakazakii 712 France Infant formula 1994    √    
C. malonaticus 1545 CR** Clinical -    √    
C. sakazakii 700 France Clinical 1994    √    
C. dublinensis 1556 USA*** Clinical 1979    √    
C. malonaticus 1558 CR** Clinical -    √    
C. dublinensis 1560 CR** Food -    √    
C. sakazakii 1533 Germany Environmental 2006    √    
C. sakazakii 1536 Germany Environmental 2009    √    
C. sakazakii 1537 Germany Environmental 2009    √    
C. sakazakii 1542 Germany Environmental 2009    √    
C. sakazakii 691 France Clinical 1994    √    
C. sakazakii 692 France Clinical 1994    √    
C. sakazakii 698 France Clinical 1994    √    
C. sakazakii 699 France Clinical 1994    √    
C. sakazakii 702 France Clinical 1994    √    
C. sakazakii 703 France Clinical 1994    √    
C. sakazakii 705 France Clinical 1994    √    
C. sakazakii 706 France Clinical 1994    √    
C. sakazakii 707 France Clinical 1994    √    
C. sakazakii 713 France Infant formula 1994    √    
C. sakazakii 714 France Infant formula 1994    √    
C. sakazakii 715 France Infant formula 1994    √    
C. malonaticus 1569 USA*** Clinical 2011    √    
C. sakazakii ES15 Korea Whole grain -    √    
C. malonaticus 1846 CR** Ingredient 2010    √    
C. sakazakii SP291 Ireland Environmental     √    
C. sakazakii ES713 USA*** Infant formula -    √    
C. sakazakii ES35 Israel Clinical -    √    
C. sakazakii 2089 France Clinical 2004    √    
C. sakazakii 2106 Belgium Clinical -    √    
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C. sakazakii 2107 Belgium Clinical -    √    
C. malonaticus 2109 Canada ††Unk -    √    
C. dublinensis 2030 France - -    √    
C. malonaticus 2045 France Environmental -    √    
C. malonaticus 2046 France Environmental -    √    
C. sakazakii 2051 France Environmental     √    
C. sakazakii 2161 Mexico Environmental 2010    √    
C. sakazakii 2064 France Environmental -    √    
C. sakazakii 2048 France Environmental -    √    
C. sakazakii NBRC102416 USA*** Clinical 1980    √    
C. malonaticus 507 CR** Clinical 1984   √ √    
C. malonaticus 681 USA*** Clinical 1977   √ √    
C.universalis 581 †UK Fresh water 1956    √    
C.turicensis 564 USA*** Clinical-Blood 1970    √    
C.turicensis 1211 Switzerland Clinical-Blood 2005   √ √ √   
C. muytjensii 530 Denmark Infant Formula 1988    √    
C.dublinesis 582 †UK ††Unk Unk    √    
C.condiementi 1330 Slovakia Food 2010    √    
C. sakazakii 721 USA*** Clinical-CSF 2003   √ √ √   
C. sakazakii 1219 USA*** Clinical-CSF 2002   √ √ 
 
√  
C. sakazakii 557 Netherlands ††Unk 1997   √ √ 
√  
C. sakazakii 730 France Clinical 1994   √ √ √   
C. sakazakii 1222 USA*** Clinical-Blood 2003   √  √   
 C. sakazakii 1240 USA*** Clinical-CSF 2008   √ √ √   
C. sakazakii 1241 USA*** Clinical 2009   √  √   
C. sakazakii 520 CR** - 1983  √ √ √ √  
C. sakazakii 6 Canada ††Unk 1990  √ √ √ √   
C. sakazakii 1242 USA*** Clinical Brain -   √  √   
C. sakazakii 1223 USA*** Clinical-Blood 2004   √  √   
C. sakazakii 558 Netherlands ††Unk 1983   √ √ √   
C. sakazakii 767 France Clinical- Trachea 1944   √ √ √   
C.sakazakii 695 France Clinical-Trachea 1944   √ √ √   
C.dublinesis 1210 Ireland Environment-Milk powder manufacturing plant 2004    √  √  
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C.dublinesis LMG23823 Ireland Environment 2004    √  √  
C.dublinesis LMG23825 Switzerland Water 2004    √  √  
C.dublinesis LMG23825 Zimbabwe Environment 2003    √  √  
C.malonaticus LMG23826 USA*** Clinical 1977    √  √  
C.malonaticus CMCC45402 China Milk 2014    √  √  
C.turicensis 92 ††Unk Herb 2004    √  √  
C.turicensis 1553 Slovakia ††Unk -    √  √  
C.turicensis 1554 Slovakia ††Unk -    √  √  
C.turicensis 1880 CR** Herb-Bay leaf 2011    √  √  
C.muytjensii ATCC51329 ††Unk ††Unk -    √  √  
Siccibacter turicensis 1974 Switzerland Fruit powder 2007    √  √  
Franconibacter 
helveticus 1975 Switzerland Fruit powder 2007    √  √  
Francobibacter 
pulveris 1978 Switzerland Infant Formula 2008    √  √  
Francobibacter 
pulveris 601 Switzerland Fruit powder 2007    √  √  
Francobibacter 
pulveris 1160 Switzerland Fruit powder 2007    √  √  
Siccibacter colletis 1383 †UK Ingredient 2011    √  √  
Francobibacter 
pulveris 1991 †UK Food 2013    √    
Franconibacter 
helveticus 1387 †UK Spice 2011    √    
Franconibacter 
helveticus 1392 †UK Ingredient 2011    √    
Franconibacter 
helveticus 1208 Portugal Follow up formula 2009    √    
E.coli K12 1230 - HB101 -  √      
Salmonella enterica 
server Enteritidis 358 - NCTC3046 -  √      
Ed.Trada 1926 - - -    √    
Citrobacter Frendii 1927 - - -    √    
Citrobacter kosri 48 USA*** Clinical-CSF Unk  √  √ √   
Citrobacter kosri CK-BAA89 USA***      √    
* Comments: A – MLST laboratory experiments and sequence data analysis performed as part of this 
project; B – Transfer of the virulence associated plasmid pESA3 into the plasmid less C. sakazakii isolate 
and its characterization data analysed as part of this project; C – PCR Screening of virulence detection & 
serum resistance data analysed as part of this project; D –Sialic acid growth data analysed as part of this 
project; E- Plasmid profile data analysed as part of this project; F-Iron acquision data analysed as part of this 
project. 
CR**: Czech Republic; USA***: United States of America; †UK: United Kingdom††Unk: Unknown. 
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Table 2.2 Plasmid used in this study: 
Plasmids Features Source 
pAJD434 6566bp Trimethoprim TmR plasmid McNally,UK 
pKD4 3267 bp kanamycin KR plasmid Datsenko & Wanner, 2000 
pESA3 The larger plasmid of C.sakazakii ATCC BAA-894 131 
KB 56% GC-encoding 127 genes. 
Kucerova et al. 2010 
pESA3K pESA3 after insertion of a kanamycin resistance cassette This study 
 
2.3 BACTERIAL STORAGE AND CULTURE 
All the Cronobacter strains of both agar plates TSA and liquid culture TSB were incubated for 24 
hours at 37°C under aerobic conditions, and stored in TSB/ glycerol (80%) at -20°C and -80 °C. 
When it was deemed suitable, culture strains were stored at 4°C for short periods. 
 
2.4 PREPARATION OF MEDIA AND BUFFERS 
 
2.4.1 TRYPTICASE SOY AGAR (TSA) 
Five hundred millilitre of distilled water was used to re-suspend 20 grams of TSA (Themo 
Fisher,UK) base. The re-suspended solution was then autoclaved at 121°C for 15 minutes. The agar 
was allowed to cool down to a temperature of 50°C. When the agar had cooled approximately 15-
20 ml of media was poured in to each sterile Petri dish. The plates were then stored for up to three 
weeks at 4°C. 
2.4.2 DRUGGAN-FORSYTHE-IVERSEN (DFI) AGAR FORMULATION 
Five hundred millilitre of distilled water was used to re-suspend 21.5 grams of DFI agar base (Lab 
M, UK) and autoclaved at 121oC for 15 minutes. When cooled down to 50oC, 15-20 ml of media 
was poured into each sterile Petri dish. These plates were then stored at 4oC for maximum three 
weeks. 
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2.4.3 LURIA-BERTANI AGAR (LBA) 
The manufacturer’s directions were followed to prepare Luria-Bertani Agar (Merck KgaA, 
Darmstad, Germany; 1102830). Thirty-seven grams was dissolved in 1 L of H2O, mixed and then 
sterilized for 15 min at 121 °C. 
2.4.4 TRYPTICASE SOY BROTH (TSB) 
For re-suspension of 15 grams of TSB (Oxoid, UK) base, 500 ml of distilled water was used. The 
re-suspended solution was then autoclaved at 121oC for 15 minutes. 
2.4.5 BRAIN HEART INFUSION BROTH (BHI) 
One liter of distilled water was used to re-suspend 37 grams of BHI (CM1135, Oxoid Thermo 
Fisher; UK). The mixture was then heated with mixing until the BHI was completely dissolved. 
The solution was then dispensed into universal bottles in 20 ml volumes, and autoclaved at 121°C 
for 15 minutes. The bottles were stored in the refrigerator at 4°C until required. 
2.4.6 LURIA-BERTANI BROTH (LB) 
The directions by the company were followed in the preparation of Luria-Bertani (Sigma Aldrich, 
UK; L3022). The LB of 25 g was mixed into 1 litre of condensed water. In 50 ml volumes, the 
mixture was distributed to 100ml bottles and sterilized for 15 min at 121 °C. 
2.4.7 PHOSPHATE BUFFERED SALINE (PBS) 
Two tablets of PBS (Sigma Aldrich, UK) were dissolved in 400ml of distilled water and 
autoclaved. 
2.4.8 SALINE SOLUTION (0.85 %) 
One tablet of saline (Fisher Scientific, UK) was added to 99ml of dH2O and autoclaved then stored 
at room temperature. 
2.4.9 TRITON X-100 (1%) 
One millilitre of Triton X-100 (Fisher Scientific, UK) was added to 99 ml of dH2O and autoclaved 
then stored at room temperature. 
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2.4.10 IRON III SOLUTION 
To prepare iron III solution, 9 ml of HCl (100 ml of distilled water added to 830 µl HCl) was 
mixed with 1 ml of FeCl3 6H2O solution (1L distilled water mixed with 2.73g of FeCl3 6H2O). 
2.4.11 CHROME AZUROL SULPHATE (CAS) SOLUTION 
ChromeazurolS (199532, Sigma) was prepared by mixing 100ml of sterile distilled water with 
0.0121g of CAS. 
2.4.12 HEXADECYLTRIMETHYLAMMONIUM BROMIDE (HDTMA) 
Distilled water (80ml) was mixed with 0.1458g of HDTMA (H6268, Sigma). 
2.4.13 SODIUM HYDROXIDE SOLUTION 
Ten gram of 50% w/v NaOH was added to distilled water (20ml). 
2.4.14 GLYCEROL (80 %) 
Eighty millimeter of glycerol (Fisher Scientific, UK) was added to 20ml dH2O, mixed, and 
autoclaved then stored at room temperature. 
2.4.15 M9 MINIMAL MEDIUM  
M9 Minimal Medium composed of 50ml 5XM9 Medium, 1ml 1M MgSO4 , 5ml 20% Glucose , 
50μl 1M CaCl2 , 500ml dH2O. They were autoclaved at 121oC for 15 minutes. 
2.4.16 PLASMID PROFILING REAGENTS 
The alkaline extraction procedure by Birnboim and Doly (1979) was used for plasmid profiling of 
Cronobacter spp. strains. 
SOLUTION I: 
Lysozyme solution composed of 2 mg/ml lysozyme (Fluka), 50 mM glucose (Sigma, UK), 10mM 
CDTA/EDTA (Sigma, UK), 25 mM Tris-HCl pH 8.0 (Sigma, UK). The stock or solution I was 
freshly prepared and stored at 4oC. 
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SOLUTION II: 
Alkaline SDS solution composed of 0.2 N NaOH and 1% SDS (Sigma, UK).  Solution was stored 
at 25oC and remained stable one week. 
SOLUTION III: 
High salt solution 3 moler of sodium acetate (Sigma, UK). 
 
2.5 PLASMID PROFILE 
The bacterial culture (2.5 ml) was grown overnight shaking in TSB for 18 hours. An aliquot (0.5 
ml) of the culture was transferred to a 1.5 ml eppendorf tube for plasmid extraction, whereas the 
remaining culture was preserved at -20oC after glycerol had been added to 40%.  Supernatant was 
carefully removed using a fine tip aspirator after the eppendorf tube has been centrifuged for 15 
seconds. The cell pellet was then thoroughly suspended in 100 μl of Solution I. After incubation at 
0oC for 30 min, 200 μl of Solution II was mixed so that the tube was softly vortexes, until the 
suspension was nearly clear and viscous. Subsequently, the tube was then preserved at 0oC for a 
period of 5 min and then 150 μl Solution III was mixed. To concentrate the DNA, the tube was 
gently mixed by inversion for a few seconds and upheld at 0oC for 60 min to permit precipitation of 
protein, fast-paced molecular weight RNA and chromosomal DNA. After that the tube was 
centrifuged for 5 min to produce a nearly clear supernatant of which 400 μl was removed and 
transferred to another tube. After 1ml of cold ethanol had been mixed, the tube was kept at -20oC 
for 30 min and then centrifuged for 2 min to discard and remove supernatant by aspiration. Once 
this was done, the pellet was dissolved in 100 μl of 0.1 M sodium acetate/0.05 M Tris-HCl (pH 8) 
and 2 volumes of cold ethanol were used for precipitating. After being held at -20oC for 10 min, 
centrifugation was again used to collect the precipitate as before. The pellet was further dissolved 
using 40 μl of water and a mixture of 10 μl of 5X sample buffer [25% sucrose (Fisher Scientific, 
UK), 5 mM sodium acetate (Sigma, UK), 0.1% SDS (Sigma, UK)] was added. The unstained 1% 
agarose (Fisher Scientific, UK) gel made with 1X TAE buffer (Geneflow, UK) was then loaded 
with 20 μl of the sample and was run for duration of 50 minutes at 90V in 1X TAE buffer. Using 
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the InGenius® gel documentation system (Syngene, UK), the gel was stained with in ethidium 
bromide solution - 25 μl EtBr (Sigma, UK) in 400 ml distilled water – for duration of an hour after 
which it was observed below the UV light to detect the DNA bands. 
 
2.6 DETECTION OF VIRULENCE ASSOCIATED GENES USING PCR 
In this work, all primers were purchased from Sigma Aldrich as dry products and rehydrated as 
directed by the manufacturers’ instructions. Primers were designed by different research groups 
(Franco et al. 2011a; Franco et al. 2011b) and the presence of investigated genes was obtained 
following the same denaturation, annealing and extension times and temperatures. All primers are 
listed in Table 2.3. The PCR was investigated as described in Kim et al. (2010), Franco et al. 
(2011a) and Franco et al. (2011b). 
 
Target gene Primer name Primer sequence (5'-3) 
Amplicon 
(bp) 
Annealing/ extension 
conditions 
Cpa 
cpafw GACAACCCTGAGTTCTGGTAAC 
306 56°-30s/ 72°-30 
cparv ATGCGTATTTCTGCTGGTAA 
T6SS R end 
t6ssfw CTCAGATTACTGATCGGCGCTG 
338 56°-30s/ 72°-40s 
t6ssrw3 GTATGGCATACCGCAATTGCGC 
IntT6SS Right 
t6ssfw3 CTCAGATTACTGATCGGCGCTG 
800 56°-30s/ 72°-60s 
∆t6ssrv3 CTGAACAGATGGCCGATCTGGT 
IntT6SS Left 
∆t6ssfw GGAATACGCCTGCGCTGATGAC 
1,168 56°-30s/ 72°-90s 
t6ssrv CCAGTAATTTCAGCGGCAGCTC 
VgrG 
vgrGfw GGTTTCACTTCCCGCTGATA 
850 52°-30s/ 70°-60s 
vgrGrv CCCGCAGTTAATCACCAGTT 
EitA 
EitAF1 CCTTTTTCACGGCGTCGAGCTG 
280 60°-30s/ 72°-30s 
EitAR1 TCTCTTCTGGTTCTCCAGCGCG 
Iucc 
iucCF TGCAGTGCCTGATGTCAGGCCAT 
660 58°-30s/ 72°-30s 
iucCR ACGCCAAACATCTCCTGATAGCG 
 
Table 2.3 Primers used for virulence genes investigations. The sequence of each primer and the 
amplicon size are listed (Franco et al. 2011b). 
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2.7 PHYSIOLOGICAL EXPERIMENTS 
2.7.1 SERUM RESISTANCE 
Bacterial cultures were grown overnight at 37°C in TSB broth 200 rpm and then centrifuged. The 
pellet was diluted to l06 cfu/ml in 5ml of PBS. From the suspension cells (0.5 ml) were added to 
1.5 ml of undiluted human serum. The bacteria and human serum were mixed and incubated at 
37°C  with shaking (200 rpm). The viable counts of cells were obtained at the beginning and after 
1, 2, 3 and 4 hours of incubation. The Miles and Misra technique was used on TSA plates at 37°C 
for 18 hours. All strains were analysed in triplicate. All bacterial strains have been assayed in 3 
independent assays. 
 
2.7.2 SIALIC ACID UTILIZATION 
Two modifications of the methods stated by Almagro-Moreno and Boyd (2009) were used. Brain 
Heart Infusion broth (Oxoid ThermoFisher, UK) was used to grow the bacterial cultures overnight. 
To remove the carryover of nutrients, the cell suspensions were washed three times in PBS. 
Absorbance increased (595 nm) when growth in M9 minimal media with 1 mg/ml sialic acid ( 
Sigma Aldrich, UK), 1 mg/ml GM1 monosialoganglioside (Sigma Aldrich, UK), 1 mg/ml mucin 
(Sigma Aldrich, UK) as the carbon source was used. Inoculation of M9 without a carbon source 
was used as a negative control, and glucose was added (1 mg/ml) to the minimal medium as a 
positive control. 
 
2.7.3 IRON SIDEROPHORE DETECTION 
For siderophore production the method of Schwyn and Neilands (1987) was used with slight 
modification. Chrome azurolsulphate (CAS) agar was prepared by using two solutions. The First 
solution (dark blue liquid) was prepared by using 50 ml of CAS solution (see section 2.4.11), 10ml 
of iron III solution; section 2.4.10 and 40 ml of HDTMA before autoclaving at 121°C for 15 
minutes (100ml in total of dark solution). The second solution was prepared by mixing 900ml of 
distilled water, 15g agar, 30.24g pipes and 12g NaOH and then autoclaving at 121°C for 15 
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minutes. After autoclaving, the first solution was mixed with the second solution and then the 
media was poured into the plates. Immediately before use, 5mm diameter holes were punched into 
the agar. To prepare the bacterial suspension, five colonies were taken from TSA and inoculated 
into LB broth containing 200µM of 2, 2´-dipyridyl (31.236mg in 1L of LB broth) and incubated 
with shaking (170 rpm) at 37°C overnight. After incubation the sample was centrifuged at 5000 
rpm for 10 minutes and 70 µl of the supernatant was added into the holes. The agar was incubated 
at 37°C for 4-8 hours. The observance of an orange zone around the hole indicated that the strain is 
positive for siderophore production. Yersinia enterocolitica strain 1880 was used as a positive 
control. 
2.8 GENOMIC COMPARISON FOR THE PRESENCE/ ABSENCE OF THE KEY 
VIRULENCE GENES 
To investigate the presence and the absence of the key genes, genome comparisons were applied to 
find the key virulence genes of the organism such as iron acquisition, serum resistance, sialic acid 
utilisation and T6SS. This comparative analysis was performed using Artimes comparative tool 
(ACT) for genome alignment, which has been developed by Carver et al. (2005). Further BLAST 
searches were performed using Cronobacter BLAST research facility at 
(http://pubmlst.org/perl/bigsdb/bigsdb.pl?db=pubmlst_cronobacter_isolates&page=plugin&name=
BLAST). 
2.9 TISSUE CULTURE INVESTIGATIONS 
2.9.1 MAMMALIAN CELL LINES 
An important experiment of this project is the use of tissue culture experiment. To make use of a 
cell line in the project, the cell lines were grown at the time needed via detailed procedure. The 
time period required by the cell lines to grow a complete cell layer that could be used in the project 
varied from two to three days depending on the time the flask was left for obtaining a single layer 
of cell. In order to maintain growth continuity, the cell lines were split twice a week. Table 2.4 
shows that liquid nitrogen has been used to preserve the cell lines that were needed in the project. 
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At the time of growing a cell layer, a flask of the cell line desired (for carrying out the project) was 
removed from liquid nitrogen and placed on ice. Seventy-five millimetres of tissue culture flask 
and a pre-warmed tissue culture growth medium and measuring 20 ml in volume were mixed 
together in a flask. After the mixture was obtained, the cell line was quickly defrosted so that it 
could be added into this culture flask which would be followed by the incubation of the cell line at 
37°C for the entire night. After the incubation process completed, the residues of the cell line 
preservatives needed to be eliminated from the mixture of cell line and culture; for this purpose 20 
ml of fresh medium was added in the tube in replacement of the older growth medium. The flask 
was then kept for a period of two or three days to obtain a confluent monolayer of cells. Five 
millimetres of TrypLe™ express (Life Technologies, UK) was then used to extract the cells. This 
was followed by the use of CENTAUR2 centrifuge (MES, UK) for centrifuging the extracted cell 
for duration of approximately 3 minutes at 1500 rpm. The pellet obtained was once again 
suspended in the growth medium and the supernatant was discarded. 
 
 
Cell line Source Passages Reference No 
Colorectal adenocarcinoma epithelial cells (Caco-2) European Collection of 
Cell Cultures 
37 to 38   ECACC #86010202 
Human brain microvascular endothelial cells (HBMEC) Inooprot, Spain 18 to 24 Ref. #P10354 
Macrophage cell line (U937) American Type Culture 
Collection 
8 to 9 ATCC#CRL-1593.2 
Rat brain capillary endothelial cell line (rBCEC4) I. E. Blasig* 5 to 7 - 
*: Forschungsinstitut für Molekulare Pharmakologie – Berlin, Germany. 
Table 2.4 Cell lines used in this study 
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Cell line Growth medium Infection medium 
Caco-2 Minimum Essential Medium (MEM) supplied 
with 10% (v:v) foetal calf serum (FCS), 1% (v:v)  
non-essential amino acid (NEAA), and 1% (v:v)  
penicillin-streptomycin (Sigma Aldrich, UK). 
Minimum Essential Medium (MEM) supplied with 
10% (v:v) FCS, and 1% (v:v) non- NEAA ( Sigma 
Aldrich, UK). 
HBMEC Dulbecco’s modified eagle medium (DMEM) 
with 10% (v:v) FCS and 1% (v:v) penicillin-
streptomycin (Sigma Aldrich, UK). 
Dulbecco’s modified eagle medium (DMEM) with 
10% (v:v) FCS (Sigma Aldrich, UK). 
rBCEC4 Dulbecco’s modified eagle medium (DMEM) 
with 10% (v:v) FCS and 1% (v:v)  penicillin-
streptomycin (Sigma Aldrich, UK). 
Dulbecco’s modified eagle medium (DMEM) with 
10% (v:v) FCS (Sigma Aldrich, UK). 
U937 RPMI medium containing 10% (v:v) FCS, 1% 
(v:v) NEAA, and 1% (v:v) penicillin-
streptomycin (Sigma Aldrich, UK) 
RPMI medium containing 10% (v:v) FCS and 1% 
(v:v) NEAA (Sigma Aldrich, UK). 
 
Table 2.5 Tissue culture media used in this study 
 
2.9.2 PREPARING BACTERIAL INOCULA 
For inoculation of the colony of every test strain, 5 ml of LB (Themo Fisher, UK) was used and 
then it took a period of 18 hours at 37°C to grow them aerobically with shaking at 200 rpm. For 
examining, 5 ml of infection medium (Table 2.5) was poured into 120 μl of overnight cultures. 
This was followed by the incubation at 37°C for approximately 1.5 hours and shaking at 200 rpm 
for achieving optical density (OD) within the range of 0.3-0.5 at 600nm utilizing spectrophotometer 
(JENWAH, UK). For obtaining 4x106 cfu/ml which is multiplicity of infection (MOI 100). 
 
2.9.3 GENTAMICIN PROTECTION ASSAY (GPA) 
The purpose of the experiment was to test whether the isolates were able to attach and invade the 
human cell. Gentamicin protection testing was applied for determining this test in vitro using 
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Human colonic carcinoma epithelial cells (Caco-2) passages 37 to 38 acquired from the European 
Collection of Cell Cultures (ECACC #86010202), human brain microvascular endothelial cells 
passages 18 to 24 (HBMEC; ref. #HMG030 Inooprot, Spain) and rat brain capillary endothelial cell 
line (rBCEC4) passages 5 to 7, which was obtained from I. E. Blasig (Forschungsinstitut für 
Molekulare Pharmakologie - Berlin; Germany). Table 2.5 enlists all the culture media used during 
the experiment. For HBMEC and rBCEC4 cell lines, Citrobacter koseri strain NTU 48 was used as 
a positive control while for Caco-2 cell line, Salmonella Enteritidis strain NTU 358 which was 
used as positive control. The negative control for all cells was Escherichia coli K12 strain NTU 
1230. 
 
2.9.3.1 ATTACHMENT 
Townsend et al. (2008) have described this experiment previously. Table 2.5 discusses in detail the 
growth method of mammalian cells. After the growth the cells were then seeded at 4x104 cell/well 
in the growth medium at 37°C containing 5% CO2 for a period of 48 hours in order to obtain the 
monolayer of cells. The wells were then filled with the suspension at 4x106 cfu/well and MOI 100 
which were then incubated at 37°C for a period of two hours in the presence of 5% CO2. 1% (v: v) 
PBS (Sigma Aldrich, UK) was used for washing the wells and Triton X-100 (Fisher Scientific, UK) 
was used for lysing. The viable count was determined by diluting the lysates and then placing on 
TSA for overnight at 37°C. 
 
2.9.3.2 INVASION 
The above method was used as per bacterial attachment mentioned earlier. The washing of the well 
was followed by addition of 0.5 ml of infection medium (Table 6) and 125 μg/ml (v: v) of 
gentamicin (Sigma Aldrich, UK). This was then incubated at 37°C for a period of two hours in the 
presence of 5% CO2. Before completing the process of lysing using 1% (v: v) Triton X-100 (Fisher 
Scientific, UK), the wells were washed once again using PBS (Sigma Aldrich, UK). The final 
result was diluted and then placed on TSA for overnight at 37°C for determining the viable count. 
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2.9.4 MACROPHAGE ASSAY 
As mentioned by Townsend and colleague (2007), section 2.9.1 described in detail the growth 
media for macrophages and then were treated with 0.1µg/ml of the PMA ( phorbol 12-myristate 
13-acetate) (Sigma Aldrich,UK;P8139) at least 24h prior to infection, and they were placed at 37°C 
into 75cm2 tissue culture flasks under 5% CO2 for stimulation. For cell adhesion the wells were 
then filled with the bacterial suspension concentration of 4x106 cfu/well at 37 °C for 72 hours in the 
presence of 5% CO2. 
The concentration of overnight bacterial cell were infected by macrophage was 4x106 cfu/ml (MOI 
10). This was incubated at 37 °C for 1 hour in 5% CO2. Then the media was replaced by infection 
media contains 125 μg/ml (v: v) of gentamicin and incubated at 37°C in the presence of 5% CO2.  
The plates were washed by PBS and supplied with infection media contain 50 μg/ml of gentamicin. 
This was then incubated, the plates were completed the process of lysing using 1 % (v:v) Triton X-
100 (Fisher Scientific, UK) The final result was diluted and then placed on TSA to obtain the 
intracellular bacteria at different points (uptake, 6 h, 24h, 48h, and 72h). Percentage of uptake and 
persistence was used for data presentation. 
 
2.9.5 STATISTICAL ANALYSIS 
Statistical analysis have been undertaken using unpaired t-test and ANOVA one way (GraphPad 
Prism program Version 5.0) of the independent experiments of the data. The P value p < 0.05 
assigned significantly to the significance variation results. Moreover, those p <0.01 and p < 0.001 
were considered highly significant, and very highly significant respectively. Also, the heat maps 
were generated using SPSS statistics software (version 21.0). 
43 
 
CHAPTER 3 DIVERSITY OF CRONOBACTER STRAINS OBTAINED FROM OUTBREAKS, AS ANALYSED BY 
MULTILOCUS SEQUENCE TYPING 
. 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 3 
 
DIVERSITY OF CRONOBACTER STRAINS OBTAINED 
FROM OUTBREAKS, AS ANALYSED BY MULTILOCUS 
SEQUENCE TYPING
44 
 
CHAPTER 3 DIVERSITY OF CRONOBACTER STRAINS OBTAINED FROM OUTBREAKS, AS ANALYSED BY 
MULTILOCUS SEQUENCE TYPING 
. 
3.1 INTRODUCTION 
 
3.1.1 OUTBREAKS 
Several cases of neonatal outbreaks of Cronobacter spp. infections in neonatal intensive care units 
(van Acker et al. 2001; Block et al. 2002; Himelright et al. 2002; Caubilla-Barron et al. 2007) were 
described previously in Chapter 1 (Section 1.3). Reconstituted powdered infant formula (PIF) has 
been held responsible for a large number of these infections, which could have been intrinsically 
contaminated while they were being prepared or through reconstitution water (Himelright et al. 
2002). The prepared product could have been affected by the growth of bacteria and this happens 
because of temperature abuse of the product (Caubilla-Barron et al. 2007). Humans can also 
asymptomatically carry the bacteria (Holy & Forsythe 2013). Effective typing schemes should exist 
for the Cronobacter spp. and studies should be conducted of all the possible sources of the bacteria 
while an outbreak is taking place. 
 
3.1.2 MULTILOCUS SEQUENCE TYPING 
Genes involved in maintaining basic cellular functions are known as housekeeping genes and these 
are scattered through the genome. Multi Locus Sequence Typing (MLST) refers to a molecular 
technique during which partial sequence analysis of several housekeeping genes is carried out to 
identify and cluster bacterial isolates. It is actually a modified form of an earlier typing technique, 
i.e. Multi Locus Enzyme Electrophoresis (MLEE). In the case of MLEE, variations in multiple 
housekeeping or basic metabolic genes are identified through analysing different gene products by 
electrophoresis (Maiden et al. 1998). In comparison to MLEE, MLST is based on sequencing of 
genes. Gene sequencing allows us to be sure that alteration in even a single nucleotide is 
considered while distinguishing between different isolates; MLST has proven later to be more 
efficient than other approaches. 
Since the MLST targets housekeeping genes which are essentially required by the organism, these 
genes are constitutively expressed and independent of any selective conditions. Moreover, analysis 
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of more than one gene allows the acquisition of extensive data and improved discrimination as 
compared to what is offered by analysis of a single gene. This approach also facilitates avoiding the 
influence of any recombination, which usually takes place at one locus. Hence, targeting multiple 
genes proves to be beneficial in a number of ways (Maiden et al. 1998; Enright & Spratt 1999). 
 
In 1998, Maiden et al. used the MLST for the first time to analyse a set of Neisseria meningitidis 
strains. At that time, the method involved analysis of six loci; however, most MLST methods used 
currently involve seven housekeeping loci thereby allowing greater discrimination and higher 
efficiency. The MLST method is quite simple in principle as shown in Figure 3.1 The procedure 
starts with the amplification of target genes followed by sequencing which is done with the help of 
primers or nested primers (amplification is performed with outer primers and nucleotide 
sequencing with inner primers). Next step is the trimming of a 400-500bp long region and its 
analysis for each locus. After this, multiple alleles at each gene locus are arranged and compared. A 
distinct allelic profile number of the locus is assigned to every variant allele. This profile number is 
assigned as follows. In a typing technique involving seven loci, each isolate is given a combination 
of 7 allelic profile numbers. Every distinct combination of these profile numbers denotes a 
sequence type (ST) for the specific isolate. Isolates demonstrating comparable STs are regarded as 
isogenic strains or clones of one another since they cannot be differentiated at all using the seven 
loci. The acquired sequence data is then recorded and stored in a central database so that it can be 
accessed online and can be reproduced in any laboratory around the world (Maiden et al. 1998).
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Central analytical facilities support and maintain these databases, which contain a huge amount of 
data regarding isolates that had been subjected to sequence typing. Besides sequence data, isolation 
history of the isolate is also recorded in the database.  Moreover, the databases contain links to 
other publications, which have reported that particular strain. Hence, abundant data regarding 
Figure 3.1 Multi Locus Sequence Typing experimental method. The procedure starts 
with (1) Amplification of target genes followed by sequencing which is done with the 
help of primers or nested primers (amplification is performed with outer primers and 
nucleotide sequencing with inner primers). (2) Trimming of a 400-500bp long region and 
its analysis for each locus. (3) Multiple alleles at each gene locus are arranged and 
compared. (4) A distinct allelic profile number of the locus is assigned to every variant 
allele. This profile number is assigned as follows. (5) In a typing technique involving 
seven loci, each isolate is given a combination of 7 allelic profile numbers. (6) Every 
distinct combination of these profile numbers denotes a sequence type (ST) for the 
specific isolate. 
OUTER 
PRIMER 
INNER 
PRIMER 
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different strains are made available at a single platform. This huge amount of data can be accessed 
freely and easily as no registration or other procedures are required for accessing or downloading 
the data. Hence, researchers investigating the same strain may compare their findings with those 
recorded in the database. High quality and authenticity of the data is first ensured before including 
it in the databases. To make a comparison between alleles and sequence types, MLSA (Multi Locus 
Sequence Analysis) is used to identify the recombination and relationship in the population, 
establish links between related STs or isolates through developing minimum spanning trees or 
phylogenetic trees; relevant links are made available on these databases for evaluating the 
sequences using different tools. For instance, the database is integrated with the BLAST tools that 
allow similarity searches of the loci. These tools can also be used to download profiles of all the 
identified STs. Certain databases like PubMLST are equipped with a tool called “Locus Explorer” 
that allows visualization of the variable sites in every locus. 
 
The MLST database for Cronobacter can be accessed at http://www.pubmlst.org/cronobacter in the 
PubMLST group of databases. Prof. Keith Jolley maintains the resources for more than forty 
MLST databases of bacteria including Yersinia spp., Pseudomonas aeruginosa, Neisseria spp., 
Clostridium difficile, Helicobacter pylori, Campylobacter spp., and Aeromonas spp. Each database 
was divided into two subsections. One subsection contains data related to the technique such as 
introduction to the MLST, material and methods employed for amplification and sequencing. 
Second subsection comprises the main data i.e. sequences of alleles, information about the isolate 
and MLST profiles. Besides typing for epidemiological objectives, sequencing data acquired 
through MLST can be used in other applications like population genetics and speciation. For that 
reason, not only pathogens but also several environmental isolates are also subjected to the MLST 
(Brady et al. 2008). 
 
3.1.3 MULTILOCUS SEQUENCE TYPING SCHEME FOR CRONOBACTER SPP. 
Researchers have suggested several different genotyping methods based on the DNA for the 
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identification, classification and characterization of Cronobacter species. The PCR probes for the 
rpoB, rpsU and dnaG genes are some of them (Seo and Brackett. 2005; Stoop et al. 2009). Still, 
utilization of these techniques for Cronobacter is limited by factors like lack of validation of these 
techniques against a set of Cronobacter strains belonging to 7 species or their discontinued 
utilization in research studies.  
Serogrouping with the help of the PCR seems to be the most advanced non-MLST profiling 
technique (Jarvis et al. 2011; Sun et al. 2011). At present, the procedure involving utilization of 
seven primer pairs screens only 4 out of 7 species and more than 20% (48 out of 231) strains do not 
yield a PCR product (Jarvis et al. 2011; Sun et al. 2011) suggesting that some serogroups remain 
unidentified. Moreover, contradictory findings have been reported indicating existence of single 
serogroup across multiple species, e.g. C. muytjensii O1 and C. sakazakii O3 (Jarvis et al. 2011). 
Unlike the above mentioned techniques, MLST utilizing only seven primers pairs has been 
developed for the entire genus of Cronobacter and has proven to be a reliable and efficient 
technique. This chapter elaborates how the seven loci method has improved our knowledge related 
to the phylogeny and profiling of Cronobacter. 
The MLSA and MLST techniques have benefited the Cronobacter studies in many ways. They 
disclosed how diverse the genus Cronobacter is and showed how the genus has descended 
evolutionarily. These techniques not only revealed how closely related are the seven species of 
Cronobacter but also enabled identification of two new species i.e. C. condimenti and C. 
universalis. Moreover, clinical studies making use of these techniques indicated that only one 
clonal lineage C. sakazakii ST4 clonal complex is responsible for most of the cases of neonatal 
meningitis. These findings laid the foundation for future studies for selecting strains in order to 
study the environmental fitness and virulence of Cronobacter. Last but not the least; they enabled 
development of a curated database available at http://www.pubMLST.org/cronobacter. Prof 
Stephen Forsythe curates the Cronobacter PubMLST database, hosted at University of Oxford, 
UK. The database contains more than 1000 strains and >350 STs studied through MLST. These 
strains demonstrate diverse distribution sources, geographically and temporally. The database also 
contains details of experimental procedures and DNA sequences of 7 alleles for offline evaluation. 
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One can find the sequence type (ST) of a strain and perform advanced DNA sequence analysis 
using this database. 
Seven housekeeping genes including atpD, fusA, glnS, gltB, gyrB, infB, and ppsA are subjected to 
partial sequence analysis while studying Cronobacter through MLST technique (Baldwin et al. 
2009). According to Kucerova et al. (2010), these loci are scattered across the genome of 
Cronobacter and are minimally affected by any potential pressures of selective evolution. 
Moreover, the primers for the seven genes have been developed in a way that the annealing 
temperatures of these primers are alike. This allows execution of all reactions in a single run 
thereby making the procedure more rapid. When the loci DNA sequences are compared with the 
MLST reference database for Cronbacter, the sequence type of strains and seven digit allele codes 
are obtained. Concatenating the 7 allele sequences gives rise to a concern sequence of 3036 nt 
length for phylogenetic and MLSA analysis. 
Initially, the MLST technique was developed for C. malonaticus and C. sakazakii (Baldwin et al. 
2009) in order to prove that it is more efficient than the conventional 16S rDNA sequence analysis 
which was unable to differentiate between these two species. Later, researchers utilized MLST for 
all of the 7 known Cronobacter species (Czerwicka et al. 2010; Kucerova et al. 2010, 2011; 
Hamby et al. 2011; Joseph and Forsythe, 2011; Hariri et al. 2012; Joseph et al. 2012a,b). It has also 
been reported that this method can reliably execute speciation by using fusA as single locus (Joseph 
et al. 2012b). 
The MLST and MLSA have played a crucial role in improving our knowledge related to 
Cronobacter. However, it is worth mentioning here that the conventional phenotyping (utilization 
of biotypes) for classification of Cronobacter species was defective since certain biotype index 
strains were classified incorrectly as per the findings made through DNA sequence based MLSA 
later (Baldwin et al. 2009). 
The C. sakazakii species has been found to be the predominant species in the strains obtained from 
the PIF and the environmental sampling of the milk powder processing factories. The C. sakazakii 
ST4 strains were found in the powdered formulas, the roof, tanker bays, and the roller driers of the 
manufacturing plants (Sonbol et al. 2013). The desiccation resistant strains of Cronobacter spp. 
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including C. sakazakii ST4 could occur in these dry environments. Many species and STs of the 
Cronobacter spp. are found in many food products and ingredients, herbs and spices. 
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3.1.4 AIMS OF THIS CHAPTER 
 
The FAO-WHO (2004) requested that reliable detection and molecular typing methods are 
developed for the control of Cronobacter spp. A multilocus sequence typing scheme (MLST) open 
access internationally based database (http://www.pubMLST.org/cronobacter/) has been 
established by our research group.  This is supported by international contributors and currently 
includes the profiles of >1000 strains and 108 whole genomes. The MLST scheme has advanced 
our understanding of the Cronobacter genus, revealing predominant and stable clones associated 
with neonatal meningitis. 
In this chapter, the MLST scheme was applied to three collections of clinical strains that had not 
previously been profiled as a continuation of previous studies by Susan Joseph (NTU), but with 
more focussed attention on particular strains. These clinical strains were from USA, Israel and the 
Czech Republic in which eleven sequence types (STs) were identified spanning the genus of 
Cronobacter. 
The key results presented in this chapter have been accepted for publication  (Hariri et al. 2013; 
Alsonosi et al. 2015). 
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3.2 MATERIALS AND METHODS 
The key methods, culture media, culturing conditions and bacterial strain list for this part were 
described previously in Chapter 2 Materials and Methods  
3.2.1 GENOMIC DNA EXTRACTION 
According to the instructions of the manufacturer, genomic DNA was prepared from 1.5 ml of 
culture grown overnight in TSB using GenElute™ Bacterial Genomic DNA Kit (Sigma-Aldrich, 
UK). Nanodrop 2000 (Thermo Scientific, UK) was used to check the concentration and purity of 
the eluted DNA. For PCR experiments DNA samples with minimum 260/280 nm values of 1.8 and 
260/230 nm values of 2 were used, otherwise the DNA was extracted again. 
3.2.2 PCR AMPLIFICATION OF MLST LOCI 
Baldwin et al. (2009) described amplification and nested sequencing primers for the MLST 
loci.  Components were used in various concentrations, i.e. ~10 ng chromosomal DNA, 20 pmol 
reverse and forward primer (Sigma-Aldrich, UK), 1× PCR buffer (Promega, UK) supplemented 
with 1.5 mM MgCl2, 0.8 mM deoxynucleotide triphosphates and 1.25 U Taq (Promega, UK) were 
included in each 25 µl amplification reaction mixture. Initial denaturation at 94°C for 2 min; 30 
cycles of denaturation at 94°C for 1 min, primer annealing at 58°C for 1 min, extension at 72°C for 
2 min; followed by a final extension step of 72°C for 5 min were the reactions conditions for all the 
primers. 
3.2.3 AGAROSE GEL ELECTROPHORESIS 
1% agarose gel was used to visualize the amplified PCR products. The gel was prepared as follows: 
1% (w/v) agarose (Fisher Scientific, UK) was dissolved in 1X Tris-acetate-EDTA (TAE) buffer 
(Geneflow, UK). To dissolve the agarose completely, the solution was heated in a microwave oven 
until the solution becomes clear. In the agarose solution, 0.1 µ/ml (v/v) of SYBR® Safe DNA gel 
stain (Life Technologies – Invitrogen, UK) was added and dissolved well. The gel was then poured 
into a tray and let it for some time to set. After making wells, 5 µl PCR products were loaded into 
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each of the well. A 1kb ladder (Promega, UK) was loaded as marker into one well. Gel 
electrophoresis was performed for 40 minutes at 100V in 1X TAE buffer. The gel was then 
visualized under ultraviolet (UV) light. After that, the DNA bands can be observed using the 
InGenius® gel documentation system (Syngene, UK). 
3.2.4 PCR PRODUCT PURIFICATION 
MinElute PCR Purification Kits (Qiagen, UK) were used to purify the amplified products using the 
manufacturer’s protocol. The products were finally eluded in 50 µl of molecular biology grade 
water (Fisher Scientific, UK). The Nanodrop 2000 (Thermo Scientific, UK) was used to check the 
concentration and purity of the samples. 
3.2.5 DNA SEQUENCING 
The ABI 3730XL sequencing machines by Eurofins MWG Operon (London, UK) and Source 
Bioscience (Nottingham, UK) were used for sequencing. The nucleotide sequences were 
determined on each DNA strand using the nested sequencing primers (Table 3.1). 
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*– Genbank locus of the gene on the C. sakazakii BAA-894 genome (Kucerova et al. 2010) 
 
Table 3.1 Details of the seven MLST loci and the primers used for their amplification and sequencing 
 
3.2.6 ALLELE AND SEQUENCE TYPE DESIGNATION 
For quality control, ChromasLite (Version 2.01, Technelysium Pty Ltd) was used to view the 
sequence chromatograms. For a given locus, the sequences from both the DNA strands were 
aligned and cut to the desired allele length with the help of Jalview (Version 2+; Waterhouse et al. 
2009) in ClustalW (http://www.ebi.ac.uk/clustalw). The newly identified alleles were assigned 
numbers ( by the database editor; Prof SJ Forsythe) arbitrarily according to the order in the 
PubMLST database, called allelic profiles. All alleles within the MLST scheme were in frame, to 
aid the analysis. 
Target 
gene 
Locus*  Putative function  Outer primers (5’-3’) Inner Primers (5’-3’) 
atpD ESA_04006 
ATP synthase β 
chain 
Forward CGACATGAAAGGCGACAT CGAAATGACCGACTCCAA 
Reverse TTAAAGCCACGGATGGTG GGATGGCGATGATGTCTT 
fusA ESA_04401 Elongation factor 
Forward GAAACCGTATGGCGTCAG GCTGGATGCGGTAATTGA 
Reverse AGAACCGAAGTGCAGACG CCCATACCAGCGATGATG 
glnS ESA_02658 
Glutaminyl tRNA-
synthetase 
Forward GCATCTACCCGATGTACG GGGTGCTGGATAACATCA 
Reverse TTGGCACGCTGAACAGAC CTTGTTGGCTTCTTCACG 
gltB ESA_03606 
Glutamate synthase 
large subunit 
Forward CATCTCGACCATCGCTTC GCGAATACCACGCCTACA 
Reverse CAGCACTTCCACCAGCTC GCGTATTTCACGGAGGAG 
gyrB ESA_03973 
DNA gyrase β 
subunit 
Forward TGCACCACATGGTATTCG CTCGCGGGTCACTGTAAA 
Reverse CACCGGTCACAAACTCGT ACGCCGATACCGTCTTTT 
infB ESA_03561 
Translation 
initiation factor IF-2 
Forward GAAGAAGCGGTAATGAGC TGACCACGGTAAAACCTC 
Reverse CGATACCACATTCCATGC GGACCACGACCTTTATCC 
ppsA ESA_02102 
Phosphoenol 
pyruvate synthase 
Forward GTCCAACAATGGCTCGTC ACCCTGACGAATTCTACG 
Reverse CAGACTCAGCCAGGTTTG CAGATCCGGCATGGTATC 
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3.3 CHOICE OF BACTERIAL STRAINS 
In this study, the MLST scheme was applied to three collections of clinical strains that had not 
previously been profiled. These clinical strains were from USA, Israel and the Czech Republic in 
which eleven sequence types (STs) were identified spanning the genus of Cronobacter ; Table 3.2. 
NTU 
ID ST CC Species Country Source atpD fusA glnS gltB gyrB infB ppsA 
1579 4 4 C.sakazakii USA CSF (Patient died) 5 1 3 3 5 5 4 
1566 4 4 C.sakazakii USA CSF 5 1 3 3 5 5 4 
1570 4 4 C.sakazakii USA CSF (Brain infarction) 5 1 3 3 5 5 4 
1567 4 4 C.sakazakii USA Feces (Asymptomatic) 5 1 3 3 5 5 4 
1568 4 4 C.sakazakii USA Opened PIF 5 1 3 3 5 5 4 
1571 4 4 C.sakazakii USA Opened PIF 5 1 3 3 5 5 4 
1576 4 4 C.sakazakii USA Tracheal secretion 5 1 3 3 5 5 4 
1565 107 4 C.sakazakii USA CSF (Brain abscess) 5 50 3 3 5 5 4 
1572 108 4 C.sakazakii USA Opened PIF 5 8 3 3 5 5 4 
1577 110 4 C.sakazakii USA CSF 11 1 3 5 8 5 4 
1578 111 8 C.sakazakii USA 
PIF 
reconstitution 
water 
5 8 7 3 5 15 10 
1573 8 8 C.sakazakii USA Opened PIF 11 8 7 5 8 15 10 
1574 8 8 C.sakazakii USA 
Faeces 
(Diarrheal 
symptoms) 
11 8 7 5 8 15 10 
1575 8 8 C.sakazakii USA 
Faeces 
(Ongoing 
diarrhoea) 
11 8 7 5 8 15 10 
1569 112 112 C.malonaticus USA 
Blood (Clinical 
meningitis 
(Patient died) 
51 7 6 7 62 30 50 
1580 4 4 C.sakazakii Israel Faeces (Asymptomatic) 5 1 3 3 5 5 4 
1581 4 4 C.sakazakii Israel Infant Formula 5 1 3 3 5 5 4 
1582 4 4 C.sakazakii Israel Blender Isolate (Environment) 5 1 3 3 5 5 4 
1583 4 4 C.sakazakii Israel Faeces (Asymptomatic) 5 1 3 3 5 5 4 
1584 4 4 C.sakazakii Israel Faeces (Asymptomatic) 5 1 3 3 5 5 4 
1585 4 4 C.sakazakii Israel Blood (Bacteraemia) 5 1 3 3 5 5 4 
1587 109 4 C.sakazakii Israel CSF (Brain damage) 5 51 3 3 5 5 4 
1586 83 83 C.sakazakii Israel Blood 19 16 19 41 19 15 23 
1826 7 7 C.malonaticus Czech Republic Cannula 10 7 6 7 9 14 9 
1827 7 7 C.malonaticus Czech Republic Cannula 10 7 6 7 9 14 9 
1828 7 7 C.malonaticus Czech Republic Nose swab 10 7 6 7 9 14 9 
1829 7 7 C.malonaticus Czech Republic Throat swab 10 7 6 7 9 14 9 
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1830 7 7 C.malonaticus Czech Republic Throat Swab 10 7 6 7 9 14 9 
1831 7 7 C.malonaticus Czech Republic Throat Swab 10 7 6 7 9 14 9 
1832 7 7 C.malonaticus Czech Republic Throat Swab 10 7 6 7 9 14 9 
1833 7 7 C.malonaticus Czech Republic Stool Dissection 10 7 6 7 9 14 9 
1834 7 7 C.malonaticus Czech Republic Throat Swab 10 7 6 7 9 14 9 
1835 7 7 C.malonaticus Czech Republic Throat Swab 10 7 6 7 9 14 9 
1914 7 7 C.malonaticus Czech Republic Sputum 10 7 6 7 9 14 9 
1917 7 7 C.malonaticus Czech Republic Sputum 10 7 6 7 9 14 9 
1836 4 4 C.sakazakii Czech Republic Wound Swab 5 1 3 3 5 5 4 
1839 4 4 C.sakazakii Czech Republic 
Smear from of 
percutaneous 
endoscopic 
gastrostomy 
5 1 3 3 5 5 4 
1840 4 4 C.sakazakii Czech Republic Sputum 5 1 3 3 5 5 4 
1841 4 4 C.sakazakii Czech Republic Sputum 5 1 3 3 5 5 4 
1842 4 4 C.sakazakii Czech Republic Sputum 5 1 3 3 5 5 4 
1901 4 4 C.sakazakii Czech Republic Sputum 5 1 3 3 5 5 4 
1902 4 4 C.sakazakii Czech Republic Sputum 5 1 3 3 5 5 4 
1903 4 4 C.sakazakii Czech Republic Sputum 5 1 3 3 5 5 4 
1915 4 4 C.sakazakii Czech Republic Sputum 5 1 3 3 5 5 4 
1916 4 4 C.sakazakii Czech Republic Sputum 5 1 3 3 5 5 4 
1838 28 28 Cmuytjensii Czech Republic Sputum 4 24 19 19 4 4 6 
 
 
Table 3.2 The bacterial stains used in this study and their MLST profiles. MLST typing technique involving 
seven loci, each isolate is given a combination of 7 allelic profile numbers. Every distinct combination of 
these profile numbers denotes a sequence type (ST) for the specific isolate. 
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3.4 RESULTS 
3.4.1 MLST OF THE CRONOBACTER CLINICAL STRAINS. 
MLST scheme which was created by Baldwin et al. (2009) is based on the seven housekeeping 
genes: atpD (ATP synthase b chain), fusA (elongation factor G), glnS (glutaminyl t RNA 
synthetase), gltB (glutamate synthase large subunit) gyrB (DNA gyrase subunit B), infB (translation 
initiation factor IF-2) and ppsA (phosphoenolypyruvate synthase A). Table 3.1. 
The alleles of the seven genes of MLST have been effectively amplified and sequenced in this 
study for 41 strains using the primers defined in (Table 3.1). The Cronobacter MLST scheme is 
hosted with open access at http://www.pubmlst.org/cronobacter. The seven housekeeping genes 
have been successfully sequenced from all the clinical strains used in this study ;Table 3.2. 
3.4.2 CRONOBACTER SAKAZAKII ST4 STRAINS (UNITED STATES) AND 
NEONATAL MENINGITIS 
This research has analysed 15 Cronobacter isolates received from Centre for Disease Control 
(CDC). Fourteen out of 15 strains were C. sakazakii and one strain was C. malonaticus. However, 
there was an uneven distribution according to clinical records: all 5 cerebrospinal fluid (CSF) 
isolates were either ST4 or within the ST4 complex (clonal group where strains are identical in 4 or 
more loci). This group included strains from cases during December in Illinois (strain 1577) and in 
Lebanon, Missouri (strain 1579). 
Strain 1577 (ST110), isolated from CSF, is a triple-loci variant of ST4, distinguished by 5/3036 
nucleotides: atpD (1/390nt),gltB (2/507nt), and gyrB (2/402nt). Strain 1578 (ST111), isolated from 
the PIF reconstitution water and associated with the case reported in Illinois, is distinguishable 
from ST4 in 4/7 loci: fusA (5/438nt), glnS (1/363), infB (4/441), and ppsA (19/495). The two 
Illinois strains, 1577 and 1578 (ST110 and ST111), differed from each other at all loci, with 
35/3,036nt differences in total. 
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Strain 1569 (ST112), isolated from blood, was the first reported meningitis case by Cronobacter 
malonaticus which was from an infant (age <1 month) with severe brain damage which led to their 
death. 
3.4.3 CRONOBACTER  SAKAZAKII ST4 STRAINS (JERUSALEM) 
Among the strains collected from Jerusalem, nine were isolated from infants of age ranging from 2 
to 36 weeks. The strains were isolated from a hospital belonging to the Hadassah Medical 
Organisation where 2 infants showed symptoms of bacteraemia and meningitis. These included 
strains 1585 and 1587 while the other strains were from asymptomatic babies (1580, 1581, 1582, 
1583, 1584, and 1586). Seven out of nine strains were previously identified as belonging to the ST4 
clonal complex (Block et al. 2001; 2002). These strains were unique in that they were all found to 
be negative for nitrite reduction. 
 
3.4.4 CRONOBACTER SAKAZAKII ST4 AND CRONOBACTER MALONATICUS 
ST7 STRAINS (CZECH REPUBLIC) 
The Czech Republic clinical strains used in this study have been mainly collected from two 
hospitals Olomouc and Prostejov, and from different departments, sources and patient age. This 
collection primarily comprised C. malonaticus (9/18) were from various age groups belonging to 
the ST7 (1826-1835) which had been isolated from the two hospitals during a six year period. 
Other strains (8/18) of C. sakazakii were ST4 (1836-1903) which had been isolated from Prostejov 
hospital, mainly from the department of internal medicine during one year period. Additionally, 
one strain (1838) was C.muytjensii ST28. This strain has been isolated from sputum in 2012 as the 
only clinical isolate from this species included in this study as shown in Table 3.1. The result 
revealed the predominance of C.sakazakii ST4 strains which have been isolated in 2012 from 
various sources wound swab and sputum. As well as the C.malonaticus ST7 strains which had been 
also obtained between 2007 and 2012, which included  9 strains. These had been isolated from 
throat swab, cannula and stool dissection. 
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Across the three Cronobacter species obtained from outbreaks, the majority of STs were identified 
as C. sakazakii CC4 (28/46) compared with (12/46) C. malonaticus ST7 and only (1/46) C. 
muytijensii ST. The main C. sakazakii STs were CC4 (60 %), and followed by 26% identified as C. 
malonaticus ST7. (Tables 3.3 -3.4) 
 
Table 3.3 Summary of multilocus sequence typing profile of 41 Cronobacter strains obtained between 2002 
and 2012.  
     
Bacterial species STs (CC)* Number of isolates Total of strains 
Percentage 
(%) 
       USA             Israel             CR     
C. sakazakii 4 (4) 7                     6                  10 28 60 
  107 (4) 1                      -                   - 
    108 (4) 1                      -                   - 
    110 (4) 1                      -                   - 
    109 (4) -                      1                   - 
    111 (8) 1                     -                    - 4 8 
  8 (8) 3                     -                    - 
    83 -                     1                    - 1 2 
    
 
    
C. malonaticus 7  -                     -                   12 12 26 
  112 1                     -                     - 1 2 
    
 
    
C. muytjensii 28 -                      -                     1 1 2 
    
 
    
Total   15                  8                     23 46 100 
     * Clonal complex described as clusters of STs with single locus variants (Joseph et al. 2012b).  
%: Total number of each clonal complex. 
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Table 3.4 Breakdown of the Cronobacter STs according to species, isolate sources, country of origin and 
time of isolation. 
 
 
 
 
 
 
Species ST 
No. of 
strains 
Isolation source Country of isolation 
Year of 
isolation 
C. sakazakii 4 21 
Opened PIF, clinical (CSF-tracheal 
secretion, blood), environment 
(blender), 
Czech Republic, USA, 
Israel 2000-2012 
C. malanoticus 7 9 Clinical Czech Republic 2007-2012 
C. sakazakii 8 3 Opened PIF, feces; exposed to PIF USA 2011 
           C. sakazakii 111 1 PIF reconstitution water USA 2011
C. sakazakii 108 1 Opened PIF USA 2011 
C. sakazakii 109 1 Clinical, weaning food Israel 2000 
C. sakazakii 83 1 
Clinical, infant formula, food, herbs, 
spice Israel 2000 
C. malanoticus 112 1 Infant formula Czech Republic 2007-2012 
C. sakazakii 107 1 CSF, exposed to PIF USA 2011 
C. muytjensii 28 1 Clinical Czech Republic 2007-2012 
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3.4.5 PHYLOGENETIC RELATIONSHIP OF THE CRONOBACTER CLINICAL 
STRAINS. 
 
The Cronobacter genus has been studied with the help of phylogenetic trees made on the basis of 
concatenated sequences (comprising of 3036 nucleotides) of the STs of 46 clinical strains (Table 
3.2). The interspecific and intraspecific diversity of the genus can be quantified and the strains can 
be classified on the basis of the source and the virulence groupings. 
The clustering of the different species of Cronobacter in the genus (Figure 3.2) can be observed by 
employing the Maximum Likelihood algorithm in MEGA5 (Tamura et al. 2011). The Maximum-
Likelihood algorithm in MEGA5 was employed for the phylogenetic tree construction. Use of 
sequences of concatenated seven MLST sequences demonstrated improved resolution and effective 
clustering of species of Cronobacter. 
It has been found through phylogenetic studies of Cronobacter genus with the help of the MLSA 
that C. malonaticus and C. sakazakii have strong genetic relationship as they are close to each other 
in the cluster. However, they can still be distinguished which is not possible with 16S rDNA 
sequencing (Baldwin et al. 2009). 
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Figure 3.2 Maximum likelihood tree based on the concatenated sequences (3036 bp) of the 7 MLST 
loci for the genus Cronobacter clinical strains. The STs and clonal complex are indicated at the leaf of 
each branch. MEGA5 with 1000 bootstrap replicates have been used to assess the quality of the tree 
produced. 
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3.4.6 GOEBURST ANALYSIS OF DIVERSITY OF CRONOBACTER STRAINS 
DISTRIBUTION IN OUTBREAKS. 
The use of the MLST scheme has revealed predominant and key stable clones, within the 
Cronobacter genus which are very important from the point of view of epidemiology of the 
organism. 
The goeBURST analysis has revealed the dominance of certain STs such as ST4 and ST7 in the 
Cronobacter population relationships in the process as shown in Figure 3.3 (A-B-C) 
The diversity of sources of isolation based goeBURST analysis of the Cronobacter STs has also 
been done and Figure 3.4 shows that most of the clinical samples contained ST4, ST8, ST7 and 
other STs related to these strains in different countries. The clinically associated Cronobacter 
strains have been grouped into certain STs (CC) by the Cronobacter MLST scheme and stable 
virulent lineages have been described. 
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C. malonaticus 
C. sakazakii 
(A) USA 
(B) Czech Republic 
(C) Israel 
 
C. sakazakii C. malonaticus 
C. muytijensii 
C. sakazakii 
Figure 3.3 goeBURST analysis of Cronobacter STs according to the diversity of the countries of 
isolation/origin. The threshold for the output was set to triple locus variation. The circles with larger 
diameters represent the dominant STs. Clusters of linked isolates correspond to clonal complexes. The strain 
collection was obtained from USA (A), Czech Republic (B) and Israel (C) and compared with the general 
STs destination (pale shade). The dark shade indicates the stability of certain STs such as the ST4 and ST7 
complex isolated from three different countries between 1998-2012.  
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3.5 DISCUSSION 
 
C. sakazakii 
C. muytijensii 
C. malonaticus 
Figure 3.4 Population snapshot of the Cronobacter MLST database generated using the 
goeBURST algorithm, indicating the clonal complexes and the diversity of the source of the  
strains. The dominant STs are presented by the circles with large diameters. The C. 
sakazakii STs 4, 110, 109, 107 and 108 are in clonal complex 4 which is a major clonal 
lineage when one considers the epidemiology of Cronobacter species. ST4 has not only 
proven to be the most common clinical ST, but also the most dominant one.   
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MLST is an efficient molecular technique for typing and has been extensively used for exploring 
numerous bacteria in the context of epidemiological studies and population genetics (Wirth et al. 
2006; Martino et al. 2011; Merga et al. 2011; Urwin and Maiden 2010). In this research, MLST has 
been used to investigate the evolution and diversity of the genus Cronobacter. 
This research began as an extension of the study conducted by Baldwin et al. (2009) which 
subjected C. malonaticus and C. sakazakii to the MLST as these two species were indistinguishable 
by 16S rDNA sequencing. This research was therefore aimed at subjecting all members of 
Cronobacter genus to the MLST while assuring execution of the technique with precision and 
accuracy. 
The multilocus sequencing of the Cronobacter strains of bacteria has helped in defining the 
Cronobacter genus and new detection techniques can be assessed on the basis of this definition. 
This can be of great use to the regulatory authorities and the food industry in ensuring compliance. 
The seven housekeeping genes used for the MLST of Cronobacter were atpD, fusA, glnS, gltB, 
gyrB, infB, and ppsA.  Researchers have used some of these genes as target genes for phylogenetic 
and typing studies of other bacteria belonging to Enterobacteriaceae (Dauga 2002; Brady et al. 
2008; Hedegaard et al. 1999; Paradis et al. 2005; Young and Park 2007). Housekeeping genes are 
present at seven sites scattered across the genome. This is the reason why combination of these 
genes offers better sequence diversity than the conventionally used techniques like 16S rDNA 
sequencing.  
The Cronobacter strains have been profiled by the 7 loci MLST scheme. These strains were 
obtained from the outbreaks occurring in USA, Israel and Czech Republic. The C. sakazakii ST4 
strain has been found to be the predominant strain in the samples taken from the cerebral spinal 
fluid (Joseph and Forsythe 2011). The Cronobacter strains sent to the CDC in 2011 were also 
profiled by the MLST and some of these cases had received a lot of public attention. The ST4 and 
C. sakazakii clonal complex 4 constituted the CSF strains and this validated the results obtained 
from previous research work (Hariri et al. 2012). 
It has been established through microbiological and epidemiological studies that substitutes of 
breast milk (PIF product) can act as a source of Cronobacter infections, although the source of 
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infection is not confirmed in many Cronobacter outbreaks (Caubilla-Barron et al. 2007; FAO-
WHO 2004, 2008). However, an important consideration usually ignored in this connection is that 
fact that a non-infant formula (not intended for neonates) was given to those infants in Tennessee 
(Himelright et al. 2001). 
It has been reported by Sonbol et al. (2013) that C. sakazakii clonal complex ST4 constituted 24% 
of the strains isolated from the manufacturing plants of milk powder located in Germany and 
Australia. Moreover, C. sakazakii ST4 is reported to be linked with meningitis cases and it must 
not be overlooked that it has been isolated on numerous occasions from PIF processing plants, milk 
powder factories and PIF in Australia, Germany, Switzerland and Ireland (Sonbol et al. 2013; 
Power et al. 2013). 
Cronobacter infections which have been found directly connected to the consumption of 
reconstituted PIF might involve extrinsic or intrinsic contamination of the formula during its 
preparation or administration. Reports indicate that in many of the cases caused by contaminated 
infant formula, the reconstituted milk was exposed to an inappropriate temperature that allowed 
growth of any bacteria present in the formula. Moreover, contamination of devices used for 
administration of milk has also been reported to be involved in causing neonatal infections. In  
outbreaks that occurred in the United States and France, young infants were fed with the help of 
perfusion devices. In particular, prepared feed was supplied gradually into the stomach of the 
neonate via enteral feeding tube at room temperature (Caubilla-Barron et al. 2007; Himelright et al. 
2001). Similarly, bacteria may also grow inside the syringe and feeding tube unit used for 
administration of infant feed thereby causing huge quantities of bacterial cells to enter the neonatal 
body. 
It is important to consider that the immune system of neonates is not fully developed and their 
intestinal microflora is also less dense. Hence, if cells of Cronobacter enter the neonatal body in 
huge numbers, the host intestinal flora is unable to manage the invasion efficiently. Once the 
intestinal cells of the host are invaded by the pathogen, the immature immune system does not offer 
sufficient protection against systemic infection. The infectious dose for neonates still needs to be 
determined. 
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According to Bowen and Bradden (2008), several neonatal cases of Cronobacter infection had no 
connection with consumption of reconstituted infant formula. Several lines of evidence are in 
agreement with this report. For instance, colonization by bacteria has been detected in nasogastric 
enteral feeding tubes. Similarly, C. sakazakii has been isolated from ready-to-use formula and 
feeding tubes from neonates fed breast milk (Hurrell et al. 2009a). Furthermore, the bacterium may 
also be present in the breast milk as isolation of the C. malonaticus type strain (LMG 23826T) has 
been reported from breast abscess. In two cases of meningitis, breast milk was found to be a 
suspected source. Neonates, in some states, are still being fed on breast milk of females having 
mastitis (Stoll et al.2004; Holy & Forsythe 2013). In the United States and Israel, Cronobacter 
infections have been reported among infants which have been fed only on breast milk (Block et al. 
2002). 
The throat and intestine of humans, as well as hospital environment have been reported to contain 
Cronobacter species. Hence, risk of Cronobacter infection among neonates cannot be completely 
eliminated by controlling bacteria in PIF. 
Intriguingly, the isolation of C. sakazakii has been reported from sources like sputum, trachea, 
feeding tubes for neonates, ready-to-use infant formula and fed breast milk but no report indicates 
its isolation from infant formula (Holy & Forsythe 2013). For that reason, it is recommended that 
broad range of possible sources of Cronobacter should be studied during an outbreak, instead of 
focusing only on PIF. The NICU outbreak that occurred in France in 1994 revealed that multiple 
strains of Cronobacter may colonize a baby and hence all isolates should be genotyped for 
epidemiological studies so that the sources involved can be traced. (Caubilla-Barron et al. 2007). 
Adults are the common victims of Cronobacter infections which are mainly caused by C. 
malonaticus (Joseph et al. 2012b; Kucerova et al. 2011). Since the bacterium is frequently present 
in food, infection is likely to occur through intake of contaminated food. Still, a nasopharyngeal 
source like that involved in N. meningitdis is also possible and this justifies the isolation of bacteria 
from sputum of pneumonia patients. 
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3.5.1 CLONALITY 
Relatedness among different STs of Cronobacter has been analysed during this research using the 
goeBURST algorithm in PHYLOViZ (Francisco et al. 2012). It can be seen in the diagram Figure 
3.2, that the STs differ in 1, 2 or 3 of the seven loci corresponding to single locus variant (SLV), 
double (DLV) and triple locus variant (TLV) respectively. ST4 and ST107, for instance, differ only 
in the fusA allele (i.e 5-1-3-3-5-5-4 and 5-50-3-3-5-5-4); therefore they are regarded as single locus 
variants. 
The C. sakazakii STs 4, 110, 109, 107 and 108 are in clonal complex 4 which is a major clonal 
lineage when one considers the epidemiology of Cronobacter species. ST4 has not only proven to 
be the most common clinical ST, but also the most dominant one (see Table 3.2 and Baldwin et al. 
2009). Still, the term 'clinical' is not specifically descriptive when it comes to the source of strains. 
These isolates may not necessary reside within the site of infection. For instance, they can be found 
in conjunctivae swabs in meningitis case patients. Some have been isolated from asymptomatic 
persons as well. Fortunately, substantial data was at hand for these clinical isolates to disclose what 
is potentially the most important information brought to light by the MLST analysis related to the 
trophism and epidemiology of Cronobacter infection in neonates. Researchers regard CC4 as the 
genetic signature for C. sakazakii meningitis affecting neonates as most of the isolates have been 
found to be linked with meningitis patients from six different states during the past 50 years 
(Joseph and Forsythe. 2011; Hariri et al. 2012). Of the sixty-four clinical isolates which have been 
studied in this research, twenty-nine are C. sakazakii ST4 and loci variants (STs 109, 107, 108, and 
110). Our knowledge regarding reasons for the predominance of CC4 in patients of neonatal 
meningitis is still deficient and may depend on the role played by virulence traits and 
environmental fitness factors. Another possible explanation for the lack of reports of meningitis in 
adults is because of the blood brain barrier’s maturity. 
Two ST4 SLVs were found in the fifteen 2011 US strains. Strain 1572 (ST108) demonstrated 
variation from ST4 profile in the fusA loci by 5/438 nt. This strain was isolated from an opened PIF 
tin. The CSF strain 1565 (ST107) demonstrated variation from the ST4 profile in fusA loci by 
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6/438 nt. Moreover, ST107 and ST108 differ from each other only by 1 nt out of 3036 
(concatenated length) in the fusA loci position 378 (A: T). The PFGE could not detect this small 
difference. It is worth mentioning that the bacterial genome is analysed through the MLST and 
PFGE in different ways. Moreover, the seven MLST loci do not contain any Xbal sites which are 
the  sites for the activity of endonucleases that are employed during the PFGE of 
Enterobacteriaceae. 
The C. malonaticus ST7 is the dominant sequence type and comprises of several strains isolated 
during last 30 years from clinical and PIF cases. ST7 includes strains 1826-1835, 1914, 1917 
isolated from clinical cases in the Czech Republic. These were detected in sputum, stool dissection, 
cannula, nose, wound and throat swabs. As per the available data, the majority of these strains were 
isolated from individuals who were not infants.  
The C. malonaticus CC112 1569 strain also belongs to the studied 2011 US isolates and was 
isolated from blood specimen of the infant (less than one month) who died of meningitis. This 
strain is also of immense importance in this study since until that time C. malonaticus was found to 
mainly cause infections among adults and none of the neonatal meningitis cases were found to be 
caused by this species (Joseph and Forsythe. 2011). It shows that substantial brain damage can be 
caused by non-clonal complex 4 strains as well, though rarely. 
It can therefore be stated that the MLST technique is an efficient and vigorous typing method for 
the genus Cronobacter as it has demonstrated an increased degree of discrimination between 
different clinical strains. 
Owing to its convenient execution and inexpensive methodology, the MLST has turned into a 
preferred typing technique as compared to other techniques calling for greater time and effort like 
the PFGE. Moreover, the enormous amount of data acquired from gene sequencing has facilitated 
the determination of the substantial diversity demonstrated by the genus Cronobacter and also the 
identification of inter-species evolutionary relationships.  
Since control of C. sakazakii ST4 can lead to considerable reduction in neonatal fatal infections, 
identification of different sources of this strain is highly important. Careful evaluation of neonatal 
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exposure allows in depth study of prevalence of Cronobacter species, especially ST4 in healthcare 
settings, PIF and other sources. 
In summary; 
The Cronobacter MLST scheme is based on the seven genes atpD, fusA, glnS, gltB, gyrB, infB and 
ppsA. The expansion of the MLST scheme across the entire genus and subsequent sequence 
analysis has contributed to a number of key aspects of the genus: 
 Revealed the phylogenetic relationships and diversity between the species. 
 
 Revealed the strong clonality of the C. sakazakii and C. malonaticus species. 
 
 Identified a clonal lineage for a majority of the neonatal meningitic cases – the C. sakazakii 
ST4 clonal complex. 
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4.1 INTRODUCTION 
4.1.1 SIALIC ACID UTILISATION AND ITS ROLE IN BACTERIAL 
PATHOGENICITY 
Sialic acid or neuraminic acid refers to a family of nine-carbon keto sugars that may be found on 
mammalian mucosal surfaces such as the intestinal gut lining, brain, secretions of the mouth and 
lungs as well as milk. These are sites colonized by a wide range of bacteria for which this sialic 
acid can act as an attachment site and a source of carbon and nitrogen (Wang 2009). 
Around fifty different forms of sialic acid have been identified and the 2-keto-3-deoxy-5-
acetamido-D-glycero-D-galacto-nonulosonic acid is the most researched form among these. It is 
mostly known by its abbreviation Neu5Ac. In general, sialic acid exists attached to sugars forming 
polysaccharides, though it can also be found attached to proteins or lipids forming sialo-
glycoconjugates. Except in a small number of eukaryotes, numerous eukaryotic lineages lack 
conjugates of sialic acid including the majority of protostomes, protists, fungi and plants. 
According to a proposition, the evolution of sialic acid production took place in animals. Later this 
process evolved in bacterial commensals and pathogens either through horizontal gene transfer or 
convergent evolution. Several mechanisms have been evolved in microorganisms which involve 
utilization of sialic acids as a target for mimicry, degradation and adherence (Severi et al. 2007; 
Almagro-Moreno and Boyd 2009). 
NanH gene is present in some bacteria enabling them to synthesize sialidase or neuraminidase 
which brings about the release of sialic acid by cleaving it from glycoconjugate forms. Studies 
indicate low homology (less than 30%) of nanH gene across different groups of bacteria and 
several organisms have been found to lack this gene (Roggentin et al. 1993). Neonatal meningitic 
E. coli K1 is one of those strains which lack sialidase enzyme though it can grow on sialic acid as 
acarbon source. It is possible that these bacteria exploit the sialidase activity of other bacteria 
present in the surroundings or that of host cells which produce this enzyme in inflammatory 
conditions (Severi et al. 2009).  
 
74 
 
CHAPTER 4 SIALIC ACID UTILIZATION AND ITS ROLE IN BACTERIAL PATHOGENICITY. 
 
A porin present in outer membrane of Gram-negative bacteria namely, NanC, is responsible for the 
uptake of sialic acid. In the case of inner membrane, three different transporters may be present 
namely ATP-binding cassette (ABC) transporter, TRAP and NanT. TRAP refers to a tripartite 
ATP-independent periplasmic transport system and NanT refers to a major facilitator superfamily 
(MFS) protein. The literature indicates that the single-component NanT transport system is present 
in all Enterobacteriaceae researched so far (Severi et al. 2007; Almagro-Moreno and Boyd 2009; 
Vimr 2012). 
As soon as the sialic acid enters the cell, it gets converted into phosphoenolpyruvate (PEP) and N-
acetylmannosamine (ManNAc) by the Neu5Ac lyase (NanA). ManNAc is acted upon by NanK 
which is an ATP-dependent kinase and this activity results in the production of N-
acetylmannosamine-6-phosphate (ManNAc-6-P) which in turn is converted into ManNAc-6-P into 
N-acetylglucosamine-6-phosphate (GlcNAc-6-P) by epimerase (NanE). This is followed by 
conversion of GlcNAc-6-P by glucosamine-6-P deaminase (NagB) and GlcNAc-6-P deacetylase 
(NagA) resulting in formation of fructose-6-phosphate which gets consumed in the glycolytic 
pathway (Figure 4.1). According to Almagro-Moreno and Boyd (2009), the activity of these genes 
is regulated by NanR which is basically a repressor. Genes encoding the initial 3 enzymes (nanA, 
nanK and nanE) are mostly present in the form of gene cluster namely nan gene cluster. Still, a few 
exceptional cases have been reported by Vimr (2013). These include Edwardsiella tarda and 
Citrobacter freundii and in these bacteria, the nanE gene is found to be present in an area separate 
from the operon. Furthermore, the nagA and nagB genes are present adjacent to each other though 
in majority of the bacteria they are not found in close proximity with the nan gene cluster. 
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Vimr (2012) reports an association between uptake of sialic acid and several virulence factors of 
pathogenic bacteria. For instance, numerous bacteria produce glycolipid capsule in order to evade 
the host’s immunity. Same is the case with neonatal meningitic E. coli K1 which utilizes sialic acid 
to alter its cell surface. Similarly, Cronobacter forms a capsule, particularly when cultured on milk 
agar. 
Genes encoding the enzymes for degradation of N-acetylmannosamine and N-acetylneuraminate 
(nanKTAR genes) and the gene cluster responsible for production of a presumed sugar isomerase 
(yhcH) are found to be present at ESA_03609-13 as reported in the past for the C. sakazakii BAA-
894 (Joseph et al. 2012a and 2012b). The rest of the nan genes involved in the metabolism of sialic 
acid still need to be investigated in detail as the bioinformatic studies conducted in past were not 
successful in identification of any sialidase (nanH) gene candidate in Cronobacter sakazakii  
Figure 4.1 Sialic acid utilization in Cronobacter sakazakii. 
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(Joseph et al. 2012b). 
A number of infections among low birth weight neonates are caused by C. sakazakii and the ability 
of the organism to grow on sialic acid may be associated with its ability to cause infection. Sialic 
acid is found in human milk in the form of sialyloligosaccharides and these are present in greatest 
quantities in colostrums (Wang 2009). 
At three of the four lactation stages, mothers of preterm infants produce milk with 13-23% greater 
quantity of sialic acid as compared to mothers of full-term infants. Sialic acid attached with 
glycoproteins is also present in infant formulas. Even though the nutritional value of sialic acid still 
needs to be investigated, it is quite possible that it has a role in the build-up of sialic acid in the 
brain as an essential part of ganglioside. Wide range of oligosaccharides, lactoferrin, secretory IgA 
and sialoglycans are also present in breast milk. Oligosaccharides present in breast milk are almost 
undigestable and hence metabolized by intestinal bacteria thereby encouraging the growth of 
bacteria in the intestine. Microvilli in the intestine of neonates contain greater quantities of N-
acetylglucosamine residues and sialic acid. Conversely, increased quantities of fructose, glucose 
and mannose residues are present in the case of adults. These microvilli act as site of attachment 
for bacteria (Sprenger and Duncan 2012; Lewis and Lewis 2012). 
According to Wang (2009), the main site of sialic acid in the form of gangliosides (sialylated 
glycolipids) is the brain. It is therefore possible that the structural and functional establishment of 
synaptic pathways involve sialic acid. Moreover, C. sakazakii might have a developmental reliance 
on access to the CNS just like the H. influenzae, S. pneumoniae and N. meningitidis that cause 
meningitis in children younger than five years. 
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4.1.2 AIMS OF THE CHAPTER 
The Cronobacter genus is composed of seven species and the most severe fatal cases have been 
reported in infants and neonates (Hariri et al. 2013). These bacteria have been known to cause 
necrotizing enterocolitis and extremely destructive type of meningitis that involves bacteria 
crossing the blood brain barrier resulting in abscess formation in brain cavity. Multilocus sequence 
typing has been used to describe the diversity of the genus in previous studies by Joseph et al. 
(2012a and 2012b). Evolutionary analysis suggests that the C. sakazakii species separated from the 
rest of the Cronobacter genus 15–23 million years ago (MYA) (Joseph et al. 2012). Previous 
whole genome studies revealed that C. sakazakii was the only Cronobacter species that has the 
nanAKT gene cluster encoding for sialic acid utilization (Kucerova et al. 2010; Joseph et al. 
2012c). It is plausible that this metabolism may account for the predominance of C. sakazakii in 
neonatal and infant infections. Prior to the study reported here no laboratory studies have been 
published investigating the growth of Cronobacter on sialic acid nor have there been reported of 
sialidase activity. 
This chapter will describe the variation in growth by members of the Cronobacter genus on sialic 
acid, genomic structure and the variation in the gene content of Cronobacter associated with sialic 
acid utilization. Part of results presented in this chapter have been accepted for publication; Joseph 
et al. (2013). 
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4.2 MATERIALS AND METHODS 
The key methods, culture media and culturing condition for this section were described  
previously in Chapter 2 Materials and Methods section. 
4.3 BACTERIAL STRAINS LIST IN THIS STUDY 
Isolate Species 
Sequence  
Type a Country Source Year 
658*b C. sakazakii ST1 USA Non-infant formula 2001 
716 C. sakazakii ST14 France Infant formula 1994 
978 C. sakazakii ST3 UK Clinical 2007 
984 C. sakazakii ST3 UK Clinical 2007 
553 C. sakazakii ST4 Netherlands Clinical 1977 
557 C. sakazakii ST4 Netherlands Clinical 1979 
558 C. sakazakii ST4 Netherlands Clinical 1983 
695 C. sakazakii ST4 France Clinical 1994 
701* C. sakazakii ST4 France Clinical 1994 
709 C. sakazakii ST4 France Clinical 1994 
767 C. sakazakii ST4 France Clinical 1994 
6 C. sakazakii ST4 Canada Clinical 1990 
20 C. sakazakii ST4 Czech Republic Clinical 2003 
377 C. sakazakii ST4 UK Milk powder 1950 
1105 C. sakazakii ST4 UK Weaning food 2008 
4 C. sakazakii ST15 Canada Clinical 1990 
12 C. sakazakii ST1 Czech Republic Clinical 2004 
150 C. sakazakii ST16 Korea Spice 2005 
680* C. sakazakii ST8 USA Clinical 1977 
1* C. sakazakii ST8 USA Clinical 1980 
5* C. sakazakii ST8 Canada Clinical 1990 
520 C. sakazakii ST12 Czech Republic Clinical 1983 
690 C. sakazakii ST12 France Clinical 1994 
696* C. sakazakii ST12 France Clinical 1994 
693 C. sakazakii ST13 France Clinical 1994 
681C C. malonaticus ST7 USA Clinical 1977 
510 C. malonaticus ST7 Czech Republic Food 1985 
507* C. malonaticus ST11 Czech Republic Clinical 1984 
564* C. turicensis ST5 USA Clinical 1970 
581* C. universalis ST54 UK Water 1956 
721 C. sakazakii ST4 USA Clinical 2003 
92 C. turicensis ST35 UK Herb 2004 
1218 C. sakazakii ST1 USA Clinical 2001 
1219 C. sakazakii ST4 USA Clinical 2009 
1211*d C. turicensis ST19 Switzerland Clinical 2005 
1249 C. sakazakii ST31 UK Clinical 2010 
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1330*e C. condimenti ST40 Slovakia Food 2010 
1220* C. sakazakii ST4 USA Clinical 2003 
1221* C. sakazakii ST4 USA Clinical 2003 
1231* C. sakazakii ST4 New Zealand Clinical 2005 
1240 C. sakazakii ST4 USA Clinical 2009 
1225* C. sakazakii ST4 USA Clinical 2007 
140 C. sakazakii ST40 India Spice 2005 
582* C. dublinensis ST36 UK Unknown  - 
685 C. malonaticus ST53 USA Clinical 1977 
1210 C. dublinensis ST106 Ireland Environment 2004 
583 C. dublinensis ST91 UK Environment 1956 
687 C. malonaticus ST60 Czech Republic Clinical 2004 
694 C. sakazakii ST4 France Clinical 1994 
708 C. sakazakii ST12 France Clinical 1994 
711 C. sakazakii ST7 France Clinical 1994 
712 C. sakazakii ST4 France Infant formula 1994 
1545 C. malonaticus ST84 Czech Republic Clinical  - 
1553 C. turicensis ST85 Slovakia Unknown  - 
1554 C. turicensis ST87 Slovakia Unknown  - 
700 C. sakazakii ST86 France Clinical 1994 
1556 C. dublinensis ST88 USA Clinical 1979 
1558 C. malonaticus ST89 Czech Republic Clinical  - 
1560 C. dublinensis ST92 Czech Republic Food  - 
1533 C. sakazakii ST4 Germany Environment 2006 
1536 C. sakazakii ST1 Germany Environment 2009 
1537 C. sakazakii ST4 Germany Environment 2009 
1542 C. sakazakii ST4 Germany Environment 2009 
691 C. sakazakii ST4 France Clinical 1994 
692 C. sakazakii ST4 France Clinical 1994 
698 C. sakazakii ST4 France Clinical 1994 
699 C. sakazakii ST1 France Clinical 1994 
702 C. sakazakii ST4 France Clinical 1994 
703 C. sakazakii ST12 France Clinical 1994 
705 C. sakazakii ST4  France Clinical 1994 
706 C. sakazakii ST4 France Clinical 1994 
707 C. sakazakii ST4 France Clinical 1994 
713 C. sakazakii ST13 France Infant formula 1994 
714 C. sakazakii ST13 France Infant formula 1994 
715 C. sakazakii ST13 France Infant formula 1994 
730 C. sakazakii ST4 France Clinical 1994 
1569 C. malonaticus ST112 USA Clinical 2011 
1587* C. sakazakii ST4 Israel Clinical 2000 
ES15 C. sakazakii ST125 Korea Whole grain  - 
1846 C. malonaticus ST60 Czech Republic Ingredient 2010 
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1880 C. turicensis ST262 Czech Republic Herb 2011 
SP291 C. sakazakii ST4 Ireland Infant formula factory  - 
Sc-1383T*F 
Siccibacter 
colletis ST227 UK Ingredients 2011 
Fh-1387* 
Franconibacter 
helveticus ST298 UK Spice 2011 
Fh-1392* 
Franconibacter 
helveticus ST229 UK Ingredients 2011 
St-1974T*G 
Siccibacter 
turicensis ST216 Switzerland Fruit powder 2007 
Fh-1975T*H 
Franconibacter 
helveticus ST217 Switzerland Fruit powder 2007 
Fh-1204* 
Franconibacter 
helveticus ST217 Jordan Follow up formula 2009 
Fh-1208* 
Franconibacter 
helveticus ST217 Portugal Follow up formula 2009 
Fp-1978* 
Franconibacter 
pulveris ST215 Switzerland Infant formula 2008 
Ck-BAA-895 Cit.koseri ST6 US    - 
LMG23826 C. malonaticus ST7 USA Clinical 1977 
ES713 C. sakazakii ST218 USA Infant formula  - 
ES35 C. sakazakii ST8 Israel Clinical  - 
G-2151 C. sakazakii ST4 USA Clinical  - 
E764 C. sakazakii ST12 USA Clinical  - 
LMG 23823 C. dublinensis ST106 Ireland Environment 2004 
LMG 23824 C. dublinensis ST80 Switzerland Water 2004 
LMG 23825 C. dublinensis ST79 Zimbabwe Environment 2003 
ATCC 51329 C. muytjensii ST81 Unknown Unknown  - 
NCTC9529T C. universalis ST54 UK Water 1956 
Fp-G-601/05T 
Franconibacter 
pulveris ST232 Switzerland Fruit powder 2007 
Fp-G-1160/04 
Franconibacter 
pulveris ST231 Switzerland Fruit powder 2007 
St-z610 
Siccibacter 
turicensis ST216 Unspecified -  2007 
Fh-1159 
(LMG23733) 
Franconibacter 
helveticus - Switzerland Fruit powder 2004 
2089 C. sakazakii ST1 France Clinical 2004 
2106 C. sakazakii ST257 Belgium Clinical  - 
2107 C. sakazakii ST12 Belgium Clinical  - 
Fp-1991* 
Franconibacter 
pulveris ST232 UK Food 2013 
CMCC 45402 C. malonaticus ST7 China Milk  - 
2109 C. malonaticus ST300 Canada Unknown  - 
530* C. muytjensii ST49 Denmark  -  - 
2030 C. dublinensis ST301 France  -  - 
2045 C. malonaticus ST302 France Environmental  - 
2046 C. malonaticus ST302 France Environmental  - 
2051 C. sakazakii ST64 France Environmental  - 
HPB5174 C. sakazakii ST40 Ireland Environment  - 
2048 C. sakazakii ST8 France Environmental  - 
2064 C. sakazakii ST1 France Environmental  - 
2087 C. sakazakii ST100 France Environmental  - 
2161 C. sakazakii ST297 Mexico Environmental 2010 
NBRC 102416T C. sakazakii ST8 Japan Clinical 1980 
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48* Cit.koseri - Unknown Clinical - 
1926* Ed. Tarda - Unknown Unknown - 
1927* Cit.freundii - Unknown Unknown - 
 
Table 4.1 List of Cronobacter spp. and related Enterobacteriaceae isolates included in this study 
a Sequence type as according to the Cronobacter genus multilocus sequence typing scheme database; 
http://www.pubMLST.org/cronobacter. 
*Bacterial strains used for laboratory studies of growth on sialic acid, GM1 and mucin as sole carbon source. 
bC. sakazakii species type strain ATCC29544T. 
c C. malonaticus species type strain LMG 28327T. 
d C.turicensis species type strain LMG 28327T. 
e C. condimenti species type strain.  
FSiccibacter colletis species type strain 
GSiccibacter turicensis species type strain 
HFranconibacter helveticus species type strain. 
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4.4 RESULT 
 
4.4.1 GROWTH OF CRONOBACTER AND CLOSELY RELATED SPECIES ON 
SIALIC ACID, GM1 AND MUCIN 
The utilization pathway for sialic acid was confirmed through two stages in this study. Firstly 19 
Cronobacter strains were selected which represented the seven recognized species, and included 
those from reported clinical cases and species type strains 
;1b,5,658,680,696,701,1220,1221,1225,1231,1587,507,681c,581,564,1211d,530,582,1330e, Table 
4.1. 
In order to verify whether these strains encoded the nan cluster have the capability to grow using 
sialic acid, ganglioside or mucin as a carbon source, the growth study have been performed by 
measuring the absorbance of the cultures at 595 nm using a plate reader on minimal media 
supplemented with A (M9+sialic acid), B (M9+ganglioside), and C (M9+mucin). The data 
obtained was exported to an excel sheet and the growth curve was made using Graphpad prism. 
Eleven strains of C. sakazakii grew in minimal medium (M9) with sialic acid, monosiaganglioside 
GM1 and mucin as the only carbon source suggesting that they may have sialidase activity as 
shown in Figure 4.2. None of other Cronobacter species demonstrated growth in these media. 
Cronobacter turicensis (1211d) and Citrobacter. koseri (48) were used as negative and positive 
control respectively. This work has been published (Joseph et al. 2013). 
During the late steps of the current PhD, whole genomes have been studied to advance our 
understanding of the Cronobacter genus (http://www.pubMLST.org/cronobacter). As a result, 
some of Cronobacter turicensis strains appear to encode the nanKTAR cluster. For this reason the 
next step was to examine the growth of all the Cronobacter turicensis strains in our database. Ten 
out of 24 (42%) have been growing in all the M9 supplemented with sialic acid substrates, showed 
in the maximum likehood tree of C. turicensis; Figure 4.3.  
83 
 
CHAPTER 4 SIALIC ACID UTILIZATION AND ITS ROLE IN BACTERIAL PATHOGENICITY. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 Growth of Cronobacter and closely related species in M9 minimal medium supplemented with a) sialic acid, b) GM1 ganglioside 
and c) Mucin as sole carbon source. Eleven strains of C. sakazakii grew in minimal medium (M9) with sialic acid, monosiaganglioside GM1 
and mucin as the only carbon source suggesting that they may have sialidase activity. None of other Cronobacter species demonstrated growth 
in these media. Cronobacter turicensis (1211) and Citrobacter. koseri (48) were used as negative and positive control respectively. 
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B) GM1 GANGLIOSIDE 
C) MUCIN 
C. turicensis 
C. turicensis 
C. turicensis 
C. sakazakii 
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Figure 4.3 Maximum likehood tree of all Cronobacter spp., closely related Enterobacteriaceae and C. 
turicensis particularly obtained from http://www.pubMLST.org/cronobacter. Eleven out of 24 (45%) have 
been growing in all the M9 supplemented with sialic acid substrates. The NTU strains IDs are showed at the 
top of each branches, the tree is drawn to scale using MEGA5, with 1000 bootstap replicates. This tree based 
on the concatenated sequences (3,036 bp) of the seven MLST loci. 
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Figure 4.4 Maximum Likelihood tree all Cronobacter spp., closely related Enterobacteriaceae and C. turicensis particularly based on the 
concatenated sequences (3,036 bp) of the seven MLST loci. The phylogeny indicated 3 clusters in C. turicensis, the red and blue circle indicated the 
positive and negative species for utilizing sialic acid respectively.  The tree is drawn to scale using MEGA, with 1000 bootstrap 
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4.4.2 GENOME STRUCTURE OF POSITIVE SIALIC ACID UTILIZATION 
GENOMES CRONOBACTER SPP. AND CLOSELY RELATED SPECIES OF 
ENTEROBACTERIACEAE.   
 
The Maximum Likelihood tree based on the concatenated sequences (3,036 bp) of the seven MLST 
loci was used to analyse the variation within Cronobacter spp. and closely related 
Enterobacteriaceae. The red and blue circle indicated the positive and negative species utilizing 
sialic acid respectively (Figure 4.4). 
Initially, the genome of C. sakazakii 658 was selected since it was the first complete C. sakazakii 
genome available publically (Kucerova et al. 2010). The comparison of isolate C. sakazakii 658  
against C. turicensis and closely related Enterobacteriaceae (E. coli, Cit. koseri, F. pulveris and S. 
turicensis) positive to utilize sialic acid was undertaken using Artemis comparison tool (Carver et 
al. 2005) to consider if the sialic acid utilization cluster genes were acquired or lost in Cronobacter 
as a result of genome evolution. 
Figure 4.5 showed the genomic structure of cluster NanKTAR encodings for the proteins involved 
in the uptake and utilization of exogenous sialic acid to the genomes of C. sakazakii BAA-894 
(Joseph et al. 2013) , C. turicensis and closely related Enterobacteriaceae. Also the high degree of 
colinearity of  the alignment between different genomes have been shown. Furthermore, the whole 
cluster is located in a certain location flanked by some conserved housekeeping trait (gltB) and 
starvation gene (sspA) thereby suggesting loss from other Cronobacter spp. instead of separate 
acquisition events.  
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Figure 4.5 shows the genomic structure of cluster nanKTAR encoding for the proteins involved 
in the uptake and utilization of exogenous sialic acid to the genomes of C. sakazakii BAA-894, 
C. turicensis and closely related Enterobacteriaceae. The high degree of colinearity of the 
alignment between different genomes have been indicated in the red arrow. The whole cluster is 
located in  a certain location flanked by the conserved housekeeping trait (gltB) and starvation 
gene (sspA) 
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4.4.3 DISTRIBUTION OF SIALIC ACID UTILIZATION GENES 
To provide a platform to confirm the findings of the current study, all of sialic acid metabolism 
genes in Cronobacter and other closely related Enterobacteriaceae have been studies (Figure 4.6)  
by using BLAST facility 
(http://pubmlst.org/perl/bigsdb/bigsdb.pl?db=pubmlst_cronobacter_isolates&page=plugin&name=
BLAST).   
One of the interesting gene clusters, unique to the genomes of C. sakazakii is the loci cluster 
ESA_03609–13 C. sakazakii BAA-894 loci number. This cluster encodes for the proteins involved 
in the uptake and utilization of exogenous sialic acid.  
 A putative sugar isomerase (YhcH) ESA_03609  
 NanKTAR genes involved in the N-acetylneuraminate and N-acetylmannosamine 
degradation pathway ESA_03610-13.  
 N-acetylmannosamine kinase nanK gene (ESA_03610) 
 Sialic acid permease transporter nanT (ESA_03611) 
 N-acetylneuraminate lyase nanA (ESA_03612)  
 Transcriptional regulator from the GntR family nanR (ESA_03613).  
The nanE locus encoding the enzyme N-acetylmannosamine-6-phosphate-2epimerase was located 
separate from this cluster at ESA_00529, and unlike the rest was found conserved across the 
genomes of the Cronobacter genus. For that reason an additional nanE locus from Cit. koseri 
(CKO_04626), Escherichia coli str. K-12 (Y75_P3143) and Edwardella tarda (ETAF_0472) have 
been used for comparative purposes. 
ESA_03302, encoding NanC was another locus involved in this metabolic cycle – the N-
acetylneuraminic acid outer membrane channel protein. This was found to be unique to the 
genomes of C. sakazakii. ESA_02661 (nagB), ESA_02662 (nagA) and ESA_03772 (neuC) were 
also essential to the sialic acid metabolism cycle. They were found preserved across the genomes 
of the Cronobacter genus and are located neighboring to each other in all the genomes. 
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Essentially nanAKRT and yhcH were only found in the genomes of 100 % (n= 73) C. sakazakii, 66 
% (n=6) of C.turicensis and none in the other Cronobacter species. These genes were also found in 
Franconibacter pulveris (n=4) and Siccibacter turicensis (n=3), and were not found in the related 
Enterobacteriaceae members Franconibacter helveticus or Siccibacter colletis. NeuC encoding for 
UDP-N-acetylglucosamine 2-epimerase was found in all Cronobacter and related species. 
All C. sakazakii strains can hypothetically transport the exogenous sialic acid into the cytoplasm of 
their cells. Interestingly, all the Cronobacter species genomes also showed the presence of the 
genes (siaPQM) encoding for the TRAP transporter. 
 
 
 
 
 
 
 
Figure 4.6 Distribution of the sialic acid utilisation and other related genes across the sequenced 
genomes of the Cronobacter genus and closely related species. 
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4.4.4 % GC CONTENT OF SIALIC ACID UTILIZATION GENES 
The GC % content analysis of each sialic acid utilization genes was carried out to indicate possible 
horizontal gene transfer via calculated using WWW.endmemo.com software. The nanT, nanA and 
nanR genes of the C.sakazakii genomes revealed average GC% values of 57.14%, 57.22% and 
56.32% respectively which is comparable to the average 56% GC content of the C. sakazakii 
genome BAA-894. Whereas nanK and nanE revealed slightly higher values of 62.21% and 63.18% 
respectively. In contrast nanC gene had a much lower 47.44 GC% content, which is closely related 
with Cit. koseri 48% organism. 
The nagA, nagB, neuC and siaPQM genes in Cronobacter sakazakii revealed GC% content values 
of 56.39%, 53.05%, 59.20% and 55.28% respectively. 
However, the nanT, nanA and nanR genes of the C. turicensis genomes revealed average GC% 
values of 57.07%, 57.45 % and 53.76% respectively which is comparable to the average 58.4% GC 
content of the Cronobacter turicensis z3032. In contrast, nanK and nanE revealed slightly higher 
values of 61.64% and 62.60% respectively. 
The nagA, nagB, neuC and siaPQM genes of the C. turicensis genomes as well revealed GC% 
content values of 57.52%, 53.8, 59.85 % and 55.18 % respectively. Table 4.2 shown the GC% 
content value of C. sakazakii and C. turicensis and other closely related species. 
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Genes      Species     
  C. sakazakii C. turicensis 
Franconibacter 
pulveris 
Siccibacter 
turicensis Cit. koseri 
Average 
(%) 56 57.21 56.60 57.80 53.80 
      
yhcH 54.62 55.05 52.96  - 55.13 
nanK 62.21 61.64 62.67 70.58 62.44 
nanT 57.14 57.07 58.69 61.46 57.44 
nanA 57.22 57.45 56.38 58.88 55.65 
nanR 56.32 53.76 56.56 60 56.34 
nanC 47.44  -  -  - 48 
nanE 63.18 62.6  -  -  - 
nagA 56.39 57.52 56.22 56.3 53.35 
nagB 53.05 53.8 53.05 54.55 52.18 
neuC 59.2 59.85 52.76 53.22 55.15 
siaPQM 55.28 55.18 57.29 57.2 54.23 
            
 
Table 4.2 GC % content values of C. sakazakii, C. turicensis and other closely related species. 
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C. sakazakii 
 
 
Figure 4.7 Maximum likehood tree of protein NanA of C.sakazakii and C.turicensis and related 
Enterobacteriaceae species. The NTU strains IDs are showed at the top of each branches, the tree is 
drawn to scale using MEGA5, with 1000 bootstap replicates. 
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Cit. koseri 
 
 
Figure 4.8 Maximum likehood tree of protein NanR of C. sakazakii, C.turicensis and related 
Enterobacteriaceae species. The NTU strains IDs are showed at the top of each branches, the tree is 
drawn to scale using MEGA5, with 1000 bootstap replicates. 
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Cit. koseri 
 
Figure 4.9 Maximum likehood tree of protein NanK of C.sakazakii, C.turicensis and related 
Enterobacteriaceae species. The NTU strains IDs are showed at the top of each branches, the tree is drawn to 
scale using MEGA5, with 1000 bootstap replicates. 
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 Cit. koseri 
 
F. pulveris 
S. turicensis 
Figure 4.10 Maximum likehood tree of protein NanT of C.sakazakii, C.turicensis and related 
Enterobacteriaceae species. The NTU strains IDs are showed at the top of each branches, the tree is 
drawn to scale using MEGA5, with 1000 bootstap replicates. 
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Figure 4.11 Maximum likehood tree of protein yhcH of C. sakazakii, C. turicensis and related 
Enterobacteriaceae species. The NTU strains IDs are showed at the top of each branches, the 
tree is drawn to scale using MEGA5, with 1000 bootstap replicates. 
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Figure 4.12 Maximum likehood tree of protein nanE of Cronobacter and related 
Enterobacteriaceae species. The NTU strains IDs are showed at the top of each branches, the 
tree is drawn to scale using MEGA5, with 1000 bootstap replicates. 
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Cit.. koseri  
Figure 4.13 Maximum likehood tree of protein NanC of C. sakazakii and related 
Enterobacteriaceae species. The NTU strains IDs are showed at the top of each branches, the tree 
is drawn to scale using MEGA5, with 1000 bootstap replicates. 
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Cit. koseri 
Figure 4.14 Maximum likehood tree of protein NagA of Cronobacter and related Enterobacteriaceae 
species. The NTU strains IDs are showed at the top of each branches, the tree is drawn to scale using 
MEGA5, with 1000 bootstap replicates. 
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 Cit. koseri 
Figure 4.15 Maximum likehood tree of protein NagB of Cronobacter and related Enterobacteriaceae 
species. The NTU strains IDs are showed at the top of each branches, the tree is drawn to scale using 
MEGA5, with 1000 bootstap replicates. 
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Figure 4.16 Maximum likehood tree of protein NeuC of Cronobacter and related 
Enterobacteriaceae species. The NTU strains IDs are showed at the top of each branches, the 
tree is drawn to scale using MEGA5, with 1000 bootstap replicates. 
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4.4.5 PHYLOGENETIC ANALYSIS 
The uniqueness of the core sialic acid-related gene cluster to the C. sakazakii and some of 
C.turicensis genomes hints at a role in the evolution of the virulence of the organism. The predicted 
amino acid sequences of the proteins encoded by these nan cluster genes were individually 
analysed and their phylogenetic relationships observed with closely related Gram-negative bacteria 
have been indicated in Fig. 4.7 to 4.16. In the case of each of the genes, the C. sakazakii sequences 
formed an independent cluster of their own, with the other Enterobacteriaceae Cit. koseri, 
Franconibacter pulveris and Siccibacter turicensis members clustering on the neighbouring 
branches. 
In the nanA (Fig.4.7) and nanR (Fig.4.8) phylogenetic trees of predicted amino acid, the C. 
sakazakii cluster appeared to evolve on the same branch as C. turicensis. With the others forming a 
separate clade Cit. koseri, Franconibacter pulveris and Siccibacter turicensis. 
As well as, the nanK (Fig.4.9) and nanT (Fig.4.10) C. sakazakii and C. turicensis clusters appears 
to have greater phylogenetic distance from the other closely species, with a clear split of the 
population into two clades, one of them being that of the C. sakazakii and C. turicensis cluster. 
The nanE gene was found across the Cronobacter genus, and the phylogenetic analysis of the nanE 
protein sequences (Fig 4.12) revealed the Cronobacter cluster to have a common and closely 
related evolutionary clade with Cit. koseri, Escherichia coli. K-12 and Edwardsiella trade. 
C. sakazakii nanC demonstrated more than 50% homology with Cit.koseri (Figure 4.13) Moreover, 
all Cronobacter species were found to have nagA, nagB, and neuC genes as shown in Figures 4.14-
4.16. When these protein sequences were subjected to phylogenetic analysis, it was found that the 
evolutionary clade of Cronobacter spp. sequences were quite distinct from other closely related 
members of Enterobacteriaceae which constitute an adjacent clade, through both share the 
evolutionary lineage. A dissimilar branching pattern has been demonstrated by nan genes sequence 
from the Cit. koseri when it was subjected to phylogenetic analysis. It implies that there can be 
distinct evolutionary paths adopted by nan genes in case of the genus Cronobacter. 
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4.5 DISCUSSION 
It has been reported by Joseph et al. (2013) that the region ESA_03609–13 on the genome of C. 
sakazakii BAA-894 encodes for the uptake and consumption of exogenous sialic acid. Moreover, 
this region was unique to the genome of C. sakazakii based on RAST analysis. This exclusive 
characteristic is quite intriguing in terms of virulence and epidemiology of Cronobacter species. 
Sialic acid metabolism might have a role in high prevalence of C. sakazakii infections among 
infants and neonates. In contrast, the nanE gene have been found located in a distinct site 
(ESA_00529) separate from the nan cluster site (ESA_03610-12). The same have been observed 
with other Gram-negative bacteria such as Cit. freundii and Ed. tarda (Vimr 2012). It potentially 
points towards a distinct evolutionary lineage for the gene. Moreover, genes for NanT inner 
membrane transporter protein and NanC outer membrane porin are present in all C. sakazakii 
strains. For that reason, all of them are able to uptake sialic acid from the environment into the 
cytoplasm of the cell. It is surprising to note that all Cronobacter possess genes for TRAP 
transporter i.e. siaPQM (Figure 4.4). 
These laboratories experiments have confirmed that C. sakazakii is not the only member of 
Cronobacter genus which can utilize sialic acid as a source of carbon as some of C. turicensis have 
this ability. Colonization by C. sakazakii in the intestinal tract of humans and consumption of sialic 
acid from the infant formula, breast milk and brain cell might be due to acquisition of genes 
responsible for utilization of sialic acid (Almagro-Moreno and Boyed 2009). 
Growth of C. sakazakii on ganglioside GM1, as shown in Figure 5 b, shows that the bacterium can 
produce the sialidase enzyme. This finding has not been reported earlier though researchers had 
carried out gene sequencing in order to detect the nanH gene in the genome of these bacteria. 
Researchers conducted an extensive research for Asp-box motifs and sialidase RIP as the 
homology between the genes coding for sialidases is found to be less than 30% (Kim et al. 2011). 
Growth of C. sakazakii on GM1 also proves that the organism is capable of degrading the 
ganglioside. Sialic acid residues, glucose, N-acetyl-galactose, and galactose constitute to form 
GM1. These building blocks are linked through β 1–3 and β 1–4 linkages and are attached to 
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steroid. Hence, it has been postulated that degradation of GM1 by different lipases (ESA_02127 & 
ESA_02202), esterases (ESA_00377 & ESA_00776), β-acetyl-hexosaminidases (ESA_02237 and 
ESA_02655) and β-galactosidases (ESA_01827, ESA_02977 & ESA_03417) results in formation 
of metabolisable sugar residues thereby enabling the organism to grow on GM1. 
An interesting observation made was that nanE and TRAP transporter (siaPQM) were found 
conserved across the genomes of the Cronobacter genus in contrast with nanA, nanT and nanK 
(Figure 4.5). GC content of the entire genome of C. sakazakii is 56% which is significantly greater 
than the GC content of nanC gene i.e. 47.44%. Slight aberration in the GC content values of the 
nanE and nanK genes have also been found (63.18%-62.21% respectively) Table 4.2. This is in 
agreement with a past observation recorded during an evolutionary investigation of the nan clusters 
present in members of Enterobacteriaceae such as Yersinia species, E. coli and Salmonella 
enterica (Almagro-Moreno and Boyed. 2009). For this reason, it can be stated that nan clusters 
might have evolved in these bacteria in a mosaic fashion.  These findings point towards the fact 
that it is highly likely that acquisition or lost of nanC and nanE clusters by the members of 
Cronobacter and nanAKT cluster by C. sakazakii could have been the result of the horizontal 
transfer events. This research also analysed the nanAKT cluster genes acquisition or loss based on 
gene location, the high degree of colinearity of  the nanAKT cluster alignment between different 
genomes have been shown in figure 4.5. Furthermore, the whole cluster is located in a certain 
location flanked by some conserved housekeeping trait (gltB) and starvation gene (sspA) 
suggesting loss from other Cronobacter spp. instead of separate acquisition events. Moreover, 
because of close adaptation of intracellular microorganism to the physiologically stable 
environments of their host cells, a reductive genome evolution happened that led to the loss of 
some genes not crucial for life within the host. This is called evolution by reduction (Dobrindt and 
Hacker 2001). Sequence of proteins coded for utilization of sialic acid in C. turensis and C. 
sakazakii have also been determined during the phylogenetic analysis (Figures 4.5-4.11). This 
finding indicated that the evolution of the nanATKR genes as a lineage in C. sakazakii and certain 
strains of C. turicensis was independent of closely related Enterobacteriaceae family. 
Expression of sialic acid utilisation gene cluster can be affected by levels of nutrients in the 
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environment since the nanATK gene cluster is found proximate to the stringent starvation gene 
homologue (sspA, ESA_03615) in C. sakazakii. C. sakazakii also possesses other related genes like 
nagA and nagB responsible for the formation of fructose-6-phosphate which is also indicative of 
the fact that the organism can utilize sialic acid as a source of carbon or nitrogen. Human milk, 
brain and GIT serve to be the three main sources of sialic acid in mammals for commensal as well 
as pathogenic bacteria. 
Researchers have found that human milk is a rich source of sialic acid and highest concentrations 
of sialic acid have been detected in colostrum up to three months after child birth. For that reason, 
human beings are exposed to sialic acid right from their infancy. It has been proposed that this 
exposure affects the concentration of sialic acid in brain (Wang et al. 2001). Concentration of sialic 
acid in cell membranes inside the brain is 20 times higher than its concentration in other mucosal 
membranes. Especially, the gangliosides of brain contains high concentration of Neu5Ac giving 
rise to sialyated glycolipids. Similarly, epithelium of human intestine contains high concentrations 
of sialic acid. Moreover, levels of sialic acid and N-acetylglucosamine that residue in intestinal 
mucosa of an infant are considerably greater than that of adults (Wang. 2009). There is an 
intriguing clinical association between the above mentioned sites of sialic acid build up and 
epidemiology of Cronobacter species. During the course of neonatal meningitis, this bacterium 
causes NEC and intensive brain damage. High concentration of sialic acid in the above mentioned 
sites relates with the C. sakazakii infections as majority of neonatal infections with C. sakazakii 
have been found to occur during infancy. In particular, half of the cases were reported in the first 
week of birth and three quarter cases were reported within one month (Lai 2001). In addition the 
sources of sialic acid, PIF products contain sialic acid, but in lesser quantity (<25%) than human 
milk. In contrast to the form of sialic acid in human milk i.e. oligosaccharide-bound form, infant 
formula usually contains sialic acid in glycoprotein bound form (Wang et al. 2001). 
In summary; 
 A key finding from the comparative genomic study was the unique cluster of genes in C. 
sakazakii and some of C. turicensis encoding for the utilization of exogenous sialic acid.  
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 Since this is also the species most associated with the neonatal meningitic infections, this 
association could prove to be a crucial link to the pathogenicity of the organism.  
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5.1 INTRODUCTION 
Despite Cronobacter spp. infections being infrequent, they are still of high concern due to the 
severity of the infection that the organism causes, as well as the sensitive age group of the neonates 
that are affected by them. Ever since the C. sakazakii BAA-894 and C. turicensis z3032 genomes 
became available, examination of the virulence of the organism can be examined at the genomic 
level (Kucerova et al. 2010; Stephan et al. 2010). Type VI secretion system, iron acquisition, 
enterobactin and aerobactin synthesis are acknowledged as potential virulence factors in 
Cronobacter spp. (Kucerova et al. 2011; Hartmann et al. 2010; Franco et al. 2011). 
 
5.1.1 IRON UPTAKE 
Iron acts as an essential mineral for many cellular functions including electron transport, ATP 
production via oxidative phosphorylation, DNA metabolism, protection against oxidative stress and 
regulation of gene expression, but it is toxic and poorly soluble in its free ferric form (Crosa et al. 
2004). Pathogenic bacteria must be able to compete for this very limited supply of iron with their 
host organism in order to survive and propagate in the host. Furthermore, the decreased iron 
availability in host organisms can serve as a stimulus triggering expression of virulence-related 
genes. It has been shown that increased iron availability correlates with increased virulence of 
Escherichia, Klebsiella, Listeria, Neisseria, Pasteurella, Shigella, Salmonella, Vibrio, and Yersinia, 
as reviewed in Raymond et al. (2003). The efficiency of iron assimilation via expression of iron 
uptake mechanisms is hence an important aspect of bacterial virulence. 
The ability of iron within a host varies with its tendency to form complexes with iron binding 
proteins such as haemoglobin, transferrin, lactoferrin and ferritin. However, bacteria can not 
directly utilise these sources (Lin et al. 2012). Therefore, pathogenic bacteria require various iron 
acquisition systems to obtain iron from the host environment. Many bacteria do this by releasing 
siderophores, which are compounds with a high affinity to chelate iron from iron binding proteins. 
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Banin et al. (2005) found that iron starvation can prevent bacterial growth and formation of a 
biofilm. 
Bacteria have evolved several mechanisms to cope with iron scarcity and scavenge iron from the 
host environment: use of proteases that cleave the iron-binding proteins to obtain free iron, 
reducing Fe3+ to Fe2+ followed by the release of iron from a protein complex, and siderophore 
synthesis (Henderson & Payne 1994). Siderophore production is probably the best studied 
mechanism of iron acquisition in pathogenic bacteria. Siderophores are high-affinity iron-binding 
compounds produced by various bacterial species as a response to iron depletion. Firstly, the ferric 
siderophore complex binds to the receptor protein on the microbial cell surface, then the complex is 
translocated across the outer and inner membrane, and finally, iron is released for metabolism 
inside the cell (Crosa et al. 2004). Iron uptake via the catechol siderophore enterobactin (or 
entrochelin) is the best described among the siderophore-mediated iron uptake systems in 
prokaryotes. The biosynthesis of aerobactin requires the expression of the operon entABCDEF and 
the transport system for enterobactin is encoded by genes fepABCD and fepG. In addition, some 
Enterobacteriaceae are able to synthesize a hydroxamate siderophore aerobactin, which has also 
been linked to increased virulence in members of Enterobacteriaceae (Lafont et al. 1987, Martinez 
et al. 1994). Aerobactin system was first described on the large E. coli plasmid pColIV-K30 by 
Warner et al. (1981) and the products of the biosynthetic pathway were identified by de Lorenzo et 
al. (1986). Aerobactin synthesis requires the expression of four genes iucABCD. Aerobactin is then 
secreted into the extracellular environment and the iron-aerobactin complex binds to a specific 
outer membrane TonB-dependent receptor IutA. Interestingly, the aerobactin synthesis genes 
iucABCD and the outer membrane receptor gene iutA are located in the same operon, whereas the 
genes required for trans-membrane transport which encode the periplasmic binding protein FhuB 
and the inner membrane permease FhuCD form a different genetic cluster that is not related to 
aerobactin synthesis (Crosa et al. 2004). 
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5.1.2 CPA (PLASMINOGEN ACTIVATOR) 
It was discovered through in silico analysis of pESA3 that there was an omptin superfamily 
homologue, pESA3p05434, present in it, recently named cpa by Franco et al. (2011). Cpa has a 
common identity with the plasminogen activators Pla of Yersinia pestis and PgtE of Salmonella 
enterica. 
After the systematic invasion by Cronobacter, excessive presence of outer-membrane protease Cpa 
(plasminogen activator) was observed by Franco et al. (2011). Not only does cpa provide 
protection from the bacterial activity of the serum by cleaving the accompanying components C3 
and C4b, it also stimulates the plasminogen and inactivates a2-AP (plasmin inhibitor) (Franco et al. 
2011a; Schwizer et al. 2013). Interestingly, it has been stated that, of all the diverse Cronobacter 
spp., C. sakazakii had the greatest resistance against the terminating impact of the serum – a 
statement which may help understand its powerful pathogenic potential and the presence of 
pESA3-borne cpa in C. sakazakii strains. The function of alternative surface structures such as 
LPS, OmpA and exopolysaccharide (capsule), which allow the pathogen to tolerate the bactericidal 
activity of serum and avert the immune system is yet to be discovered (Schwizer et al. 2013). 
 
5.1.3 TYPE VI SECRETION SYSTEMS  
T6SS is one of the bacterial secretory machinery that help in the transportation of proteins over the 
bacterial cell membranes. There are different types of T6SS in organisms, with the various systems 
being formed of a variety of genes, from 12 to over 20. There may be various clusters of T6SS 
genes, which are not essentially the same as each other, and it is highly likely that not all of them 
are functional. In several organisms like P. aeruginosa and E. coli, these areas have been 
categorized as pathogenicity islands. 
These secretion systems have facilitated the transportation of molecules over the membranes so 
that they can be discharged into the adjacent medium or the eukaryotic host cell. The translocation 
process in Gram-negative bacteria may either carry on as a single step process through the inner 
and outer membranes (as can be seen in types 1, 3, 4 and 6 secretion systems), or as a step-by-step 
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procedure that includes transport into the periplasmic space, followed by secretion out of the cell 
across the outer membrane (as can be seen in types 2 and 5 secretion systems).(Tseng et al. 2009). 
It was as early as 1996 that there were reports of a protein transport system in studies that were 
carried out on the secretion of the haemolysin co-regulated protein Hcp in Vibrio cholerae 
(Williams et al. 1996), and consequently, in other groups of micro-organisms. In 2003, there were 
further investigations of such a region using an in silico study of the V. cholerae genome, which 
was referred to as IAHP (IcmF-associated homologous protein) clusters at that time due to the 
similarity of a particular protein to IcmF proteins seen in certain T4SSs (Das et al. 2003). This 
protein secretion system was categorized as “Type VI” in 2006 in a subsequent study on V. 
cholerae, which explained the export process of the Hcp and VgrG proteins, and their contribution 
towards virulence of the organism (Pukatzki et al. 2006). 
A classic T6SS mainly consists of the IcmF and IcmH-like proteins, CIpV ATPase, a putative 
lipoprotein and the proteins Hcp and VgrG (valine glycine repeats), in which the last two are also 
the secreted factors. This secretory system may be managed either through transcriptional activator 
of the AraC family or σ-54, or with the help of a threonine phosphorylation signalling cascade. 
There are reports of a relationship between T6SSs and virulence functions in several pathogens, 
like E. coli, P. aeruginosa, V. cholerae and several others. These carryout activities like host cell 
adhesion and invasion, macrophage survival and cytotoxicity. However, in addition to 
pathogenicity, T6SS has also been linked to physiological functions of certain organisms like root 
colonization by the nitrogen-fixing Rhizobium spp., in addition to other activities like quorum 
sensing and biofilm creation (Bingle et al. 2008; Cascales. 2008; Leung et al. 2011). 
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5.1.4 AIMS OF THIS CHAPTER 
 
It is not proven that all Cronobacter species are infective in infants. Until now C. sakazakii has 
been the most prevailing among clinical cases. It has been found in sequence analysis that there are 
several plausible reasons for virulence; however, most of them need to be tested further in 
laboratories for affirmation (Kucerova et al. 2010; Joseph et al. 2012). Also, there are now (April, 
2015) genomes of 107 Cronobacter strains, including 37 C. sakazakii ST4. 
The aim of this chapter was to investigate the pathogenesis of Cronobacter sakazakii by 
determining the presence of a number of key virulence associated genes which included: two iron 
acquisition system gene clusters (eitA and iucC), Cronobacter plasminogen activator (Cpa), and 
type IV secretion (T6SS) gene cluster using laboratory studies in Cronobacter sakazakii strains, 
particularly with ST4 strains regarding the location on plasmid and total DNA.  
In addition, C. sakazakii clinical strains have been examined furthermore using BLAST analysis 
from PubMLST Cronobacter database with a particular interest in the iron acquisition system. 
Plasmid profiling experiments were carried out in this study as well. 
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5.2 MATERIALS AND METHODS  
The key methods, culture media and culturing conditions for this part were described previously in 
Chapter 2 (Section 2.6) Materials and Methods. 
5.3 BACTERIAL STRAINS USED IN PCR SCREENING STUDY 
Isolate Species 
Sequence  
Type a Country Source Year 
658*b C. sakazakii ST1 USA Non-infant formula 2001 
555 C. sakazakii ST1 Netherlands Clinical 1979 
12 C. sakazakii ST1 - Faecal- Clinical 2003 
680* C. sakazakii ST8 USA CSF -Clinical 1977 
1* C. sakazakii ST8 USA Throat - Clinical 1980 
5* C. sakazakii ST8 Canada Clinical 1990 
520* C. sakazakii ST12 Czech Republic Clinical 1983 
696* C. sakazakii ST12 France Faecal-Clinical (NECII) 1994 
553* C. sakazakii ST4 Netherlands Clinical 1977 
557* C. sakazakii ST4 Netherlands Clinical 1979 
558* C. sakazakii ST4 Netherlands Clinical 1983 
695* C. sakazakii ST4 France Trachea-Clinical(Fatal NECII) 1994 
701* C. sakazakii ST4 France Peritoneal- Clinical(Fatal NECII) 1994 
767* C. sakazakii ST4 France Trachea-Clinical(Fatal meningitis) 1994 
6* C. sakazakii ST4 Canada Clinical 1990 
20* C. sakazakii ST4 Czech Republic Faecal-Clinical 2003 
721* C. sakazakii ST4 USA CSF –Clinical 2003 
1219* C. sakazakii ST4 USA CSF-Clinical (Fatal meningitis) 2009 
1220* C. sakazakii ST4 USA CSF –Clinical (Brain abscess) 2003 
1221* C. sakazakii ST4 USA CSF –Clinical (Meningitis) 2003 
1222 C. sakazakii ST4 USA Blood- Clinical 2003 
1223 C. sakazakii ST4 USA Blood- Clinical 2004 
1231* C. sakazakii ST4 New Zealand Faecal-Clinical (Meningitis) 2005 
1240* C. sakazakii ST4 USA CSF –Clinical 2009 
1241 C. sakazakii ST4 USA Blood- Clinical 2009 
1242 C. sakazakii ST4 USA Brain- Clinical 2009 
1225* C. sakazakii ST4 USA Blood -Clinical(Fatal meningitis) 2007 
730* C. sakazakii ST4 France Clinical(NECI) 1994 
1585 C. sakazakii ST4 Israel Blood –Clinical (Bacteraemia) 1999 
1587* C. sakazakii ST4 Israel CSF –Clinical (Sever anatomical damage brain) 2000 
4* C. sakazakii ST15 Canada Clinical 1990 
1588 C. sakazakii ST14 Israel Blood- Clinical 2012 
1586 C. sakazakii ST9 Israel Blood –Clinical 1998 
150* C. sakazakii ST16 Korea Spice 2005 
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140* C. sakazakii ST40 India Spice 2005 
1249* C. sakazakii ST31 UK Clinical 2010 
*Strain have been genome sequenced in the Cronobacter PubMLST Cronobacter database 
Table 5.1 List of Cronobacter. sakazakii isolates included in this study. 
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5.4 RESULTS 
5.4.1 SCREENING OF VIRULENCE ASSOCIATED GENES CARRIAGE IN 
PLASMID AND TOTAL DNA (CHROMOSOME AND PLASMID) 
Genes implicated in virulence and associated with RepFIB plasmids were studied as designated 
by Franco et al. (2011b) with some modification. Plasmids and total DNA were used because 
some genes such as T6SS are located on both chromosomal and plasmid DNA. Plasmid extraction 
was prepared as described in Chapter 2 (Section 2.5). Thirty-six strains were used to compare 
their virulence traits, according to their sequence type. Heat mapping was generated to show the 
presence/absence or location of these genes. Of these 36 strains, 23 were ST4 and 13 strains were 
non-ST4 strains of which three strains were ST1, three strains were ST8 and two strains were 
ST12. 
5.4.1.1 CRONOBACTER PLASMINOGEN ACTIVATOR (CPA) GENE 
The presence of cpa gene was investigated in the plasmids and results are shown in Figure 5.1-
5.2. To confirm the presence of the cpa locus, the conserved flanking regions upstream and 
downstream of the cpa locus on pESA3 plasmid were amplified as a positive control. Most of the 
strains produced 306bp amplicons, negative strains were unable to show any PCR products. The 
plasmid PCR screening indicated that 87% of C. sakazakii ST4 strains (n=23) were harbouring the 
cpa gene. The cpa gene was present in all ST1 strains (n=3) while none of the ST8 (n=3) or ST12 
(n=2) strains contained this gene. Similarly, the presence of the cpa gene was investigated in total 
DNA and the results have been shown in Figure 5.1-5.2. Ninety-six percent of C. sakazakii ST4 
strains (n=23), 100 % of ST1, 50% of ST12 and 11% of ST8 strains were harbouring the cpa 
gene. 
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5.4.1.2 TYPE VI SECRETION SYSTEM (T6SS) LOCUS 
A previous investigation by Franco and colleagues (2011) revealed that the T6SS cluster in the 
pESA3 plasmid is large, 16,937bp in size. Due to the large size of the T6SS cluster, four separate 
PCR assays have been designed based on the conserved flanking regions of the type T6SS present 
in pESA3. Primers specific to the vgrG gene as well as the regions IntT6SS  left, T6SS R end and 
IntT6SS Right have been used in this work as previously designed by Franco et al. (2011). Figure 
(5.1): T6SS cluster of pESA3 consist of 16 ORF (16.937 bp) long (ESA_pESA3p05491 to -5506)* 
Table (2.3) Section 2.6. Primers used for virulence genes investigations.  
 
 
All investigated strains were harbouring at least one of the investigated sites in the T6SS loci in 
plasmid DNA. Based on the plasmid and total DNA, 71% of C. sakazakii ST4 strains (n=23) 
harboured the vgrG effector protein,  while all of ST1 and ST8 were positive. However, 50% of 
ST12 strains were harboured for this effector. Figure 5.2. 
Out of the 23 strains tested, based on plasmid PCR screening one ST4 strain 553 (4 %) was 
harbouring the 5’ region of the T6SS loci (IntT6SS Left), (100%) ST1, 1 of 3 (33 %) ST8 strains; 
Figure 5.1 T6SS cluster of pESA3 consist of 16 ORF (16.937 bp) long (ESA_pESA3p05491 to -5506*) 
PCR primer showed in arrow with number; Primer 1, ∆t6ssfw; primer 2, ∆t6ssrv; primer 3, t6ssrv; primer 
4, vgrGfw; primer 5, vgrGrv; primer 6, t6ssfw; primer 7, t6ssrv3. 
*– Genbank locus of the gene on the C. sakazakii BAA-894 genome (Kucerova et al. 2010) 
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and 50% ST12 strains possessing the region of this cluster IntT6SS Left. These amplicons could 
have a similar DNA sequence to the primers or there are other T6SS regions. Similarly, the 
presence of the IntT6SS Left, the cluster was investigated in total DNA and the results shown in 
Figures 5.1-5.2. Ten out of 23 (43 %) of C. sakazakii ST4 strains, 100% of ST1(n=3), 50% of 
ST12 (n=2) and 33% (n=3) of ST8 strains were harbouring  this region. 
Moreover, based on plasmid PCR screening 3% of ST4 strain (n=23) was harbouring another 
right side region of T6SS loci which have been amplified (T6SS R end and Int T6SS Right), 
While all of ST1(n=3), 33% of ST8 strains (n=3); and 50% ST12 strains (n=2) were positive. 
These amplicons could have a similar DNA sequence to the primers or there are other T6SS 
regions. Similarly, the presence of the T6SS R end and Int T6SS Right, for right side of the T6SS 
cluster was also investigated in total DNA and the results have been shown in Figures 5.1-5.2. 
Nine out of 23 (39 %) of C. sakazakii ST4 strains, 50% of ST12 and 33% of ST8 strains were 
harbouring both of T6SS R end and Int T6SS Right region. While all strains of ST1 were positive 
for this regions. 
In order to verify the presence of T6SS patterns in the genomes, BLAST analysis have been used 
to confirm the presence of this region (ESA_pESA3p05491-5506) (Franco et al. 2011). As a 
result, they were a variation observed within all the C. sakazakii clinical strains. However, T6SS 
patterns have been detected in the most clinical cases such as NECII and severe meningitis strains 
696 (ST12), 5 (ST8), 553, 721, 1219, 1220, 1221, 1225, 1231, 1240, 1251 (ST4) and 140 (ST40). 
Table 5.2. Some of these strain lacking plasmid pESA3 such as 696 (ST12) and 1220 and 1241 
(ST4). Therefore is not necessarily plasmid borne, but could be inserted in the chromosome. 
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Table 5.2 Type VI Secretion System (T6SS) patterns, of screening of clinical C. sakazakii strains in plasmid         
and total DNA (chromosome and plasmid) including PCR results and genome BLAST analysis.  
* BLAST analysis from PubMLST Cronobacter database               N:  was not investigated. 
 
 
 
 ID   ST  Source 
 Plasmid PCR   
Total DNA 
PCR  
% of present  
T6SS patterns  
in the 
Cronobacter 
PubMLST 
genomic 
database* 
IntT6SS  
left 
T6SS 
R  end 
IntT6SS 
Right 
IntT6SS 
left 
T6SS 
R end 
IntT6S
S 
Right 
C. sakazakii 520 12 Clinical   -   -   -   -   -   - 6 
C. sakazakii 696 12 Clinical  +  +  +  +  +  + 78 
C. sakazakii 1 8 Clinical  -  -  -  -  -  - 33 
C. sakazakii 5 8 Unk  +   +   +   +   +   +  63 
C. sakazakii 680 8 Clinical  -  -  -  -  -  - 33 
C. sakazakii 
555 
1 Clinical   +   +   +   +   +   + 
N 
C. sakazakii 
658 
1 Non-infant formula  +  +  +  +  +  + 100 
C. sakazakii 12 1 Clinical  +  +  +  +  +  + N 
C. sakazakii 558 4 Unk  -  -  -  -  -  - 15 
C. sakazakii 553 4 Unk  +   +   +   +   +   +  87 
C. sakazakii 767 4 Clinical   -   -   -   -   -   - 27 
C. sakazakii 695 4 Clinical   -   -   -   -   -   - 22 
C. sakazakii 20 4 Clinical   -   -   -   -   -   - 34 
C. sakazakii 557 4 Unk   -   -   -   -   -   - 33 
C. sakazakii 6 4 N   -   -   -   -   -   - 8 
C. sakazakii 730 4 Clinical   -   -   -   -   -   - 22 
C. sakazakii 1242 4 Clinical   -   -   -   -   -   - N 
C. sakazakii 1223 4 Clinical   -   -   -   -   -   - N 
C. sakazakii 1222 4 Clinical   -   -   -   -   -   - N 
C. sakazakii 1585 4 Clinical   -   -   -   -   -   - N 
C. sakazakii 1587 4 Clinical   -   -   -   -   -   - 34 
C. sakazakii 701 4 Clinical   -   -   -   -   -   - 27 
C. sakazakii 721 4 Clinical  -  -  -  +  +  + 50 
C. sakazakii 1219 4 Clinical  -  -  -  +  +  + 50 
C. sakazakii 1220 4 Clinical  -  -  -  +  +  + 50 
C. sakazakii 1221 4 Clinical  -  -  -  +  +  + 50 
C. sakazakii 1225 4 Clinical  -  -  -  +  +  + 50 
C. sakazakii 1231 4 Clinical  -  -  -  +  +  + 50 
C. sakazakii 1240 4 Clinical  -  -  -  +  +  + 50 
C. sakazakii 1241 4 Clinical  -  -  -  +  +  + N 
C. sakazakii 4 15 CC4 Clinical  -  -  -   -  -  - 34 
C. sakazakii 140 40 Spice  -  -  -  +  -  - 50 
C. sakazakii 150 16 Spice  -  -  -  -  -  - 13 
C. sakazakii 1586 9 Clinical  -  -  -  -  -  - N 
C. sakazakii 1588 14 Clinical  -  -  -  -  -  - N 
C. sakazakii 1249 31 Clinical  -  -  -  -  -  - 32 
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5.4.1.3 IRON ACQUISITION GENES eitA AND iucC  
 
The presence of the iron acquisition gene clusters eitA and iucC was investigated using designed 
PCR probes of eitA and iucC genes (Franco et al. 2011b). The results are shown in Figure 5.2. 
The presence of the gene eitA was confirmed in 96% of C. sakazakii ST4(n= 23) while all of ST1 
and ST8 (n=3), and 50% of ST12 strains were harbouring the eitA gene in both plasmid and total 
genomic DNA. The presence of iron acquisition iucC gene was also investigated. Ninety-six 
percent of ST4 strains (n=23), 50% of ST12 strains (n=2).While all of ST1 and ST8 strains were 
found to be positive for the iucC gene in both plasmid and total genomic DNA. 
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Figure 5.2 The heat map showing the presence/absence of  a number of key virulence associated 
genes which included: two iron acquisition system gene clusters (eitA and iucC), Cronobacter 
plasminogen activator (Cpa), and type IV secretion (T6SS) gene cluster using laboratory studies in 
Cronobacter sakazakii clinical strains (A) on plasmid DNA (B) on total DNA in different 
sequence types of C. sakazakii. The difference in colour indicates the presence/absence or 
percentage of a gene present on plasmid. The heat map was generated using SPSS (version 21). 
 
(n=23) (n=3) (n=3) (n=2) 
(n=23) 
(n=3) (n=3) (n=2) 
Percentage 
Percentage 
(A) 
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5.4.2 CORRELATION OF CRONOBACTER PLASMINOGEN ACTIVATOR (CPA) 
GENE LOCUS, SERUM RESISTANCE AND GENOME STUDY. 
This section was to determine whether cpa is required for serum resistance and virulence of C. 
sakazakii. Serum resistance assay was carried out on a selection of the clinical C. sakazakii strains 
(n = 36) from the MLST database and PCR screening of cpa gene. Most of ST4, ST1, ST8 and 
ST12 clinical strains were tested (Table 5.3). The presence of Cpa in the plasmid could be essential 
for survival in human serum in all ST4 except strain 6.  
 
In order to verify the present of this gene in the genome, BLAST facility analysis have been used to 
confirm the presence of cpa gene (ESA_pESA3p05434) in C.sakazakii. Moreover, the present of  
Pla plasminogen activator of Yersinia pestis (NC_019235) have been undertaken in this research 
also because its significant homology share with the cpa.  
As a result, there was no variation observed within the ST4 lineage. In contrast, a considerable 
degree of variation was observed within non ST4 the ST1 strain 658 with ST8, ST12, ST16, ST40 
and ST31 that could some extent explain the variation the host susceptibility. The sequences of cpa 
and Pla plasminogen activator were trimmed, aligned using the online tool of Cluster W and 
MEGA 5 and the phylogeny tree was constructed as shown in figure 5.3. 
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Species Strains ST Source 
Laboratory PCR screening Laboratory  
Plasmid Total DNA 
Serum 
resistance 
assay 
Cpa gene in the 
Cronobacter 
PubMLST 
genomic 
database* 
C. sakazakii 520 12 Clinical  -  -  S Absent 
C. sakazakii 696 12 Clinical  -  + R Present 
C. sakazakii 1 8 Clinical  -  - S Absent 
C. sakazakii 5 8 Unk  -  +  R Present 
C. sakazakii 680 8 Clinical  -  - S Absent 
C. sakazakii 555 1 Clinical  +  + R N 
C. sakazakii 658 1 
Non-infant 
formula  +  + R Present 
C. sakazakii 12 1 Clinical  +  + R N 
C. sakazakii 558 4 Unk  +  + R Present 
C. sakazakii 553 4 Unk  +  + R Present 
C. sakazakii 767 4 Clinical  +  + R Present 
C. sakazakii 695 4 Clinical  +  + R Present 
C. sakazakii 20 4 Clinical  +  + R Present 
C. sakazakii 557 4 Unk  +  + R Present 
C. sakazakii 6 4   -  - S Absent 
C. sakazakii 730 4 Clinical  +  +  R Present 
C. sakazakii 1242 4 Clinical  +  +  R N 
C. sakazakii 1223 4 Clinical  +  +  R N 
C. sakazakii 1222 4 Clinical  +  +  R N 
C. sakazakii 1585 4 Clinical  +  +  R Absent 
C. sakazakii 1587 4 Clinical  +  +  R Present 
C. sakazakii 701 4 Clinical  +  +  R Present 
C. sakazakii 721 4 Clinical  +  +  R Present 
C. sakazakii 1219 4 Clinical  -  +  R Present 
C. sakazakii 1220 4 Clinical  +  +  R Present 
C. sakazakii 1221 4 Clinical  +  +  R Present 
C. sakazakii 1225 4 Clinical  +  +  R Present 
C. sakazakii 1231 4 Clinical  +  +  R Present 
C. sakazakii 1240 4 Clinical  +  +  R Present 
C. sakazakii 1241 4 Clinical  +  +  R N 
C. sakazakii 4 
15 
CC4 Clinical  -  +  R Present 
C. sakazakii 140 40 Spice  -  +  R Present 
C. sakazakii 150 16 Spice  -  +  R Present 
C. sakazakii 1586 9 Clinical  +  +  R N 
C. sakazakii 1588 14 Clinical  +  +  R N 
C. sakazakii 1249 31 Clinical  +  +  R Present 
E.coli 1230  - ve - N N S N 
Salmonella  583  +ve - N N R N 
* BLAST analysis from PubMLST Cronobacter database  N:Unknown genome  S: Serum sensitivity  R: Serum resistance   – : Absent 
PCR product   + : present PCR product   ST: Sequence type  
Table 5.3 Correlation of C. sakazakii plasminogen activator (cpa) gene locus and Serum resistance. In the serum resistance assay the viable 
counts of cells were obtained at the beginning and after 1, 2, 3 and 4 hours of incubation. All bacterial strains have been assayed in 3 
independent assays  
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Figure 5.3 Maximum likehood tree of (A) cpa gene and (B) Pla plasminogen activator of C. sakazakii 
clinical strains. The NTU strains IDs are showed at the top of each branches. The tree is drawn to scale using 
MEGA5, with 1000 bootstap replicates. 
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5.4.3 PLASMID PROFILING 
The sequenced strain C. sakazakii BAA-894 contains two plasmids; pESA2 (31 kb) and pESA3 
(131 kb). Thirty-eight genes were annotated on pESA2 and 127 genes on pESA3 by Kucerova et 
al. (2010). C. turicensis z3032 revealed the three plasmids similar to sizes reported by Stephan et 
al. (2011) - pCTU1 (138 kb), pCTU2 (22.5 kb) and pCTU3 (53.8 kb). pESA3 and pCTU1 have 
been identified several virulence gene clusters encoded on these plasmids in silico analysis, such as 
two iron acquisition system loci (eitCBAD and iucABCD/iutA), a type six secretion system (T6SS) 
locus, and a two-partner secretion system (TPS)/filamentous hemagglutinin gene (fhaB), and a 
transporter gene (fhaC) and associated putative adhesins (FHA locus). Also, Power et al. (2013) 
published the complete genome of Cronobacter sakazakii SP291, with the sequences of three 
plasmids 118 kb, 52 kb, and 4.4 kb. SP291 have been identified interesting genes associated to the 
resistance to toxic and antimicrobial and bacterial stress response. Recently Choi et al. (2014) 
identified in C. sakazakii ATCC29544 a new plasmid sequenced pCSA2, which encodes mcp ( 
methyl-accepting chemotaxis protein) gene. Mcp of C. sakazakii ATCC29544 has been reported as 
essential encoded gene regulated biofilm formation and motility. Furthermore this study 
demonstrated that the putative mcp encoded in pCSA2 was essential for adhesion and 
invasion.(Choi et al. 2014) 
In this study, plasmid profiling experiments were carried out on 34 Cronobacter sakazakii clinical 
strains of different sequenced type. It was found that the 34 clinical strains harboured a single or 
more than two plasmids sized between 138-2.5 kb as summarized in Table 5.3. Because of the large 
sizes of the Cronobacter plasmids, appropriate size DNA ladders could not be used and hence the 
well-characterized plasmid profiles of the genomes of C. sakazakii BAA-894 and C. turicensis 
z3032 were used as reference markers.  
Figure 5.4 was showed there is no correlation observed between sequence type and presence or 
absence of the plasmid. Also, plasmid DNA analysis showed that there was no specific plasmid 
profiling among clinical strains. 
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The results showed the presence of the three plasmids or more across C. sakazakii strains. A third 
unstated plasmid similar in size to pCTU3 (53.8 kb) was detected, suggesting the probability that 
this had not been sequenced with the rest of the genome. The high-size plasmid (molecular weight 
between 138 and 131 kb) of pCTU1/pESA3 was observed as common in 27/34 of all strains, except 
C. sakazakii 520, 696 (ST12) and strain 6, 1220,1241,4 (ST4).  
An intact plasmid corresponding to the size of pCTU3 53.8-52 kb was observed in the strains 658 
(ST1), 1219,1220,1221,1223,1240,1241,1225,1585,1587 (ST4) and 1588,150,140 ( non ST4). 
An intact plasmid matching to the sizes of pCTU2/pESA2 (22.5- 31 kb) was showed by all the C. 
sakazakii strains except 5 (ST8), 520 (ST12), 553,557, 695,767,6,730 (ST4) and 1586 (non ST4)  
A slightly smaller sized plasmid was also detected in the profiles of strain 1, 5 (ST8), 
558,721,1221,1222,1223,1231,1242,1225,1587( ST4) and 1586,140 (non ST4). 
Both strains 6 (ST4) and 520 (ST12) were plasmid less strains. This most significant observation of 
missing virulence associated genes  is in agreement with results in this chapter (Section 5.4.1). The 
aim of next chapter was to verify the important of presence of plasmids associated with virulence 
of C. sakazakii by transforming the large plasmid to plasmid-less strains and observe any 
phenotypic change. 
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138 kb 
Figure 5.4 The agarose gel was analysed using BioNumerics software, version 3.5. Dice coefficient, unweight pair group 
method with arithmetic mean (UPGMA) for cluster analysis of the plasmid profiles of the Cronobacter spp. strains sequenced 
in this study. The plasmid profiles of the strains C. sakazakii BAA-894 and C. turicensis z3032 (indicated by the red circles) 
were used as markers, as their sizes had been accurately determined by sequencing studies (Kucerova et al. 2010; Stephan et 
al. 2011). 
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Strain 
No  STs Origin 
(138-
131-118) (53.8-52) (31-22.5) (8-4-2.5) 
Plasmid 
No 
658*b ST1 Non-infant formula √ √ √  3 
555 ST1 Clinical √  √  2 
12 ST1 Faecal- Clinical √  √  2 
1* ST8 Throat – Clinical √  √ √ 3 
5* ST8 Clinical √   √ 2 
520* ST12 Clinical 
 
    - 
696* ST12 Faecal-Clinical (NECII) 
 
 √  1 
553* ST4 Clinical √    1 
557* ST4 Clinical √    1 
558* ST4 Clinical √  √ √ 3 
695* ST4 Trachea-Clinical (Fatal NECII) √    1 
701* ST4 Peritoneal- Clinical (Fatal NECII) √  √  2 
767* ST4 Trachea-Clinical(Fatal meningitis) √    1 
6* ST4 Clinical 
 
     - 
20* ST4 Faecal-Clinical √  √  2 
721* ST4 CSF –Clinical √  √ √ 3 
1219* ST4 CSF-Clinical (Fatal meningitis) √ √ √  3 
1220* ST4 CSF –Clinical (Brain abscess) 
 
√ √  2 
1221* ST4 CSF –Clinical (Meningitis) √ √ √ √ 4 
1222 ST4 Blood- Clinical √  √ √ 3 
1223 ST4 Blood- Clinical √ √ √ √ 4 
1231* ST4 Faecal-Clinical (Meningitis) √  √ √ 3 
1240* ST4 CSF –Clinical √ √ √  3 
1241 ST4 Blood- Clinical 
 
√ √  2 
1242 ST4 Brain- Clinical √  √ √ 3 
1225* ST4 Blood -Clinical(Fatal meningitis) √ √ √ √ 4 
730* ST4 Clinical(NECI) √    1 
1585 ST4 Blood –Clinical (Bacteraemia) √ √ √  3 
1587* ST4 
CSF –Clinical (Sever anatomical 
damage brain) √ √ √ √ 4 
4* ST15 Clinical 
 
 √  1 
1588 ST14 Blood- Clinical √ √ √  3 
1586 ST9 Blood –Clinical 
 
  √ 1 
150* ST16 Spice √ √   2 
140* ST40 Spice √ √ √ √ 4 
*Strain have been genome sequenced in the Cronobacter PubMLST database                      ST: Sequence type 
Table 5.4 Plasmid profile patterns of Cronobacter sakazakii strains isolated from clinical sources. 
 
 
Plasmid sizes (kb) 
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5.4.4 IDENTIFICATION OF CRONOBACTER IRON ACQUISITION SYSTEM 
 
Whole genomes have been studied in the last stage of the current thesis in order to advance our 
understanding of the Cronobacter genus (specific C. sakazakii in this study) and to verify the 
important of specific associated virulence trait such as iron acquisition system by using BLAST 
facility(http://pubmlst.org/perl/bigsdb/bigsdb.pl?db=pubmlst_cronobacter_isolates&page=plugin&
name=BLAST). 
Bacterial strains used in this study are detailed in Table 2.1 Chapter 2 Section (2.2). The 
Cronobacter and closely related genomes strains species screened for iron acquisition system 
including plasmids carry several putative virulence genes eitCBDA (ABC transporter genes cluster) 
and iucABCD/iutA (aerobactin sidrophore receptor genes). Also non-plasmid iron acquisition genes 
(ferric dicitrate transport system) targets that have been consisted of C. sakazakii (n=70), C. 
malonaticus (n=14), C. turicensis (n= 6), C. dublinesis (n=8), C. universalis (n=1), C. muytjensii 
(n=3) and C. condimenti (n=1). In addition, closely related species (n=4) Franconibacter pulveris  
(n=3) Siccibacter turicensis, (n=6) and Franconibacter helveticus were included for comparative 
reasons. 
The present study was shown in Figure 5.5, that iucABCD/iutA is a siderophore present in 97% of 
C. sakazakii (n= 70). The strains missing these genes were plasmid-less strain 6 (ST4) and 520 
(ST12) which were confirmed later as a negative for siderophore production in the selected 
numbers of C. sakazakii (n=16 ) as shown using the CASAD assay; Figure 5.7.  
Moreover, one of striking features of ferric dicitrate transport system investigation was found 
especially in small subset of C. sakazakii 18 % (n= 70) (plasmid-less strain, non-ST4) and 30 % 
(n=14) C. malonaticus. Most of these were isolated from clinical sources. This system is capable of 
maintaining bacterial growth in the absence of other iron uptake system. In contrast, this system 
have been missing in other species; Figure 5.6. 
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Figure 5.5 The heat map showing the presence/absence of potentially virulence associated traits for iron 
acquisition system including plasmids carry several putative virulence genes eitCBDA (ABC transporter 
genes cluster) and iucABCD/iutA (aerobactin sidrophore receptor genes) in the Cronobacter and closely 
related species genomes strains. The difference in colour indicates the presence/absence or percentage gene 
based on BLAST analysis from PubMLST Cronobacter database. The heat map was generated using SPSS 
(version 21). 
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n=70 n=14 n=6 n=1 n=8 n=1 
Percentage 
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Figure 5.6 The heat map showing the presence/absence of potentially virulence associated traits for iron 
acquisition system including non- plasmid iron acquisition genes (ferric dicitrate transport system) in the 
Cronobacter and closely related species genomes strains. The difference in colour indicates the 
presence/absence or percentage gene based on BLAST analysis from PubMLST Cronobacter database. The 
heat map was generated using SPSS (version 21). 
 
 
 
 
 
Figure 5.7 Siderophore activity using CASAD assay, wells were filled with cell free culture supernatant of 
different clinical strains of C. sakazakii (1- 16) shows all of these strains have been able to produce iron 
sidrophores CAS agar showing orange halo around the site of inoculation, however NTU #6 and 520 strains 
was negative.
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5.5 DISCUSSION 
 
Bacterial plasmids are found to be encode a wide-ranging of pathogenic factors which include 
resistance to antibiotics, toxins, factors causing adherence, and secretion systems (types 3, 4 and 6) 
(Johnson and Nolan 2009). 
The study of the difference in plasmid content extends from our group’s earlier CGH studies 
(Kucerova et al. 2010).  It was reported  that the publicly available C. sakazakii BAA-894 plasmid 
pESA3 (131 kb) or C. turicensis z3032 pCTU1 (138 kb) made a conserved backbone, with one 
copy being present in most of the strains and this was confirmed by both the plasmid profiling as 
well as by in silico analysis. In the earlier laboratory studies of the plasmid regions ( Franco et al. 
2011), showed the presence of this plasmid in 97% of their 229 Cronobacter spp. strains using by 
PCR. They also recognised these plasmids to belong to RepFIB incompatibility group, 
characterized by the repA gene as an origin of replication. This plasmid backbone is especially 
essential for this bacterium as they have been considered to be virulence plasmids, with genes 
encoding for potential virulence traits for example, iron acquisiton systems (eitCBAD and 
iucABCD/iutA).  
The finding of this research indicate that 34 clinical strains harboured a single or more than two 
plasmids sized between (138-2.5 kb).The high-size plasmid (molecular weight between 138 and 
131 kb) was observed as common in (27/34) of all strains which known to encode an assortment of 
virulence factors such as iron acquisition and cpa plasminogen activator genes. This finding 
suggested the present of large plasmid may be essential for systemic survival of C. sakazakii in a 
host ( Franco et al. 2011). 
 
Also, plasmid DNA analysis showed that there was no specific plasmid profiling among clinical 
strains. This could be due to a high rate of plasmid transfer or instability amongst strains. 
Furthermore, it shown there is no correlation observed between sequence type and present or 
absent the plasmid. 
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The present study showed also a group of interesting clinical strains ST4 (1223,1221,558,1224 and 
1242) and ST8 (1 and 5) which have been isolated from CSF, blood and throat encoding smaller 
plasmid molecular weight between 6 and 2 bp. This research confirmed the findings of previous 
studies by Choi et al. (2014) that identified a new plasmid sequenced pCSA2 in C. sakazakii 
ATCC29544 (5,103 bp), which encoding mcp ( methyl-accepting chemotaxis protein) gene. This 
putative mcp was essential virulence factor regulated genes of adhesion and invasion, biofilm 
formation and motility. Also in agreement with Power et al. (2013) published study of complete 
genome of Cronobacter sakazakii SP291, which contain small plasmid pSP291-3 (4.4 kb). SP291 
carries interesting genes associated with the resistance to toxic and antimicrobial and bacterial 
stress response. 
 
5.5.1 CPA (PLASMINOGEN ACTIVATOR) 
 
Plasmid pESA3 of Cronobacter sakazakii BAA 894 contains a Cronobacter plasminogen activator 
gene (cpa), an outer membrane protease reported to provide serum resistance to C. sakazakii 
possibly enhancing its invasion and ability to spread within the host. The cpa gene is closely 
related to plasminogen activators in Salmonella enterica and Yersinia pestis (Franco et al. 2011). 
This suggests possible horizontal genetic transfer to C. sakazakii. 
There are protective mechanisms in invasive microorganisms which work against serum-mediated 
killing. Bacterial structures, comprising of outer membrane proteases and proteins were known to 
prevent such bactericidal action (Schwizer et al. 2013; Rautemaa and Meri 1999; Taylor 1983). 
Lately, a study by Franco et al. (2011b) indicated that one such plasminogen activator is the 
Cronobacter outer membrane protease Cpa. It is quite significant with regard to serum resistance. 
In this research, a group of C. sakazakii strains were tested to determine their capability to resist 
human serum. Most of the strains were considered to be resistant and able to replicate in serum 
and they seem to entirely refractory to serum killing. that is similar to S. Enteritidis the positive 
control strains for this experiment. The negative strains included C. sakazakii strains 6 (ST4), 680 
and 1 (ST8), 520 (ST12) and E. coli K12 (negative control), which was sensitive. Resistance of 
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serum killing is a significant factor that results in survival in the host blood. It could also be 
involved in development of bacteraemia. Serum bactericidal activity were resisted by all the 
strains which contain the cpa gene, whilst the sensitive strains were 680,1 (ST8),520 (ST12) and 6 
(ST4) as they did not have the cpa gene (Table 5.3). An interesting point in this study, some of the 
isolates lacking plasmid pESA3 which encoding cpa gene such as strain NTU 520, 696 (ST12) 
and 1220, 1241, 4 (CC4) showed serum resistance. Therefore cpa is not necessarily a plasmid 
borne trait but could also be inserted in the chromosome. In addition, strains lacking plasmid 
pESA3 were associated with severe clinical cases; 696 NECII and 1220 with meningitis. Plasmid 
profiles showed the discrimination by molecular size only, not the gene content of each strains.  
There were other genes which could be contributing to serum resistance such as kpsA 
(polysaccharide capsular gene) and rcsA (responsible for colonic acid production) (work 
unpublished). The interest of studies in this field has also increased regarding serum resistance 
mechanism. But there is not much published data regarding C. sakazakii. Schwizer et al. (2013) 
performed a study using transposon knock out mutants, which observed that serum sensitivity 
decreased due to removal of some structural and regulatory genes of C. sakazakii strain ES5. They 
stated that eradicated expression of the major element of type 1 fimbriae occurred due to the 
removal of the ybaJ element, which is part of anti-toxin pair YbaJ-Hha. This results in increased 
survival in the human serum. Nevertheless, this observation does not include the pathogenicity of 
the bacterium, since type 1 fimbriae is a significant aspect for adhesion. It has also been 
associated to E. coli K1 invasion of human brain micro vascular cells (Adegbola and Old, 1983 
and Teng et al. 2005).  
5.5.2 TYPE IV SECRETION SYSTEMS 
Secretion systems, commonly known as type VI secretion systems, which have the ability to 
transport proteins and nucleoprotein complexes are understood to be essential virulence factors as 
they had been revealed in C. sakazakii and C. turicensis as a plasmid-borne (pESA2/pCTU2) gene 
cluster (Franco et al. 2011b). On the other hand, quite a few newly identified type VI secretion 
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systems (T6SSs) were present in the chromosomes of many Cronobacter spp. and on pESA3 which 
is carried by C. sakazakii, and include pathogenic C. sakazakii ST4 strains (Joseph et al. 2012c). It 
is important to note that the T6SS was also discovered to be essential for E. coli K1 invasion of the 
BBB (Zhou et al. 2012). 
Type VI secretion system (T6SS) is a recently discovered system which may challenge different 
bacteria in host-cell invasion, adherence, growth inside macrophages, and survival inside the host. 
One specific T6SS related gene which was found isolated from the central T6SS gene cluster, 
vgrG, encodes for a lipoprotein (ESA_00292-4). In the Cronobacter genomes, six putative T6SS 
clusters were found (Joseph et al. 2012), of which some had been reported before by Kucerova et 
al. (2010, 2011).  
 
5.5.3 IRON ACQUISITION SYSTEM 
It was shown by Franco et al. (2011a) that Cronobacter RepFIB plasmids encode two iron 
acquisition systems – a siderophore-mediated system for iron acquisition (iucABCD/iutA operon) 
and ATP-binding cassette transport- mediated iron uptake and a system of siderophore (eitCBAD 
operon) –which suggested that such plasmids are ordinary essential plasmids and might also play 
an important role in the systematic survival of Cronobacter. To develop an infection after they 
have penetrated the host cell, iron-acquisition abilities are necessary for many pathogens. Franco et 
al. (2011b) explained that the iucABCD/iutA siderophore (cronobactin) is the singular functional 
siderophore which Cronobacter possesses. But Grim et al. (2012) showed that cronobactin – a 
hydroxamate-type, aerobactin-like siderophore –was not the singular iron acquisition system which 
was possessed by Cronobacter. In the present study showed that iucABCD/iutA is the active 
siderophore genes present in 97% of C. sakazakii. The strains missing these genes were plasmid-
less strain. However, due to the presence of iron utilization genes in all of the Cronobacter spp., the 
details of its function still have not been understood (Joseph et al. 2012c).  
Grim et al. (2013) described analysis which were silico sequence targeted of nine Cronobacter 
genomes and demonstrated that there is sharing of iron acquisition systems between the seven 
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species in Cronobacter. This contain iron acquisition genes ferric and ferrous transporters and 
haem-iron extractors, along with putative TonB-dependent iron receptors and ferric reductases.  
This study also showed, the ferric dicitrate transport system had been revealed majorly in a small 
subset of C. sakazakii and C. malonaticus strains, many of which had been isolated from clinical 
samples, describing that this iron acquisition system contributes to the virulence of Cronobacter. 
Such studies also gave proof of the presence of two other receptors, Fct and FcuA, in C. 
dublinensis and C. muytjensii, for the heterologous siderophores formed by plant pathogens, 
suggesting the advantage of these receptors to Cronobacter spp. to fight more successfully for iron 
in a plant niche. It also supports the hypothesis stating that Cronobacter arose from a shared 
ancestor containing a plant-associated lifestyle before it had been species-level bi-directionally 
divided. 
The analysis of this chapter indicated that the pathogenesis of Cronobacter sakazakii by 
determining the presence of a number of key virulence associated genes which included: two iron 
acquisition system gene clusters, Cronobacter plasminogen activator (Cpa), and type IV secretion 
(T6SS) gene were not unique to specific STs. Moreover, the finding of this research indicate that 
28 out of 34  clinical strains harboured the large plasmid which is known to encode an assortment 
of virulence factors. As well as, it shown there is no correlation observed between sequence type 
and present or absent the plasmid. 
Hence, from this point onward, it was decided to investigate whether the presence of plasmids is 
associated with virulence of C. sakazakii by transforming the plasmid pESA3 into a plasmid-less 
strain and to observe any changes in the phenotypic and virulence associated behaviour. The 
analysis is presented in Chapter 6. 
In summary; 
• Number of key traits such as type six secretion systems, iron acquisition systems and 
serum resistance were found to be scattered across the clinical strains, with varying levels 
of diversity. Some of the virulence traits were also identified to be plasmid-borne.  
• The genome did not reveal any unique virulence traits exclusive to ST4, hinting at the 
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possibility of gene expression playing a greater role in the virulence phenotype of the 
organism, rather than just the presence or absence of the virulence associated genes. 
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6.1 INTRODUCTION 
6.1.1 VIRULENCE STUDIES 
 
Most plasmids have selectable phenotypic traits, one of the most frequently targeted being 
resistance to antibiotics. Plasmid genomes contain clusters of genes termed antibiotic cassettes, 
which play a very essential role in the protection mechanism of the bacterial cell against antibiotic 
activity. It has been reported that the vast majority of plasmids carry important virulence correlated 
genes related to adhesion factors, secretion systems, siderophores, serum resistance, and toxin 
encoding genes. In addition there can be genes linked to metabolic functions. Through the 
evolutionary process, as a consequence of positive selection, plasmids could at times lose these 
accessory regions by conjugative transfer to the host chromosome (Frost et al. 2005; Johnson and 
Nolan 2009; Rankin et al. 2011). 
The in silico analysis of C. sakazakii BAA-894 (pESA3) and C. turciensis z3032 (pCTU1) was 
performed by Franco et al. (2010). The analysis led to the identification of various virulence gene 
clusters encoded on these plasmids pESA3 (131 kb, 56% GC), encoding for 127 genes. In contrast, 
pCTU1 (138 kb, 56% GC), encoding for 136 genes respectively. Amongst them were two iron 
acquisition system loci (eitCBAD and iucABCD/iutA), a type six secretion system (T6SS) locus, a 
transporter gene (fhaC), a two-partner secretion system (TPS)/filamentous hemagglutinin gene 
(fhaB) and associated putative adhesins (FHA locus). The occurrence of these homologous 
plasmids among the species groups as well as the distributions of the virulence gene clusters was 
ascertained through laboratory screening of large collections of Cronobacter spp.  
The outer membrane protease (cpa) was encoded by the pESA3, which has significant identify to 
the pla sub family of omptins. This protease was observed to increase spread and invasion in the 
host and ability to resist serum by activating the plasminogen, plasmin inhibitor α 2-AP and 
cleaving complement (Franco et al. 2011). 
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The fact that Cronobacter can attach to human intestinal Caco2 cells and survive in macrophages 
was reported by Townsend et al. (2007a). The ability of the Cronobacter to invade the CSF 
circulation was also proved by these researchers. Their research further claimed that a massive 
influx of inflammatory cells was caused by the organisms into the ventricles and meninges, thus 
resulting in the breakdown of adhesion junctions and consequently accessing the brain 
parenchyma. Also the ability of the Cronobacter to invade the capillary endothelial cells was 
reported. They were also found to resist for 96 hours in the macrophages. There were variations in 
the ability of the strains to cross the blood brain barrier and cause CNS infections.  
Seven Cronobacter strains linked to the largest reported NICU outbreak (Caubilla et al. 2007) was 
studied by Townsend et al. (2008a) have been caused the most fatalities. As compared to the E coli 
K12 and Salmonella, all strains were seen to attach and invade the intestinal cell line Caco2 and 
survival on macrophage for up to 96h. Recently, Eshwar et al (2015) studying the possible 
influence of macrophage infectivity potentiator (Mip) such as (fkpA) gene in the intracellular 
survival of Cronobacter spp in human macrophages as a virulence factor. Also the finding showed 
a variation in Cronobacter spp within macrophage survival and replication as a result to the 
differences in amino acid of  fkpA protein (Eshwar et al.2015) 
The genetic basis of Cronobacter virulence needs further study, to date the virulence studies have 
focused upon the effects of the organism on tissue culture cell lines or in vivo models. The role of 
the outer membrane protein, OmpA, was emphasized in various studies through the invasion of 
intestinal epithelial and brain microthelial cells (Singamsetty et al. 2008; Mittal et al. 2009b; Wang 
& Kim 2002; Kim et al. 2010). As compared to wild type strains, Cronobacter strains deficient in 
the OmpA gene showed lower invasion of HBMEC. According to the studies, microfilaments were 
needed in the invasion of intestinal epithelial cells by the bacterium, while microtubules are needed 
in the invasion of HBMEC. 
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6.1.2 TARGETED GENE DISRUPTION USING λ -RED TECHNIQUE 
Various methods can be used to create gene disruptions through targeted gene deletions. A 
common example is the transformation of linear or plasmid DNA carrying an antibiotic resistance 
marker flanked by regions of homology to the target gene into bacterial cells. A recombination 
event between the homologous regions is created. The newly developed antibiotic resistance and 
genetic disruptions are ascertained through the screening of the cells while identifying the accurate 
phenotype by PCR and sequencing of the target region. 
This strategy has been explored through a wide range of experimental methods. At first strains 
deficient in the RecBCD nuclease system were only included in the first protocols that used linear 
DNA for gene replacement (Jasin and Schimmel 1984; Winans et al. 1985), while facing the 
chances of degradation of the linear double stranded phage DNA in the other case (Murphy. 1998). 
The combination of the plasmid with the bacterial chromosome and subsequent resolution of the 
integrated complex is utilized in other methods. These methods have led to the regeneration of the 
wild type locus or any other alternative. The protocols were limited by the restriction of only using 
plasmids that do not replicate under the conditions applied for the selection of the required mutants. 
This meant that temperature sensitive plasmids or phagemid-based vectors had to be used. The cell 
division resulted in the disappearance of the plasmids carrying the marker. The low frequency of 
the resolution of cointegrate was also a drawback. In addition, the unintentional gene replacements 
created by the replacement can also create problems. 
Murphy (1998) developed the first gene replacement protocols that were based on bacteriophage λ 
recombination genes known as”Red” or “λ-Red”. The activity of λ bacteriophage genes exo, bet 
and gam were used by the λ-Red system. Single stranded DNA overhangs are created by the (5′-3′) 
exonuclease Exo that binds to the dsDNA in the presence of the host RecA protein. The 
recombinations between the overhangs and homologous regions of the chromosomes are induced 
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by the BET protein. The hostRecBCDexonuclease is obstructed by the Gam, which is responsible 
for the digestion of the phage DNA. 
A simple and effective method was developed by Datsenko and Wanner (2000) to improve the 
replacement technigue of λ-Red gene which have been widely used for generating the 
chromosomal genes in Escherichia coli and other bacteria. The homology is provided in this 
method in desired chromosomal sequence have been replaced by ~26 nt homology of PCR product 
at each end to target sequence flanking the gene to be replaced. Gene replacement occurs via λ-Red 
recombination that have been mediated by pKD46. pKD46 has a sensitive temperature replicon 
that could eliminate by growth at 37°C. 
6.1.3 STUDIES IN THE CRONOBACTER  
Regarding to Cronobacter researches, it has been reported by Kim et al. (2010) as the first time 
using lambda red recombination method as described previously by Datsenko and Wanner (2000). 
This study generated deletion mutants of C. sakazakii ATCC29544 for outer membrane protein A 
(OmpA) and (OmpX). This study showed the presence of OmpX played roles in the invasion of the 
host cells and translocate into liver and spleen of rats (Kim et al. 2010). Another study was 
undertaken in 2013 showed a deletion mutants of C. sakazakii ATCC29544 by modified λ-red 
recombination method of thermotolerance island (Datsenko and Wanner 2000). This 
thermotolerance island could  promote the survival in production facilities (Orieskova et al. 2013).  
Recently, Kim et al. (2015) generated mutants using lambda red recombination (Datsenko and 
Wanner 2000) to demonstrate the role of hfq in pathogenesis of C. sakazakii ATCC29544. The 
mutant have been generated indicating defect in invasion and survival within host cells (Kim et al. 
2015)  
In the earlier study by Franco and his colleagues (2011), showed the ability of Cpa in the wild type 
strain of BAA-894 to serum resistance than the construction of Cpa isogenic mutant strain. This 
mutant have been generated by detected the Cpa gene and flanking region in pESA3. The result 
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indicated that Cpa isogenic mutant strain reduced serum resistance in comparison to C. sakazakii 
BAA-894 parent strain. Also the observation made show the over express of Cpa protein caused 
inactivation of α 2-AP and activation of plasminogen (Franco et al. 2011 a) 
Another research in 2011 by the same author have determined if pESA3 encoding the functional 
active siderophore system by curing the pESA3 from C. sakazakii BAA-894. This curing method 
have been done by labelling with ampicillin resistance gene to disrupt specific target gene. The 
finding was the wild type strain (harbouring plasmid pESA3) possessed siderophore activity as a 
unique plasmid associated. (Franco et al. 2011b).  
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6.1.3 AIMS OF THE CHAPTER 
 
Developing a tool in order to show inserted of plasmid well characterized pESA3 into plasmid less 
strain (NTU 6) and observing any changes in its phenotypic and virulence associated behaviour 
including serum resistance, siderophore and tissue culture. Due to the variation within Cronobacter 
sakazakii strains during this research based on plasmid profile and virulence gene contents such as 
iron acquisition system loci (eitCBAD and iucABCD/iutA), outer membrane protease (cpa) and type 
six secretion system (T6SS). Moreover, it is known in our group at NTU (work unpublished) some 
of Cronobacter spp. resistance to serum which have not encoding Cpa.  
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6.2 METHODS AND MATERIALS 
The key methods, culture media and culturing condition for this section were described previously 
in Chapter 2 Materials and Methods section. 
 
6.2.1 BACTERIAL STRAINS AND PLASMIDS: 
Strains, plasmid and primer Features Source 
E.coli K12 (NTU 1230)                                              HB101     NTU collection 
Salmonella enterica serovar 
Enteritidis (NTU 358) 
NCTC3046 NTU collection 
Citrobacter koseri (NTU 48) SMT319 CSF, meningitis case, USA NTU collection 
C. sakazakii ATCC BAA-894 
(pESA3) (NTU 658) 
The first sequenced strain of C. sakazakii -sequence type 1 from  
formula, 2001,USA 
Townsend et al 
2007-Kucerova et 
al 2010 
C. sakazakii (NTU 6) Plasmid- less strain, negative siderophore production, non-
invasive 
NTU collection 
NTU 6 (pESA3K) 
Y. enterocolitica 8081  
Strain 6 after insertion of a kanamycin resistance cassette. 
 
BT1B O: 8. Sequenced strain of human origin from                
septicaemic patient 
This study 
Portnoy et al. 
(1981) 
C. sakazakii (NTU 520) 
Primers 
Plasmid- less strain, negative siderophore production  NTU collection  
 
KanpESA3_F 
 
CGAGCGGCGGCGTCATTAAACCGTTATTAGT 
GTGTAGGCTTGGACTGCTTC 
 
This study 
 
KanpESA3_R 
 
            CGCGTGATGTTATATTGCGCCAGCGCCGATCA 
                        TATGAATATATCCTCCTTAG 
   
Kan_F TGTGTAGGCTGGACTGCTTC        Datsenko &    
Wanner, 2000 
Kan_R CATATGAATATCCTCCTTAG  
   
FusA_F                           GAAACCGTATGGCGTCAG http://pubbmlst.org/ 
cronobacter.  
FusA_R                           AGAACCGAAGTGCAGACG 
 
Plasmids 
 
    
pAJD434 6566 bp  Trimethoprim TmR  plasmid Alan Mcnally,UK 
pKD4 3267 bp Kanamycin KR  plasmid Datsenko & 
Wanner, 2000 
pESA3 The larger plasmid of C. sakazakii ATCC BAA-894  131 KB, 
56 % GC-encoding 127 genes 
Kucerova et al 
2010 
pESA3K pESA3 after insertion of a kanamycin resistance cassette This study 
Table 6.1 List of strains used in this study 
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6.2.2 PCR VERIFICATION 
To verify the insertion sites in the identified plasmid, specific primers were designed to amplify the 
insertion site by PCR. Both forward and reverse primers were designed. 
KanpESA3_F  
CGAGCGGCGGCGTCATTAAACCGTTATTAGTGTGTAGGCTGGACTGCTTC 
KanpESA3_R  
CGCGTGATGTTATATTGCGCCAGCGCCGATCATATGAATATCCTCCTTAG 
PCR products were generated by using several pairs of 50nt containing a good mixture of A , C , T 
and G that includes 30nt homology extensions of 658 plasmid pESA3 and 20nt priming sequence 
for PKD4 as template. PCR products were purified and the correct structure of the amplicons was 
observed using gel electrophoresis. 
 
6.2.3 GENERATION OF LINEAR DNA PCR FRAGMENT 
Oligonucleotide primers were either designed manually. All primers were synthesised by eurofins 
mwg /operon. Primers used in this study are shown in Table 1.6. Each PCR reaction was carry out 
in a final volume of 50 µl. 
PCR amplification were carried out as follows: 
Tag DNA polymerase 0.3 µl 
10% buffer 5 µl 
d H2O 33.7µl 
Forward primer ( 10 pmol/ µl) 1 µl 
Reverse primer ( 10 pmol/ µl) 1 µl 
dNTP 2 µl 
MgCl2 5 µl 
pKD4 2 µl 
 
 
PCR CONDITION: 
1 cycle of: 
Denature                  94°C                            5 minutes 
30 cycles of: 
Denature                  94°C                            30 seconds 
Anneal                     70°C                            30 seconds 
Elongation               72°C                            10 minutes   
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5 µl was checked on an agarose gel before the remaining PCR reaction was cleaned up with Qiagen 
AIA quick PCR purification kit. The DNA eluted using 50 µl elution buffer. 
 
6.2.4 MINI PREP PLASMID PURIFICATION OF pKD4 
Bacteria were grown overnight in 5 ml TSB with appropriate antibiotic at 37°C at 200 rpm. For 
medium to high copy numbers of plasmids, 1.5 ml of culture was used to purify the plasmid with 
QIAGEN plasmid miniprep kit (Qiagen, UK) according to the manufacturers instructions. All 
plasmid prep strains were then reconstituted in a final volume of 50 µl sterile d H2O  
 
6.2.5 ETHANOL PRECIPITATION OF DNA 
The DNA samples were precipitated by the addition of 0.1 × volume of either 5 M NaCl – 3 M Na 
acetate and 2.5 × volume of 100% ethanol. The mixture was incubated at -20°C for 60 minutes, 
before centrifugation at 13,000 rpm for 10 minutes. The pellet was washed with 500 µl ice-cooled 
70 % ethanol, followed by centrifugation at 13.000 for 5 minutes. The DNA sample was then re-
suspended into 40 µl d H2O and stored at -20°C until required. 
 
6.2.6 ELECTROPORATION OF C.SAKAZAKII 658 WITH pAJD434 
 
The pAJD434 plasmid was electroporated into the desired C. sakazakii strain and trimethoprim (35 
µg/ ml) was used to maintain the plasmid. Five millimetre TSB was inoculated with one colony of 
C. sakazakii harbouring pAJD434 and grown with trimethoprim (35 µg/ ml) overnight at 30C°, 200 
rpm. The following day the culture was diluted 1/100 into 50 ml TSB with (35 µg/ ml) and 0.1% L-
arbinose and grown at 30C°, 200 rpm until an OD600 of ≈ 0.6 was reached. This culture was used 
to prepare of electrocompetent cells. Electroporation was done by using a Cell-porator™ (BIO-
RAD Gene Pulser X cell) with a voltage booster and 0.2 cm chambers according to manufacture 
instruction by using 50 µl of cell and 25µl of PCR product. Shocked cells were added to 1 ml SOC, 
incubated 1h at 37°C and then 100 µl of the electrooperation sample was spread onto TSB agar 
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plates supplemented with 125 µg/ ml kanamycin for selection of mutants. pAJD434 plasmid is 
thermosensitive and will not replicate at 37°C. 
 
6.2.7 INSERTION OF THE KANAMYCIN RESISTANT CASSETTE INTO THE 
PLASMID PESA3. 
This procedure is based on the λ-Red system which enables us to make insertions in to the 
Cronobacter plasmid without inactivating any gene. The basic strategy is to label a plasmid of C. 
sakazakii (plasmid pESA3) with a selective antibiotic resistance gene from pKD4 using the lambda 
Red helper plasmid pAJD434, which can then be amplified by PCR (Figure 6.1). 
 
 
 
 
 
 
 
Figure 6.1 Insertion site of the Km-R cassette from pKD4 into pESA3.  Black arrows show the site located 
midway between 2 convergent genes, pESA3p05432 and pESAp05433. The green box shows location of 
Km-R cassette into pESA3. 
 
 
 
 
 
 
 
Km-R cassette from pKD4 
ESA_pESA3p05432 
ESA_pESA3p05433 
Plasmid pESA3 
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6.2.8 TISSUE CULTURE INVESTIGATIONS 
6.2.8.1 INVASION ASSAYS 
Invasion assays were completed to examine the capability of selected bacterial strains to invade 
mammalian cells Caco 2 (Human colonic carcinoma epithelial cells, ECACC# 86010202),Human 
brain microvascular endothelial cells (HBMEC) and rat brain capillary endothelial cell line 
(rBCEC4) as previously described by Townsend et al. (2007). Attachment and invasion assays 
were performed at the same time using the same cell line passage with same inoculum of 
mammalian cell line and bacterial suspension. Salmonella enterica serovar Enteritidis strain 
number NCTC 3046 (358 NTU) was used as positive control for the Caco-2 cell line. While 
Citrobacter koseri strain number SMT319 (NTU 48) was used as positive control for rBCEC and 
HBMEC. Both were used in this investigated as standard enteric pathogens capable of attachment 
and invasion. E. coli K12 (NTU 1230) was used as a negative control for all cell lines used in this 
study, which is non-pathogenic and incapable of invading the Caco-2 cell line (Townsend et al. 
2008). 
6.2.8.2 MACROPHAGE ASSAY 
As given by Townsend and colleagues (2007), Section 2.9.1 described in detail the growth media 
for macrophages and then were treated with 0.1µg/ml of the PMA (phorbol 12-myristate 13-
acetate) (Sigma Aldrich, UK; P8139) at least 24h prior to infection, and they were placed at 37°C 
into 75cm2 tissue culture flasks under 5% CO2 for stimulation. For cell adhesion the wells were 
then filled with the suspension concentration of 4x106 cfu/well at 37 °C for 72 hours in the 
presence of 5% CO2. 
The concentration of overnight bacterial cell used to infect the macrophages was 4x106 cfu/ml 
(MOI 10). This was incubated at 37 °C for 1 hour in 5% CO2. Then the media was replaced by 
infection media containing 125 μg/ml of gentamicin and incubated at 37°C in the presence of 5% 
CO2.  The plates were washed by PBS and supplied with infection media contain 50 μg/ml of 
gentamicin. This was then incubated, the plates were completed the process of lysing using 1 % 
(v:v) Triton X-100 (Fisher Scientific, UK) The final result was diluted and then placed on TSA to 
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obtain the intracellular bacteria at different points (uptake, 6 h, 24h, 48h, and 72h). Percentage of 
uptake and persistence was used for data presentation. 
 
6.2.9 SERUM RESISTANCE 
Bacterial cultures were grown overnight at 37°C in TSB broth and then centrifuged (200 rpm). The 
pellet was diluted to 106 cfu/ml in 5ml of PBS. Suspended cells 0.5ml were added to 1.5 ml of 
undiluted human serum, the equal volume was 2.0 ml. The suspended bacterial cells and human 
serum were mixed and incubated at 37°C (200 rpm) (Hughes et al. 1982). The viable counts of 
cells were obtained at the beginning and after 1, 2, 3 and 4 hours of incubation. Miles and Misra 
technique were used on TSA plates at 37°C for 18 hours. All strains were analysed in triplicate. All 
bacterial strains have been assayed in 3 independent assays. 
 
6.2.10 IRON SIDEROPHORE DETECTION 
For siderophore production, the method of Schwyn and Neilands (1987) was used with slight 
modification. Chrome azurolsulphate (CAS) agar was prepared by using two solutions. First 
solution (dark blue liquid) was prepared by using 50 ml of CAS solution (see section 2.4.11), 10ml 
of iron III solution; section 2.4.10 and 40 ml of HDTMA before autoclaving at 121 °C for 15 
minutes (100ml in total of dark solution). The second solution was prepared by mixing 900ml of 
distilled water, 15g agar, 30.24g PIPES and 12g NaOH and then autoclaving at 121°C for 15 
minutes. After autoclaving, the first solution was mixed with the second solution and then the 
media was poured into the plates. Immediately before use, 5mm diameter holes were punched into 
the agar. To prepare the bacterial suspension, five colonies were taken from TSA and inoculated 
into LB broth containing 200µM of 2, 2´-dipyridyl (31.236mg in 1L of LB broth) and incubated 
with shaking (170 rpm) at 37°C overnight. After incubation the sample was centrifuged at 5000 
rpm for 10 minutes and 70 µl of the supernatant was added into the holes. The agar was incubated 
at 37°C for 4-8 hours. The observance of an orange zone around the hole indicated that the strain is 
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positive for siderophore production. Yersinia enterocolitica strain 8081 was used as a positive 
control. 
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6.3 RESULTS 
 
6.3.1 CONSTRUCTION OF C.SAKAZAKII 658 USING PAJD434 
 
This method is based upon the plasmid pAJD434 and the system described by Datsenko and 
Wanner (2000) however, this method involves designing two primers that amplify a kanamycin 
resistance cassette. Linear fragments were generated directly in a single step by PCR amplification 
of a kanamycin cassette with the plasmid pKD4 as the source of the template using primer pairs 
KanpESA3_F and KanpESA3_R. The priming sites used on pKD4 incorporates 50 bp of DNA 
flanking the deletion site on the chromosome; Figures 6.2- 6.3. PCRs were carried out as detailed 
in 6.2.2. The transfare procedure is detailed in 6.2.6 and 6.2.7. 
 
 
 
 
 
 
 
 
 
 
Figure 6.2 PCRs were used to show that all PCR products have the correct structure of primer designing 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3 PCR cleaning up of pKD4 with KanR cassette, transformed into bacteria carrying Red helper 
plasmid 
 
 
10 KP 
8  
6  
5 
4 
3 
2.5 
2 
1.5 
1 
750 
500 
250 
 1        L         2           L         3          L         4         L         5          L        6          L 
3100 bp 
   L           1             2          L 
3100 bp 
10 KP 
8  
6  
5 
4 
3 
2.5 
2 
1.5 
1 
750 
500 
250 
152 
 
CHAPTER 6 TRANSFER OF THE VIRULENCE ASSOCIATED PLASMID pESA3 INTO THE PLASMID LESS C. SAKAZAKII 
ISOLATE AND ITS CHARACTERIZATION. 
6.3.2 CONFIRMATION OF KANAMYCIN CASSETTE INSERTION BY PCR 
 
As further confirmation that the correct chromosomal region had been disrupted by the insertion of 
kanamycin cassette (3267 bp). Specific PCR probes were carried out in this study. Sequence 
specific probes were generated for detection of the kanamycin cassette using primers kan_F -
Kan_R and pKD4 as the template. For confirmation that the kanamycin cassette had been inserted 
into the correct CDS, specific probes were generated which amplified the kanamycin cassette using 
pESA3_F and pESA3_R primers within C. sakazakii 658 (Figure 6.4). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.4 Confirmation of insertion of kanamycin cassette- Ladder: 1 kb - WT1-2: Wild Type C. sakazakii 
(NTU 6) - M 1-2: NTU 6 (pESA3K). 
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6.3.3 TISSUE CULTURE INVESTIGATIONS 
6.3.3.1 CACO-2 INVASION 
The gentamicin protection assays were performed to investigate the ability of the virulence 
plasmid-containing C. sakazakii strain 658 (ATCC BAA-894), NTU 6 (lacking pESA3) and NTU 6 
(pESA3K) to invade the Caco-2 cell line. S. Enteritidis (NTU 358) and E. coli K12 were used as 
positive and negative controls, respectively for comparative data. Figure 6.5 shows both strains 
ATCC BAA-894 (658) and NTU 6 (pESA3K) have a significantly greater ability to invade Caco-2 
cells than NTU 6 (P <0.003). 
The number of recovered cells of 658 and strain 6 with plasmid were in the range between 5.8 log10 
to 6 log10 CFU/ml. However the original plasmid-less strain NTU 6 displayed low invasive rates of 
about 4.3 log10 CFU/ml. 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.5 Invasion of Caco-2 cells by wild Type C. sakazakii NTU 6, NTU 6 (pESA3K) and 658 
(pESA3). S. Enteritidis 358 and E. coli K12 were used as positive and negative controls 
respectively. 
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6.3.3.2 HBMCE INVASION 
Figure 6.6 displays the ability of NTU 658, NTU 6 and NTU 6 (pESA3K) to invade the HBMEC. 
The gentamicin protection assay used C. koseri (NTU 48) as an invasive positive control for this 
cell line and E. coli K12 as a negative control and the number of recovered cells was approximately 
2 log10 CFU/ml. Both strains 658 and NTU 6 (pESA3K) were significantly higher invaders 
compared with NTU 6 (P = 0.0294), which were recovered in the range 5 log10 to 6 log10 CFU/ml. 
However the original plasmid-less strain NTU 6 displayed low invasive rates of about 4 log10 
CFU/ml. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.6 Invasion to HBMCE cells by wild Type C. sakazakii NTU 6, NTU 6 (pESA3K) and 658 
(pESA3). S. Enteritidis 358 and E. coli K12 were used as positive and negative controls respectively 
 
 
Strains 
Viable 
count / Log 
scale 
155 
 
CHAPTER 6 TRANSFER OF THE VIRULENCE ASSOCIATED PLASMID pESA3 INTO THE PLASMID LESS C. SAKAZAKII 
ISOLATE AND ITS CHARACTERIZATION. 
 
6.3.3.3 rBCEC INVASION 
Figure 6.7 displays the abilities of NTU 658, NTU 6 and NTU 6 (pESA3K) to invade the rat brain 
capillary endothelial cell line (rBCEC4). The gentamicin protection assay used C. koseri NTU 48 
as an invasive positive control for this cell line and E. coli K12 as a negative control and the 
number of recovered cells was approximately 3 log10 CFU/ml. 
Both strains 658 and NTU 6 (pESA3K) were significantly higher invaders compared with the 
original plasmid-less strain NTU 6 (P = 0.0009), which were recovered in the range 5 log10 to 6 
log10 CFU/ml. However the original plasmid-less strain NTU 6 displayed low invasive rates of 
about 4 log10 CFU/ml. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.7 Invasion to rBCEC cells by wild type C. sakazakii NTU 6, NTU 6 (pESA3K) and 658 
(pESA3). S. Enteritidis 358 and E. coli K12 were used as positive and negative controls respectively 
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6.3.3.4 UPTAKE AND PERSISTENCE INTO MACROPHAGE CELL LINE (U937) 
Figure 6.8 shows the results of the same strains bacteria used with previous cell lines which were 
investigated for their ability to persist in human macrophages after phagocytosis. This was 
performed using the U937 macrophage cell line. Strains of C. koseri SMT319 (NTU 48) and E. 
coli K12 (NTU 1230) were used as positive and negative controls respectively (Townsend et al. 
2008). 
Both bacterial strains NTU 658 and NTU 6 (pESA3K) were shown to persist and replicate inside 
macrophages following the initial 45 min incubation, the macrophages internalised about 10 % of 
the inoculated cells of these strains which duplicated and increased to 23 % within 24 h, the 
number of survival cells has been reduced to 3 % from the initial inoculum of 48 hours which 
ultimately reduced to 0.1 % after 72 h. 
In contrast, the wild type strain of C. sakazakii NTU 6 were higher only in their persistent within 
the macrophage which able to uptake 16 % from the initial inoculum and decreased to 10 % within 
24h, the number of survival cells has been reduced to 3% within 48h. While Cit. koseri strain 
SMT319 (NTU 48) continued to replicate until the end of the observation time of 27 hour, however 
E.coli k12 (NTU 1230) was killed by human macrophage. Furthermore, it is interesting to note that 
the persistence of C. sakazakii strains within macrophages is likely to be higher than positive 
control of Cit. koseri as showed in figure (6.8) ANOVA one way was used to obtain the 
consistence of the independent experiments, the significance was set at p < 0.0001. 
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Figure 6.8 Level of uptake and survival of C. sakazakii strains by U937 macrophage cells were 
calculated and determined after 45, 24, 48 min and 72h incubation. The uptake of the C. 
sakazakii strains was in higher count than the positive control. The Plasmid less strain 6 reduced 
gardually after the uptake. Cit. koseri 48 and E. coli K12 were used as positive and negative 
controls. Error bar represent of three independent experiment. 
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Figure 6.9 Level of uptake and survival of C. sakazakii strains by U937 macrophage cells were 
calculated and determined after 45, 24, 48 min and 72h incubation. Three of C. sakazakii strains 
uptake in higher count than positive control. Strain plasmid less strain 6 reduced gardually after 
the uptake.cit. koseri 48 and E. coli K12 were used as positive and negative controls. Error Bar 
represent ANOVA of three independent experment. 
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6.3.4 SERUM RESISTANCE 
 
The survival of C. sakazakii strains after incubation for 4h in undiluted human serum was 
determined for all the same strains used in the previous tissue culture experiment (Figure 6.9). 
Variable count over an extended period of time of the strains, 658 and 6 (pESA3K) were 
characterized as serum resistant showing survival rate of about 8 log10 CFU/ml or higher, however 
NTU 6 was sensitive to the killing action of undiluted human serum with low survival range of 4 
log10 CFU/ml comparing to 658 and 6 (pESA3K). 
The positive control of S. Enteritidis showed increased growth rates overtime representing their 
tolerance to human serum. However, E. coli K12 the negative control strain revealed a declined 
growth levels and that is a sign for serum sensitivity. 
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Figure 6.9 Grades of response to undiluted human serum of C. sakazakii strains over 4 hours of incubation. 
The strains 658, 6 (pESA3K) and showed increase in their viable counts, however strain 6 and E.coli showed 
significantly values declined. S. Enteritidis 358 and E. coli K12 were used as positive and negative controls 
respectively 
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6.3.4 IRON SIDEROPHORE PRODUCTION BY C.SAKAZAKII STRAINS USING 
CASAD ASSAY 
 
Figure 6.10 shows both strains 658 and NTU 6 (pESA3K) have been able to produce iron 
siderophores. CAS agar showed orange halo around the site of inoculation. However NTU #6, the 
plasmid less strain was negative for siderophore production. Strains of Y. enterocolitica (8081) and 
C.sakazakii NTU 520 were used as positive and negative controls respectively. Strains 6 (ST4) and 
520 (ST12) were not able to produce iron siderophores. This is in agreement with the results that 
have obtained previously in chapter 5 (Section 5.4.4) in the absence of the iron acquisition genes in 
their genomes using Cronobacter BLAST research facility at http://pubmlst.org/cronobacter/. 
.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.10 Iron siderophore activity using CASAD assay. Wells were filled with bacterial suspension, 
contain five colonies and inoculated into LB broth containing 200µM of 2, 2´-dipyridyl. 70 µl of the 
supernatant was added into the holes. The agar was incubated at 37⁰C for 4-8 hours. The observance of an 
orange zone around the hole indicated that the strain is positive for siderophore production. Yersinia 
enterocolitica strain 1880 was used as a positive control.  
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6.4 DISCUSSION 
 
The present study clarifies the transfer of plasmid well characterized pESA3 into plasmid less 
strain (NTU 6) without inactivating any gene. The basic strategy is to label a plasmid of C. 
sakazakii (plasmid pESA3) with a selective antibiotic resistance gene from pKD4 using the lambda 
Red helper plasmid pAJD434, which can then be amplified by PCR. This technique have been used 
for many years in E.coli (Datsenko & Wanner. 2000), yeast (Baudin et al. 1993) and Cronobacter 
spp. (Kim et al. 2015; Orieskova et al. 2013; Kim et al. 2010). The plasmid PAJD343 express the 
red system (exo, bet and gam) under control of a well regulated promotor to avoid unwanted 
recombinational events under noninducing condition. When making gene disruption using the 
templates and priming sites elimination of the antibiotic resistance gene leaves behind an 50 nt scar 
in a place of the disruption gene in strain 658. pKD4 (plasmid encoding Kanamycin cassatte) are 
identical except for the region, an identical scar have been created for the limitation homology 
using the Red system and new PCR fragment. The transfer of plasmid well characterized pESA3 
into plasmid less strain (NTU 6)  has been verified by PCR strategy which indicted for the presence 
of new locus fragments of predicted size by direct transform carring a red helper plasmid with PCR 
product having short homology extension for the targeted locus. This method has been widely 
useful based on previous study Datsenko & Wanner (2000) and Baudin et al. (1993).  
 
6.4.1 TISSUE CULTURE 
The tissue culture study of viable account showed the ability of virulence plasmid Cronobacter 
sakazakii pESA3 and NTU 6 (pESA3K) to significantly invade the mammalian cell lines Caco-2 
(Human colonic carcinoma epithelial cells), human brain microvascular endothelial cells 
(HBMEC) and rat brain capillary endothelial cell line (rBCEC4). Nevertheless, the plasmid less-
strain NTU 6 was low invade in these cell lines. The detection of viable count of bacterial cells, 
after exposure to gentamicin could be due to clumping or biofilm formation (Schwarz et al 2004). 
Attachment to host cells might be crucial to cause infection; one attached to the host surfaces then 
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certain biochemical developments may result in the establishment of infection within the host after 
invasion. (Wilson et al.2002).   
Invasion of intestinal epithelial cells is a key characteristic of many microorganisms. It permits 
them to reach a safe environment where they could consequently proliferate and spread from cell to 
cell and be less subject to the host immune defenses or therapeutic mediations (Pereira et al. 2008). 
Macrophage studies were conducted to investigate the ability of the test strains to survive and 
multiply within this type of immune cell. Both bacterial strains (NTU 658) and NTU 6 (pESA3K) 
were shown to grow to 23 % within 24 h. In contrast, the wild type strain were decreased to 10 % 
within 24h. Thus, the plasmid encoded virulence associated traits such as plasminogen activator  
cpa and iron acquisition genes could be essential for the virulence of C. sakazakii to enter and 
persist within macrophages. The plasmid less strain NTU 6 was unable to survive the intracellular 
environment. 
There is some similarity between the current study and the study by Townsend et al. (2008) which 
has shown that C. sakazakii strains which cause severe infections in neonates such as fatal 
meningitis and necrotizing enterocolitis have the ability to invade intestinal Caco2 cells and survive 
within macrophage. 
Several previous researchers have shown that there has been widely divergent views on the genetic 
base of Cronobacter virulence need and their effects of the organisms on the tissue culture cell 
(Mittal et al. 2009, Wang and Kim 2002 and Kim et al.2010). It is predictable that Cronobacter 
possesses various virulence factors which could help in the invasion of a number of human 
mucosal cell lines as the initial step in the systemic spread of the bacterium. Similarly, such 
pathogens have developed mechanisms to escape the immune system of defence, for example 
surviving inside macrophages, and having resistance to serum. Cronobacter seems to avoid the 
host’s immune system by adapting to a lifestyle of replication in the intracellular environment 
limited within macrophages. 
Macrophages provide one of the essential defence of innate immune system in microbial uptake to 
exhibit antibacterial strategy for example oxidative stress, acidic compartmentalization and nutrient 
deprivation (Townsend et al. 2007). The microorganism which evade phagocytic killing have the 
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ability to persist and replicate within macrophages which is crucial to develop severe diseases such 
as meningitis and sepsis (Eshwar et al. 2015).  
 
6.4.2 SERUM RESISTANCE 
Bacteria that cause invasive infections such as bacteraemia and sepsis have developed strategies to 
defend themselves against serum mediated component. Bacterial structures containing cell surface, 
for example outer-membrane proteins, capsules and LPS have been recognised as being responsible 
of bacteria for the complement resistance Schwizer et al. (2013). 
In the earlier study by Joseph et al. (2011), the plasmid pESA3 in ATCC BAA-894 (658) encoded 
plasminogen activator gene cpa as a virulence factor providing serum resistance. Moreover, it has 
previously been showed that plasmid borne genes associated with antibiotic resistance which could 
increase the degree of serum activity in E.coli (Tylor and Hughes 1978, Binns at al.1979). 
The observation made in this research show that presence of pESA3 plasmid associated virulence 
could play an important role in pathogenies of C. sakazakii, also has been pointed out the ability of 
strain NTU 6 (pESA3K) after transform the plasmid to resist human serum compared to the wild 
type plasmid less strain NTU 6. However, as mentioned in the previous chapter (Chapter 5) there 
were two clinical strain 696 (ST12) and strain 4 (ST15) which do not encode large plasmid (only 
31 kb) were serum resistant. Also it is known in our group at NTU (work unpublished) some of 
Cronobacter spp. resistance to serum, which have not encoding cpa gene. This finding leads us to 
believe that there could be additional factors producing serum resistance such as capsules and LPS 
,or cpa  might be located on the chromosome. 
 
6.4.3 IRON SIDEREPHORE 
Iron is an essential factor for bacterial pathogenesis and it is involved for many process including 
electron transfer, superoxide metabolism and cellular respiration. It has been reported in 2011 by 
Franco et al that the bacteria under iron limiting condition, can produce siderophore which is a high 
affinity iron binding molecules to scavenge iron from their environmental. Moreover, it has been 
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found from Barron (1995) work that siderophore can help the bacteria to scavenge iron from 
human brain cell. 
This research indicates that strain NTU 6 (pESA3K) after transformation with the plasmid, were 
able to produce iron siderophore. However, NTU 6 the plasmid-less strain was negative. This is 
evidence in the present study that produce siderophore contributes the benefit to the Cronobacter to 
survive in the human body and support pathogenesis. This results were compatible with those 
reported in 2011 by Franco and his colleague which have been determined if pESA3 encoding the 
functional active siderophore system by curing the pESA3 from C. sakazakii BAA-894 (Franco et 
al. 2011 b). 
In summary;  
• The study of this chapter indicates that pESA3 plasmid is positively correlated with 
invasion or virulence of C. sakazakii. However, it must be remembered that some of the 
isolates lacking plasmid pESA3 such as strain (NTU 520, 696 and 4) showed serum 
resistance and were obtained from clinical sources.  
• Plasmid pESA3 is likely to be crucial for the virulence of C. sakazakii; it may not be solely 
responsible for its virulence. 
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7.1 CONCLUSIONS AND FUTURE DIRECTIONS 
 
Cronobacter spp. (previously known as Enterobacter sakazakii) is opportunistic pathogen that can 
cause serious infection in premature neonates and all age groups such as meningitis, bacteraemia 
and NEC. As a recently recognised bacterial pathogen of considerable importance, regulatory 
control and appropriate identification methods are required following the association of 
Cronobacter spp. to numerous publicized deadly outbreaks in neonatal intensive care units of 
bacteraemia, necrotizing enterocolitis and meningitis. 
 
 The first part of this project was in response to FAO-WHO (2004) request to develop a 
reliable detection and molecular typing methods to facilitate the control of this bacterium. 
An multilocus sequence typing scheme (MLST) has been established (Baldwin et al.2009) 
and is available as an open access internationally based database 
(http://www.pubMLST.org/cronobacter/). This is supported by international contributors 
and currently includes the profiles of >1000 strains and >100 whole genomes. The MLST 
scheme has advanced our understanding of the Cronobacter genus, revealing predominant 
and stable clones associated with neonatal meningitis. 
The clinical strains have been studied were from USA, Israel and the Czech Republic in 
which eleven sequence types (STs) were identified spanning the genus of Cronobacter. 
This analysis has contributed to a key aspect of the genus by identifing  a clonal lineage for 
a majority of the neonatal meningitis, NEC and bacteraemia cases- the C. sakazakii ST4 
clonal complex. This identification of ST4 clonal complex as the lineage responsible for 
the majority of fatal neonatal infection caused in Cronobacter spp. has reported  a unique 
molecular signature caused by microorganism. In addition this research reported the first 
meningitis case by Cronobacter malonaticus (CC112) which was from an infant (age <1 
month) with severe brain damage which led to their death. 
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 In the second part of this project, the functionality of sialic acid trait in C. sakazakii as well 
as the potential mechanisms of the pathogenicity in the neonatal brain were investigated. 
Laboratory studies have been published investigating the variation in growth in sialic acid 
of Cronobacter spp. of 19 Cronobacter strains were selected which represented the seven 
recognized species, and included those from reported clinical cases and species type 
strains. Initial results confirmed C. sakazakii is the only species able to utilize the sialic 
acid. During the late steps of the current project, 107 Cronobacter genomes were analysed 
to expand our research using Cronobacter PubMLST 
(http://www.pubMLST.org/cronobacter). As a result, some of Cronobacter turicensis 
strains were found to also encode the nanAKT cluster. For this reason the next step was to 
examine the growth of all the Cronobacter turicensis strains in our database. Ten out of 24 
(42%) have been growing in all the M9 supplemented with sialic acid substrates. Also the 
variation in the gene contents of Cronobacter associated with sialic acid utilization have 
been reported. As a result, the functionality of this trait in C. sakazakii and some strains of 
C. turiensis revealed the possible mechanisms of the pathogenicity in the neonatal brain 
and mucin. The high degree of colinearity of  the alignment between different genomes of 
Enterobacterice have been shown. Also the whole cluster is located in  a certain location 
flanked by some conserved housekeeping trait (gltB) and starvation gene (sspA) suggesting 
loss from other Cronobacter spp. instead of two separate acquisition events. 
Moreover, because of close adaptation of intracellular microorganism to the 
physiologically stable environments of their host cells, a reductive genome evolution 
happened that led to the loss of some genes not crucial for life within the host which is 
called evolution by reduction to  assume loss from other Cronobacter spp. instead of 
separate acquisition events.  
 
 Study of clinical strains of C. sakazakii have been used in order to gain a better 
understanding of bacterium pathogenicity. For this purpose in the beginning of my PhD 
study, 36 representative clinical strains, 23 were ST4 and 13 strains were non-ST4 strains 
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of which three strains were ST1, three strains were ST8 and two strains were ST12. A 
number of key traits such as plasmid profiling, PCR probes for virulence genes including 
Type six secretion system, iron acquisition system and Cronobacter plasminogen 
activator Cpa were found to be scattered across the C. sakazakii genus. Some of the 
virulence traits varied in their level of the diversity, and were also identified to be plasmid 
borne. This observation making the plasmids one of the obvious targets for future studies 
especially the strains lacking the large plasmid and encoding most of virulence genes 
such as strain 696 (ST12) isolated from a NECII case. Diversity of the physiological traits 
and in vitro tissue culture assay were being individually characterized by laboratory 
studies as part of PhD projects in our group, in order to gain a better understanding of the 
pathogenicity of the organism. C. sakazakii is a newly emerging pathogen, and 
understanding the mechanism of serum resistance could assist in clarifying the difference 
in resistance between the strains. In addition, this could also increase the information 
about this organism’s pathogenicity and present other potential methods of virulence. The 
chances of surviving and multiplying in human blood is present in the strains which have 
resistance against serum bactericidal activity and many virulence genes like the iron 
acquisition genes. This can result in increased pressure and organs could have collateral 
damage, particularly to the CNS since the bacterium has been known since long to have 
caused meninges and brain damage cases.  
Some factors of C. sakazakii virulence which increases the infection and the pathogenic 
process have been reviewed in this study. To result in a successful infection, it is important 
for C. sakazakii to have invasion potential. Different iron acquisition systems were 
encoded by 97% C. sakazakii  to attain iron from the host. They were also able to survive 
and spread in the host under a little supply of iron which is associated with a rise in 
virulence (Raymond et al.2003). Majority of C. sakazakii were serum resistance (32/36), 
and thus, they had the ability to survive in blood by preventing serum-mediated killing. 
Also, the organism can survive and even multiply inside macrophages. This will enable the 
development of bacteraemia through dissemination in the entire body and through 
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intracellular reproduction. Correlation between T6SS and virulence function in some of C. 
sakazakii has been detected in the most of clinical cases such as NECII and severe 
meningitis strains 696 (ST12), 5 (ST8), 553, 721, 1219, 1220, 1221, 1225, 1231, 1240, 
1251 (ST4). These results are being analysed by other member of our group includes host 
cell adhesion and invasion, cytotoxicity, and macrophage survival study.  
 
 It is believed C. sakazakii strains vary in plasmid profile and gene contents. Thus, some of 
the virulence traits need more investigation. the plasmid pESA3 as the largest plasmid 
which contains several potential virulence-associated traits have been chosen as well 
characterized plamid in this study. It was of interest to insert plasmid pESA3 as well 
characterized plasmid into plasmid less strain. Stains encoding large plasmid were able to 
invade human intestinal epithelial cells Caco-2, brain endothelial cells HBMEC and 
rBCEC4. Also have been reported significant observation in siderophore production and 
serum survival values whereas plasmid less strain and not shown less significant associated 
virulence. 
In summary, the impact of this research work to the existing knowledge of Cronobacter sakazakii 
are represented by the following: 
I. First to study the whole genus population to better understand how this microorganism 
could cause irreparable destruction to neonate brain. 
II. Determined the ability of this organism could help us to answer the destructive pathogenic 
mechanism of Cronobacter spp., that could afterward assistance to put better control 
procedures in place. 
III. Proved the capacity of some Cronobacter sakazakii strains to survive inside the brain, 
intestinal cell and blood as a result of the invasion process. 
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7.2  FUTURE DIRECTIONS 
Consequently, this is not the end of this research, now the Cronobacter MLST database contains 
records of 1007 isolates indicating the source, geographic and temporal diversity of the genus. Now 
genomes are available for further analysis in the PubMLST database. Different strains of 
Cronobacter have been isolated from 36 different states and from various sources. The huge study 
by Forsythe et al. (2014) was the end of the beginning to better understand this microorganism 
which can effect severe damage to a newborn baby’s brain. This research has also opened up many 
new ways into the investigation of this opportunistic food-borne bacterium, that could thereafter 
help to put improved control measures in place. 
 
I. The effect of the presence of a large plasmid of most significant STs (ST4) associated with 
virulence of C. sakazakii by transform the large plasmid into another sequence type strain 
such as ST12 and ST8 to determine of unique phenotypic characterization. 
II. To mutate (knock out) and functionally characterise selected virulence genes from those 
identified using bioinformatics analysis which could be involved in bacterial pathogenesis 
for example, genes responsible for siderophore production and nanAKT gene cluster of 
sialic acid utilization. These can be used to find mechanisms of invasion and spreading in 
the infected host and observe significant changes in the phenotypic traits including tissue 
culture of different cell lines and virulence associated behaviour. 
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